BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Nair H, Nokes DJ, Gessner BD, Dherani M, Madhi SA, Singleton RJ, O'Brien KL, Roca A, Wright PF, Bruce N, Chandran A, Theodoratou E, Sutanto A, Sedyaningsih ER, Ngama M, Munywoki PK, Kartasasmita C, Simões EA, Rudan I, Weber MW, Campbell H. Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis. Lancet 2010;375:1545-55. [PMID: 20399493 DOI: 10.1016/S0140-6736(10)60206-1] [Cited by in Crossref: 1677] [Cited by in F6Publishing: 1063] [Article Influence: 139.8] [Reference Citation Analysis]
Number Citing Articles
1 Paes BA, Mitchell I, Banerji A, Lanctôt KL, Langley JM. A decade of respiratory syncytial virus epidemiology and prophylaxis: translating evidence into everyday clinical practice. Can Respir J 2011;18:e10-9. [PMID: 21499597 DOI: 10.1155/2011/493056] [Cited by in Crossref: 43] [Cited by in F6Publishing: 40] [Article Influence: 4.3] [Reference Citation Analysis]
2 Jans J, Vissers M, Heldens JG, de Jonge MI, Levy O, Ferwerda G. Fc gamma receptors in respiratory syncytial virus infections: implications for innate immunity. Rev Med Virol 2014;24:55-70. [PMID: 24227634 DOI: 10.1002/rmv.1773] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
3 Bohmwald K, Espinoza JA, Rey-Jurado E, Gómez RS, González PA, Bueno SM, Riedel CA, Kalergis AM. Human Respiratory Syncytial Virus: Infection and Pathology. Semin Respir Crit Care Med 2016;37:522-37. [PMID: 27486734 DOI: 10.1055/s-0036-1584799] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 3.5] [Reference Citation Analysis]
4 Vanover D, Smith DV, Blanchard EL, Alonas E, Kirschman JL, Lifland AW, Zurla C, Santangelo PJ. RSV glycoprotein and genomic RNA dynamics reveal filament assembly prior to the plasma membrane. Nat Commun 2017;8:667. [PMID: 28939853 DOI: 10.1038/s41467-017-00732-z] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 3.6] [Reference Citation Analysis]
5 Elgizouli M, Logan C, Grychtol R, Rothenbacher D, Nieters A, Heinzmann A. Reduced PRF1 enhancer methylation in children with a history of severe RSV bronchiolitis in infancy: an association study. BMC Pediatr 2017;17:65. [PMID: 28253869 DOI: 10.1186/s12887-017-0817-9] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
6 Salimi V, Viegas M, Trento A, Agoti CN, Anderson LJ, Avadhanula V, Bahl J, Bont L, Brister JR, Cane PA, Galiano M, Graham BS, Hatcher EL, Hellferscee O, Henke DM, Hirve S, Jackson S, Keyaerts E, Kragten-Tabatabaie L, Lindstrom S, Nauwelaers I, Nokes DJ, Openshaw PJ, Peret TC, Piedra PA, Ramaekers K, Rector A, Trovão NS, von Gottberg A, Zambon M, Zhang W, Williams TC, Barr IG, Buchholz UJ. Proposal for Human Respiratory Syncytial Virus Nomenclature below the Species Level. Emerg Infect Dis 2021;27:1-9. [PMID: 34013862 DOI: 10.3201/eid2706.204608] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
7 Green RJ, Kolberg JM. Neonatal pneumonia in sub-Saharan Africa. Pneumonia (Nathan) 2016;8:3. [PMID: 28702283 DOI: 10.1186/s41479-016-0003-0] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
8 Sanchez-Luna M, Burgos-Pol R, Oyagüez I, Figueras-Aloy J, Sánchez-Solís M, Martinón-Torres F, Carbonell-Estrany X. Cost-utility analysis of Palivizumab for Respiratory Syncytial Virus infection prophylaxis in preterm infants: update based on the clinical evidence in Spain. BMC Infect Dis 2017;17:687. [PMID: 29041909 DOI: 10.1186/s12879-017-2803-0] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 2.8] [Reference Citation Analysis]
9 Manini MB, Matsunaga NY, Gianfrancesco L, Oliveira MS, Carvalho MRV, Ribeiro GLMT, Morais EO, Ribeiro MAGO, Morcillo AM, Ribeiro JD, Toro AADC. Risk factors for recurrent wheezing in preterm infants who received prophylaxis with palivizumab. J Bras Pneumol 2021;47:e20210157. [PMID: 34669834 DOI: 10.36416/1806-3756/e20210157] [Reference Citation Analysis]
10 Rodríguez DA, Rodríguez-Martínez CE, Cárdenas AC, Quilaguy IE, Mayorga LY, Falla LM, Nino G. Predictors of severity and mortality in children hospitalized with respiratory syncytial virus infection in a tropical region. Pediatr Pulmonol 2014;49:269-76. [PMID: 23401345 DOI: 10.1002/ppul.22781] [Cited by in Crossref: 47] [Cited by in F6Publishing: 42] [Article Influence: 5.2] [Reference Citation Analysis]
11 Rudraraju R, Jones BG, Sealy R, Surman SL, Hurwitz JL. Respiratory syncytial virus: current progress in vaccine development. Viruses 2013;5:577-94. [PMID: 23385470 DOI: 10.3390/v5020577] [Cited by in Crossref: 37] [Cited by in F6Publishing: 38] [Article Influence: 4.1] [Reference Citation Analysis]
12 Fan R, Fan C, Zhang J, Wen B, Lei Y, Liu C, Chen L, Liu W, Wang C, Qu X. Respiratory syncytial virus subtype ON1/NA1/BA9 predominates in hospitalized children with lower respiratory tract infections. J Med Virol 2017;89:213-21. [PMID: 27358012 DOI: 10.1002/jmv.24619] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 2.3] [Reference Citation Analysis]
13 Butt ML, Elliott L, Paes BA. Respiratory syncytial virus hospitalization and incurred morbidities the season after prophylaxis. Paediatr Child Health 2018;23:441-6. [PMID: 30374219 DOI: 10.1093/pch/pxy046] [Cited by in Crossref: 2] [Article Influence: 0.5] [Reference Citation Analysis]
14 Liu Y, Guo Y, Wang C, Li W, Lu J, Shen S, Xia H, He J, Qiu X. Association between temperature change and outpatient visits for respiratory tract infections among children in Guangzhou, China. Int J Environ Res Public Health 2015;12:439-54. [PMID: 25568973 DOI: 10.3390/ijerph120100439] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 3.7] [Reference Citation Analysis]
15 Restori KH, Srinivasa BT, Ward BJ, Fixman ED. Neonatal Immunity, Respiratory Virus Infections, and the Development of Asthma. Front Immunol 2018;9:1249. [PMID: 29915592 DOI: 10.3389/fimmu.2018.01249] [Cited by in Crossref: 26] [Cited by in F6Publishing: 22] [Article Influence: 6.5] [Reference Citation Analysis]
16 Malkin E, Yogev R, Abughali N, Sliman J, Wang CK, Zuo F, Yang CF, Eickhoff M, Esser MT, Tang RS, Dubovsky F. Safety and immunogenicity of a live attenuated RSV vaccine in healthy RSV-seronegative children 5 to 24 months of age. PLoS One 2013;8:e77104. [PMID: 24204744 DOI: 10.1371/journal.pone.0077104] [Cited by in Crossref: 60] [Cited by in F6Publishing: 56] [Article Influence: 6.7] [Reference Citation Analysis]
17 Paes B, Fauroux B, Figueras-Aloy J, Bont L, Checchia PA, Simões EA, Manzoni P, Carbonell-Estrany X. Defining the Risk and Associated Morbidity and Mortality of Severe Respiratory Syncytial Virus Infection Among Infants with Chronic Lung Disease. Infect Dis Ther 2016;5:453-71. [PMID: 27864751 DOI: 10.1007/s40121-016-0137-7] [Cited by in Crossref: 33] [Cited by in F6Publishing: 30] [Article Influence: 5.5] [Reference Citation Analysis]
18 Somayaji R, Goss CH, Khan U, Neradilek M, Neuzil KM, Ortiz JR. Cystic Fibrosis Pulmonary Exacerbations Attributable to Respiratory Syncytial Virus and Influenza: A Population-Based Study. Clin Infect Dis 2017;64:1760-7. [PMID: 28329304 DOI: 10.1093/cid/cix203] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 5.0] [Reference Citation Analysis]
19 Kenmoe S, Bigna JJ, Well EA, Simo FBN, Penlap VB, Vabret A, Njouom R. Prevalence of human respiratory syncytial virus infection in people with acute respiratory tract infections in Africa: A systematic review and meta-analysis. Influenza Other Respir Viruses 2018;12:793-803. [PMID: 29908103 DOI: 10.1111/irv.12584] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
20 Malinczak CA, Rasky AJ, Fonseca W, Schaller MA, Allen RM, Ptaschinski C, Morris S, Lukacs NW. Upregulation of H3K27 Demethylase KDM6 During Respiratory Syncytial Virus Infection Enhances Proinflammatory Responses and Immunopathology. J Immunol 2020;204:159-68. [PMID: 31748348 DOI: 10.4049/jimmunol.1900741] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 4.0] [Reference Citation Analysis]
21 McDermott DS, Weiss KA, Knudson CJ, Varga SM. Central role of dendritic cells in shaping the adaptive immune response during respiratory syncytial virus infection. Future Virol 2011;6:963-73. [PMID: 21887154 DOI: 10.2217/fvl.11.62] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 1.9] [Reference Citation Analysis]
22 Jorquera PA, Choi Y, Oakley KE, Powell TJ, Boyd JG, Palath N, Haynes LM, Anderson LJ, Tripp RA. Nanoparticle vaccines encompassing the respiratory syncytial virus (RSV) G protein CX3C chemokine motif induce robust immunity protecting from challenge and disease. PLoS One 2013;8:e74905. [PMID: 24040360 DOI: 10.1371/journal.pone.0074905] [Cited by in Crossref: 37] [Cited by in F6Publishing: 36] [Article Influence: 4.1] [Reference Citation Analysis]
23 Liu H, Lu B, Tabor DE, Tovchigrechko A, Wilkins D, Jin H, Madhi SA, Soofie N, Esser MT, Nunes MC. Characterization of human respiratory syncytial virus (RSV) isolated from HIV-exposed-uninfected and HIV-unexposed infants in South Africa during 2015-2017. Influenza Other Respir Viruses 2020;14:403-11. [PMID: 32126161 DOI: 10.1111/irv.12727] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
24 Ren J, Wu W, Zhang K, Choi EJ, Wang P, Ivanciuc T, Peniche A, Qian Y, Garofalo RP, Zhou J, Bao X. Exchange Protein Directly Activated by cAMP 2 Enhances Respiratory Syncytial Virus-Induced Pulmonary Disease in Mice. Front Immunol 2021;12:757758. [PMID: 34733289 DOI: 10.3389/fimmu.2021.757758] [Reference Citation Analysis]
25 Agoti CN, Mbisa JL, Bett A, Medley GF, Nokes DJ, Cane PA. Intrapatient variation of the respiratory syncytial virus attachment protein gene. J Virol 2010;84:10425-8. [PMID: 20660195 DOI: 10.1128/JVI.01181-10] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
26 Eichinger KM, Kosanovich JL, Gidwani SV, Zomback A, Lipp MA, Perkins TN, Oury TD, Petrovsky N, Marshall CP, Yondola MA, Empey KM. Prefusion RSV F Immunization Elicits Th2-Mediated Lung Pathology in Mice When Formulated With a Th2 (but Not a Th1/Th2-Balanced) Adjuvant Despite Complete Viral Protection. Front Immunol 2020;11:1673. [PMID: 32849580 DOI: 10.3389/fimmu.2020.01673] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 6.5] [Reference Citation Analysis]
27 Sloan C, Heaton M, Kang S, Berrett C, Wu P, Gebretsadik T, Sicignano N, Evans A, Lee R, Hartert T. The impact of temperature and relative humidity on spatiotemporal patterns of infant bronchiolitis epidemics in the contiguous United States. Health Place 2017;45:46-54. [PMID: 28285184 DOI: 10.1016/j.healthplace.2017.02.010] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
28 Chow WZ, Chan YF, Oong XY, Ng LJ, Nor'E SS, Ng KT, Chan KG, Hanafi NS, Pang YK, Kamarulzaman A, Tee KK. Genetic diversity, seasonality and transmission network of human metapneumovirus: identification of a unique sub-lineage of the fusion and attachment genes. Sci Rep 2016;6:27730. [PMID: 27279080 DOI: 10.1038/srep27730] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 4.0] [Reference Citation Analysis]
29 Meng J, Lee S, Hotard AL, Moore ML. Refining the balance of attenuation and immunogenicity of respiratory syncytial virus by targeted codon deoptimization of virulence genes. mBio 2014;5:e01704-14. [PMID: 25249281 DOI: 10.1128/mBio.01704-14] [Cited by in Crossref: 58] [Cited by in F6Publishing: 42] [Article Influence: 7.3] [Reference Citation Analysis]
30 Blau DM, Baillie VL, Els T, Mahtab S, Mutevedzi P, Keita AM, Kotloff KL, Mehta A, Sow SO, Tapia MD, Tippett Barr BA, Oluoch BO, Onyango C, Revathi G, Verani JR, Abayneh M, Assefa N, Madrid L, Oundo JO, Scott JAG, Bassat Q, Mandomando I, Sitoe A, Valente M, Varo R, Bassey IA, Cain CJ, Jambai A, Ogbuanu I, Ojulong J, Alam M, El Arifeen S, Gurley ES, Rahman A, Rahman M, Waller JL, Dewey B, Breiman RF, Whitney CG, Madhi SA; CHAMPS Consortium. Deaths Attributed to Respiratory Syncytial Virus in Young Children in High-Mortality Rate Settings: Report from Child Health and Mortality Prevention Surveillance (CHAMPS). Clin Infect Dis 2021;73:S218-28. [PMID: 34472577 DOI: 10.1093/cid/ciab509] [Reference Citation Analysis]
31 Turi KN, Romick-Rosendale L, Ryckman KK, Hartert TV. A review of metabolomics approaches and their application in identifying causal pathways of childhood asthma. J Allergy Clin Immunol 2018;141:1191-201. [PMID: 28479327 DOI: 10.1016/j.jaci.2017.04.021] [Cited by in Crossref: 38] [Cited by in F6Publishing: 33] [Article Influence: 7.6] [Reference Citation Analysis]
32 Li X, Li J, Meng L, Zhu W, Liu X, Yang M, Yu D, Niu L, Shen X. Viral etiologies and epidemiology of patients with acute respiratory infections based on sentinel hospitals in Gansu Province, Northwest China, 2011-2015. J Med Virol 2018;90:828-35. [PMID: 29388679 DOI: 10.1002/jmv.25040] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
33 Simpson MD, Kieke BA Jr, Sundaram ME, McClure DL, Meece JK, Sifakis F, Gasser RA Jr, Belongia EA. Incidence of Medically Attended Respiratory Syncytial Virus and Influenza Illnesses in Children 6-59 Months Old During Four Seasons. Open Forum Infect Dis 2016;3:ofw081. [PMID: 27419158 DOI: 10.1093/ofid/ofw081] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
34 Sloan CD, Gebretsadik T, Wu P, Carroll KN, Mitchel EF, Hartert TV. Spatiotemporal patterns of infant bronchiolitis in a Tennessee Medicaid population. Spat Spatiotemporal Epidemiol 2013;6:17-23. [PMID: 23956809 DOI: 10.1016/j.sste.2013.05.001] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
35 Caffarelli C, Santamaria F, Di Mauro D, Mastrorilli C, Montella S, Tchana B, Valerio G, Verrotti A, Valenzise M, Bernasconi S, Corsello G. Advances in pediatrics in 2017: current practices and challenges in allergy, endocrinology, gastroenterology, genetics, immunology, infectious diseases, neonatology, nephrology, neurology, pulmonology from the perspective of Italian Journal of Pediatrics. Ital J Pediatr 2018;44:82. [PMID: 30016966 DOI: 10.1186/s13052-018-0524-7] [Reference Citation Analysis]
36 Ren S, Shi T, Shan W, Shen S, Chen Q, Zhang W, Dai Z, Xue J, Zhang T, Tian J, Zhao G. Hospitalization rate of respiratory syncytial virus-associated acute lower respiratory infection among young children in Suzhou, China, 2010-2014. Influenza Other Respir Viruses 2022. [PMID: 34989118 DOI: 10.1111/irv.12958] [Reference Citation Analysis]
37 Onyango CO, Njeru R, Kazungu S, Achilla R, Bulimo W, Welch SR, Cane PA, Gunson RN, Hammitt LL, Scott JA, Berkley JA, Nokes DJ. Influenza surveillance among children with pneumonia admitted to a district hospital in coastal Kenya, 2007-2010. J Infect Dis 2012;206 Suppl 1:S61-7. [PMID: 23169974 DOI: 10.1093/infdis/jis536] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 2.3] [Reference Citation Analysis]
38 Xu J, Wu W, Chen H, Xue Y, Bao X, Zhou J. Substituted N-(4-amino-2-chlorophenyl)-5-chloro-2-hydroxybenzamide analogues potently inhibit respiratory syncytial virus (RSV) replication and RSV infection-associated inflammatory responses. Bioorg Med Chem 2021;39:116157. [PMID: 33895704 DOI: 10.1016/j.bmc.2021.116157] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
39 Amanna IJ, Slifka MK. Successful Vaccines. Curr Top Microbiol Immunol 2020;428:1-30. [PMID: 30046984 DOI: 10.1007/82_2018_102] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
40 Walpita P, Johns LM, Tandon R, Moore ML. Mammalian Cell-Derived Respiratory Syncytial Virus-Like Particles Protect the Lower as well as the Upper Respiratory Tract. PLoS One 2015;10:e0130755. [PMID: 26172453 DOI: 10.1371/journal.pone.0130755] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
41 Bermingham IM, Chappell KJ, Watterson D, Young PR. The Heptad Repeat C Domain of the Respiratory Syncytial Virus Fusion Protein Plays a Key Role in Membrane Fusion. J Virol 2018;92:e01323-17. [PMID: 29212939 DOI: 10.1128/JVI.01323-17] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
42 Reeves RM, Hardelid P, Gilbert R, Warburton F, Ellis J, Pebody RG. Estimating the burden of respiratory syncytial virus (RSV) on respiratory hospital admissions in children less than five years of age in England, 2007-2012. Influenza Other Respir Viruses 2017;11:122-9. [PMID: 28058797 DOI: 10.1111/irv.12443] [Cited by in Crossref: 36] [Cited by in F6Publishing: 35] [Article Influence: 7.2] [Reference Citation Analysis]
43 Murphy C, MacLeod WB, Forman LS, Mwananyanda L, Kwenda G, Pieciak RC, Mupila Z, Thea D, Chikoti C, Yankonde B, Ngoma B, Chimoga C, Gill CJ. Risk Factors for Respiratory Syncytial Virus-Associated Community Deaths in Zambian Infants. Clin Infect Dis 2021;73:S187-92. [PMID: 34472570 DOI: 10.1093/cid/ciab453] [Reference Citation Analysis]
44 Simpson J, Lynch JP, Loh Z, Zhang V, Werder RB, Spann K, Phipps S. The Absence of Interferon-β Promotor Stimulator-1 (IPS-1) Predisposes to Bronchiolitis and Asthma-like Pathology in Response to Pneumoviral Infection in Mice. Sci Rep 2017;7:2353. [PMID: 28539639 DOI: 10.1038/s41598-017-02564-9] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
45 Picot VS, Bénet T, Messaoudi M, Telles JN, Chou M, Eap T, Wang J, Shen K, Pape JW, Rouzier V, Awasthi S, Pandey N, Bavdekar A, Sanghvi S, Robinson A, Contamin B, Hoffmann J, Sylla M, Diallo S, Nymadawa P, Dash-Yandag B, Russomando G, Basualdo W, Siqueira MM, Barreto P, Komurian-Pradel F, Vernet G, Endtz H, Vanhems P, Paranhos-Baccalà G; pneumonia GABRIEL network. Multicenter case-control study protocol of pneumonia etiology in children: Global Approach to Biological Research, Infectious diseases and Epidemics in Low-income countries (GABRIEL network). BMC Infect Dis 2014;14:635. [PMID: 25927410 DOI: 10.1186/s12879-014-0635-8] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 2.8] [Reference Citation Analysis]
46 Mauskopf J, Margulis AV, Samuel M, Lohr KN. Respiratory Syncytial Virus Hospitalizations in Healthy Preterm Infants: Systematic Review. Pediatr Infect Dis J 2016;35:e229-38. [PMID: 27093166 DOI: 10.1097/INF.0000000000001163] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 4.2] [Reference Citation Analysis]
47 Adiku TK, Asmah RH, Rodrigues O, Goka B, Obodai E, Adjei AA, Donkor ES, Armah G. Aetiology of Acute Lower Respiratory Infections among Children Under Five Years in Accra, Ghana. Pathogens 2015;4:22-33. [PMID: 25629622 DOI: 10.3390/pathogens4010022] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
48 Sande CJ, Mutunga MN, Medley GF, Cane PA, Nokes DJ. Group- and genotype-specific neutralizing antibody responses against respiratory syncytial virus in infants and young children with severe pneumonia. J Infect Dis 2013;207:489-92. [PMID: 23175761 DOI: 10.1093/infdis/jis700] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 2.7] [Reference Citation Analysis]
49 Kovacs SD, Mullholland K, Bosch J, Campbell H, Forouzanfar MH, Khalil I, Lim S, Liu L, Maley SN, Mathers CD, Matheson A, Mokdad AH, O'Brien K, Parashar U, Schaafsma TT, Steele D, Hawes SE, Grove JT. Deconstructing the differences: a comparison of GBD 2010 and CHERG's approach to estimating the mortality burden of diarrhea, pneumonia, and their etiologies. BMC Infect Dis 2015;15:16. [PMID: 25592774 DOI: 10.1186/s12879-014-0728-4] [Cited by in Crossref: 33] [Cited by in F6Publishing: 30] [Article Influence: 4.7] [Reference Citation Analysis]
50 Currie SM, Gwyer Findlay E, McFarlane AJ, Fitch PM, Böttcher B, Colegrave N, Paras A, Jozwik A, Chiu C, Schwarze J, Davidson DJ. Cathelicidins Have Direct Antiviral Activity against Respiratory Syncytial Virus In Vitro and Protective Function In Vivo in Mice and Humans. J Immunol 2016;196:2699-710. [PMID: 26873992 DOI: 10.4049/jimmunol.1502478] [Cited by in Crossref: 72] [Cited by in F6Publishing: 71] [Article Influence: 12.0] [Reference Citation Analysis]
51 Hirsch HH, Martino R, Ward KN, Boeckh M, Einsele H, Ljungman P. Fourth European Conference on Infections in Leukaemia (ECIL-4): guidelines for diagnosis and treatment of human respiratory syncytial virus, parainfluenza virus, metapneumovirus, rhinovirus, and coronavirus. Clin Infect Dis. 2013;56:258-266. [PMID: 23024295 DOI: 10.1093/cid/cis844] [Cited by in Crossref: 201] [Cited by in F6Publishing: 164] [Article Influence: 20.1] [Reference Citation Analysis]
52 Openshaw PJ, Chiu C. Protective and dysregulated T cell immunity in RSV infection. Curr Opin Virol 2013;3:468-74. [PMID: 23806514 DOI: 10.1016/j.coviro.2013.05.005] [Cited by in Crossref: 69] [Cited by in F6Publishing: 68] [Article Influence: 7.7] [Reference Citation Analysis]
53 Chahar HS, Corsello T, Kudlicki AS, Komaravelli N, Casola A. Respiratory Syncytial Virus Infection Changes Cargo Composition of Exosome Released from Airway Epithelial Cells. Sci Rep 2018;8:387. [PMID: 29321591 DOI: 10.1038/s41598-017-18672-5] [Cited by in Crossref: 39] [Cited by in F6Publishing: 37] [Article Influence: 9.8] [Reference Citation Analysis]
54 Chen H, Weng H, Lin M, He P, Li Y, Xie Q, Ke C, Jiao X. The Clinical Significance of FilmArray Respiratory Panel in Diagnosing Community-Acquired Pneumonia. Biomed Res Int 2017;2017:7320859. [PMID: 29018819 DOI: 10.1155/2017/7320859] [Cited by in Crossref: 14] [Cited by in F6Publishing: 18] [Article Influence: 2.8] [Reference Citation Analysis]
55 Bashir U, Alam MM, Sadia H, Zaidi SS, Kazi BM. Molecular characterization of circulating respiratory syncytial virus (RSV) genotypes in Gilgit Baltistan Province of Pakistan during 2011-2012 winter season. PLoS One 2013;8:e74018. [PMID: 24058513 DOI: 10.1371/journal.pone.0074018] [Cited by in Crossref: 29] [Cited by in F6Publishing: 32] [Article Influence: 3.2] [Reference Citation Analysis]
56 McGill JL, Kelly SM, Guerra-Maupome M, Winkley E, Henningson J, Narasimhan B, Sacco RE. Vitamin A deficiency impairs the immune response to intranasal vaccination and RSV infection in neonatal calves. Sci Rep 2019;9:15157. [PMID: 31641172 DOI: 10.1038/s41598-019-51684-x] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 7.7] [Reference Citation Analysis]
57 Perron M, Stray K, Kinkade A, Theodore D, Lee G, Eisenberg E, Sangi M, Gilbert BE, Jordan R, Piedra PA, Toms GL, Mackman R, Cihlar T. GS-5806 Inhibits a Broad Range of Respiratory Syncytial Virus Clinical Isolates by Blocking the Virus-Cell Fusion Process. Antimicrob Agents Chemother 2015;60:1264-73. [PMID: 26666922 DOI: 10.1128/AAC.01497-15] [Cited by in Crossref: 52] [Cited by in F6Publishing: 24] [Article Influence: 7.4] [Reference Citation Analysis]
58 Matias G, Taylor R, Haguinet F, Schuck-Paim C, Lustig R, Shinde V. Estimates of hospitalization attributable to influenza and RSV in the US during 1997-2009, by age and risk status. BMC Public Health 2017;17:271. [PMID: 28320361 DOI: 10.1186/s12889-017-4177-z] [Cited by in Crossref: 51] [Cited by in F6Publishing: 48] [Article Influence: 10.2] [Reference Citation Analysis]
59 Awad S, Hatim R, Khader Y, Alyahya M, Harik N, Rawashdeh A, Qudah W, Khasawneh R, Hayajneh W, Yusef D. Bronchiolitis clinical practice guidelines implementation: surveillance study of hospitalized children in Jordan. Multidiscip Respir Med 2020;15:673. [PMID: 33117531 DOI: 10.4081/mrm.2020.673] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
60 Schmidt ME, Varga SM. Identification of Novel Respiratory Syncytial Virus CD4+ and CD8+ T Cell Epitopes in C57BL/6 Mice. Immunohorizons 2019;3:1-12. [PMID: 31356172 DOI: 10.4049/immunohorizons.1800056] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
61 Muenchhoff M, Goulder PJ. Sex differences in pediatric infectious diseases. J Infect Dis 2014;209 Suppl 3:S120-6. [PMID: 24966192 DOI: 10.1093/infdis/jiu232] [Cited by in Crossref: 140] [Cited by in F6Publishing: 131] [Article Influence: 17.5] [Reference Citation Analysis]
62 Ortiz JR, Neuzil KM, Shay DK, Rue TC, Neradilek MB, Zhou H, Seymour CW, Hooper LG, Cheng PY, Goss CH, Cooke CR. The burden of influenza-associated critical illness hospitalizations. Crit Care Med 2014;42:2325-32. [PMID: 25148596 DOI: 10.1097/CCM.0000000000000545] [Cited by in Crossref: 43] [Cited by in F6Publishing: 31] [Article Influence: 5.4] [Reference Citation Analysis]
63 Nyoka R, Omony J, Mwalili SM, Achia TNO, Gichangi A, Mwambi H. Effect of climate on incidence of respiratory syncytial virus infections in a refugee camp in Kenya: A non-Gaussian time-series analysis. PLoS One 2017;12:e0178323. [PMID: 28570627 DOI: 10.1371/journal.pone.0178323] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.4] [Reference Citation Analysis]
64 Lorenzo VB, Nascimento-Carvalho CM. Differences between children with severe acute lower respiratory infection with or without SARS-Cov-2 infection. J Infect 2021;83:e1-3. [PMID: 34090916 DOI: 10.1016/j.jinf.2021.05.038] [Reference Citation Analysis]
65 Hatanaka M, Miyamura T, Koh K, Taga T, Tawa A, Hasegawa D, Kajihara R, Adachi S, Ishii E, Tomizawa D. Respiratory syncytial virus infection in infants with acute leukemia: a retrospective survey of the Japanese Pediatric Leukemia/Lymphoma Study Group. Int J Hematol 2015;102:697-701. [PMID: 26520649 DOI: 10.1007/s12185-015-1890-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
66 Brock LG, Liu X, Liang B, Lingemann M, Liu X, Herbert R, Hackenberg AD, Buchholz UJ, Collins PL, Munir S. Murine Pneumonia Virus Expressing the Fusion Glycoprotein of Human Respiratory Syncytial Virus from an Added Gene Is Highly Attenuated and Immunogenic in Rhesus Macaques. J Virol 2018;92:e00723-18. [PMID: 29925656 DOI: 10.1128/JVI.00723-18] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
67 Zhang Q, Guo Z, Langley JM, Bai Z. Respiratory syncytial virus-associated intensive care unit admission in children in Southern China. BMC Res Notes 2013;6:447. [PMID: 24206961 DOI: 10.1186/1756-0500-6-447] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
68 Garofalo RP, Kolli D, Casola A. Respiratory syncytial virus infection: mechanisms of redox control and novel therapeutic opportunities. Antioxid Redox Signal 2013;18:186-217. [PMID: 22799599 DOI: 10.1089/ars.2011.4307] [Cited by in F6Publishing: 49] [Reference Citation Analysis]
69 Lamarão LM, Ramos FL, Mello WA, Santos MC, Barbagelata LS, Justino MC, da Silva AF, Quaresma AJ, da Silva VB, Burbano RR, Linhares AC. Prevalence and clinical features of respiratory syncytial virus in children hospitalized for community-acquired pneumonia in northern Brazil. BMC Infect Dis 2012;12:119. [PMID: 22591236 DOI: 10.1186/1471-2334-12-119] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 2.1] [Reference Citation Analysis]
70 Ayeni OA, Walaza S, Tempia S, Groome M, Kahn K, Madhi SA, Cohen AL, Moyes J, Venter M, Pretorius M, Treurnicht F, Hellferscee O, von Gottberg A, Wolter N, Cohen C. Mortality in children aged <5 years with severe acute respiratory illness in a high HIV-prevalence urban and rural areas of South Africa, 2009-2013. PLoS One 2021;16:e0255941. [PMID: 34383824 DOI: 10.1371/journal.pone.0255941] [Reference Citation Analysis]
71 Root ED, Lucero M, Nohynek H, Anthamatten P, Thomas DS, Tallo V, Tanskanen A, Quiambao BP, Puumalainen T, Lupisan SP, Ruutu P, Ladesma E, Williams GM, Riley I, Simões EA. Distance to health services affects local-level vaccine efficacy for pneumococcal conjugate vaccine (PCV) among rural Filipino children. Proc Natl Acad Sci U S A 2014;111:3520-5. [PMID: 24550454 DOI: 10.1073/pnas.1313748111] [Cited by in Crossref: 11] [Cited by in F6Publishing: 14] [Article Influence: 1.4] [Reference Citation Analysis]
72 Kapikian AZ, Morens DM, Fauci AS. In Memoriam: Robert M. Chanock, MD, 1924–2010. J Infect Dis 2011;203:3-5. [PMID: 21998882 DOI: 10.1093/infdis/jiq019] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
73 McLellan JS, Yang Y, Graham BS, Kwong PD. Structure of respiratory syncytial virus fusion glycoprotein in the postfusion conformation reveals preservation of neutralizing epitopes. J Virol 2011;85:7788-96. [PMID: 21613394 DOI: 10.1128/JVI.00555-11] [Cited by in Crossref: 257] [Cited by in F6Publishing: 189] [Article Influence: 23.4] [Reference Citation Analysis]
74 Martínez I, Oliveros JC, Cuesta I, de la Barrera J, Ausina V, Casals C, de Lorenzo A, García E, García-Fojeda B, Garmendia J, González-Nicolau M, Lacoma A, Menéndez M, Moranta D, Nieto A, Ortín J, Pérez-González A, Prat C, Ramos-Sevillano E, Regueiro V, Rodriguez-Frandsen A, Solís D, Yuste J, Bengoechea JA, Melero JA. Apoptosis, Toll-like, RIG-I-like and NOD-like Receptors Are Pathways Jointly Induced by Diverse Respiratory Bacterial and Viral Pathogens. Front Microbiol 2017;8:276. [PMID: 28298903 DOI: 10.3389/fmicb.2017.00276] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 3.2] [Reference Citation Analysis]
75 Outlaw VK, Kreitler DF, Stelitano D, Porotto M, Moscona A, Gellman SH. Effects of Single α-to-β Residue Replacements on Recognition of an Extended Segment in a Viral Fusion Protein. ACS Infect Dis 2020;6:2017-22. [PMID: 32692914 DOI: 10.1021/acsinfecdis.0c00385] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
76 Flynn JA, Durr E, Swoyer R, Cejas PJ, Horton MS, Galli JD, Cosmi SA, Espeseth AS, Bett AJ, Zhang L. Stability Characterization of a Vaccine Antigen Based on the Respiratory Syncytial Virus Fusion Glycoprotein. PLoS One 2016;11:e0164789. [PMID: 27764150 DOI: 10.1371/journal.pone.0164789] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
77 Galván JM, Rajas O, Aspa J. Review of Non-Bacterial Infections in Respiratory Medicine: Viral Pneumonia. Arch Bronconeumol 2015;51:590-7. [PMID: 25957460 DOI: 10.1016/j.arbres.2015.02.015] [Cited by in Crossref: 10] [Cited by in F6Publishing: 14] [Article Influence: 1.4] [Reference Citation Analysis]
78 Bradley BD, Howie SR, Chan TC, Cheng YL. Estimating oxygen needs for childhood pneumonia in developing country health systems: a new model for expecting the unexpected. PLoS One 2014;9:e89872. [PMID: 24587089 DOI: 10.1371/journal.pone.0089872] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
79 Paynter S, Yakob L, Simões EA, Lucero MG, Tallo V, Nohynek H, Ware RS, Weinstein P, Williams G, Sly PD. Using mathematical transmission modelling to investigate drivers of respiratory syncytial virus seasonality in children in the Philippines. PLoS One 2014;9:e90094. [PMID: 24587222 DOI: 10.1371/journal.pone.0090094] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 2.4] [Reference Citation Analysis]
80 van Diepen A, Brand HK, de Waal L, Bijl M, Jong VL, Kuiken T, van Amerongen G, van den Ham HJ, Eijkemans MJ, Osterhaus AD, Hermans PW, Andeweg AC. Host proteome correlates of vaccine-mediated enhanced disease in a mouse model of respiratory syncytial virus infection. J Virol 2015;89:5022-31. [PMID: 25694607 DOI: 10.1128/JVI.03630-14] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
81 Tahamtan A, Samieipoor Y, Nayeri FS, Rahbarimanesh AA, Izadi A, Rashidi-Nezhad A, Tavakoli-Yaraki M, Farahmand M, Bont L, Shokri F, Mokhatri-Azad T, Salimi V. Effects of cannabinoid receptor type 2 in respiratory syncytial virus infection in human subjects and mice. Virulence 2018;9:217-30. [PMID: 28992427 DOI: 10.1080/21505594.2017.1389369] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 6.0] [Reference Citation Analysis]
82 Katzov-Eckert H, Botosso VF, Neto EA, Zanotto PM; VGND consortium. Phylodynamics and dispersal of HRSV entails its permanence in the general population in between yearly outbreaks in children. PLoS One 2012;7:e41953. [PMID: 23077477 DOI: 10.1371/journal.pone.0041953] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 1.6] [Reference Citation Analysis]
83 Schepp RM, de Haan CAM, Wilkins D, Layman H, Graham BS, Esser MT, Berbers GAM. Development and Standardization of a High-Throughput Multiplex Immunoassay for the Simultaneous Quantification of Specific Antibodies to Five Respiratory Syncytial Virus Proteins. mSphere 2019;4:e00236-19. [PMID: 31019002 DOI: 10.1128/mSphere.00236-19] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]
84 Mitchell JA, Cardwell JM, Renshaw RW, Dubovi EJ, Brownlie J. Detection of canine pneumovirus in dogs with canine infectious respiratory disease. J Clin Microbiol 2013;51:4112-9. [PMID: 24088858 DOI: 10.1128/JCM.02312-13] [Cited by in Crossref: 20] [Cited by in F6Publishing: 12] [Article Influence: 2.2] [Reference Citation Analysis]
85 Ison MG, Hirsch HH. Community-Acquired Respiratory Viruses in Transplant Patients: Diversity, Impact, Unmet Clinical Needs. Clin Microbiol Rev 2019;32:e00042-19. [PMID: 31511250 DOI: 10.1128/CMR.00042-19] [Cited by in Crossref: 41] [Cited by in F6Publishing: 21] [Article Influence: 13.7] [Reference Citation Analysis]
86 Fauroux B, Simões EAF, Checchia PA, Paes B, Figueras-Aloy J, Manzoni P, Bont L, Carbonell-Estrany X. The Burden and Long-term Respiratory Morbidity Associated with Respiratory Syncytial Virus Infection in Early Childhood. Infect Dis Ther 2017;6:173-97. [PMID: 28357706 DOI: 10.1007/s40121-017-0151-4] [Cited by in Crossref: 65] [Cited by in F6Publishing: 58] [Article Influence: 13.0] [Reference Citation Analysis]
87 Jamrozik E, Heriot G, Bull S, Parker M; Oxford-Johns Hopkins Global Infectious Disease Ethics (GLIDE). Vaccine-enhanced disease: case studies and ethical implications for research and public health. Wellcome Open Res 2021;6:154. [PMID: 34235275 DOI: 10.12688/wellcomeopenres.16849.1] [Reference Citation Analysis]
88 van den Berg E, Bal SM, Kuipers MT, Matute-Bello G, Lutter R, Bos AP, van Woensel JB, Bem RA. The caspase inhibitor zVAD increases lung inflammation in pneumovirus infection in mice. Physiol Rep 2015;3:e12332. [PMID: 25780096 DOI: 10.14814/phy2.12332] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
89 Steff AM, Monroe J, Friedrich K, Chandramouli S, Nguyen TL, Tian S, Vandepaer S, Toussaint JF, Carfi A. Pre-fusion RSV F strongly boosts pre-fusion specific neutralizing responses in cattle pre-exposed to bovine RSV. Nat Commun 2017;8:1085. [PMID: 29057917 DOI: 10.1038/s41467-017-01092-4] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 3.2] [Reference Citation Analysis]
90 Weinberger DM, Warren JL, Steiner CA, Charu V, Viboud C, Pitzer VE. Reduced-Dose Schedule of Prophylaxis Based on Local Data Provides Near-Optimal Protection Against Respiratory Syncytial Virus. Clin Infect Dis 2015;61:506-14. [PMID: 25904370 DOI: 10.1093/cid/civ331] [Cited by in Crossref: 14] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
91 Wagatsuma K, Koolhof IS, Shobugawa Y, Saito R. Shifts in the epidemic season of human respiratory syncytial virus associated with inbound overseas travelers and meteorological conditions in Japan, 2014-2017: An ecological study. PLoS One 2021;16:e0248932. [PMID: 33765037 DOI: 10.1371/journal.pone.0248932] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
92 Vereen S, Gebretsadik T, Johnson N, Hartman TJ, Veeranki SP, Piyathilake C, Mitchel EF, Kocak M, Cooper WO, Dupont WD, Tylavsky F, Carroll KN. Association Between Maternal 2nd Trimester Plasma Folate Levels and Infant Bronchiolitis. Matern Child Health J 2019;23:164-72. [PMID: 30027465 DOI: 10.1007/s10995-018-2610-2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
93 Shirey KA, Lai W, Pletneva LM, Finkelman FD, Feola DJ, Blanco JC, Vogel SN. Agents that increase AAM differentiation blunt RSV-mediated lung pathology. J Leukoc Biol 2014;96:951-5. [PMID: 25009233 DOI: 10.1189/jlb.4HI0414-226R] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
94 Zhong Q, Feng H, Lu Q, Liu X, Zhao Q, Du Y, Zhang XH, Wang JR. Recurrent wheezing in neonatal pneumonia is associated with combined infection with Respiratory Syncytial Virus and Staphylococcus aureus or Klebsiella pneumoniae. Sci Rep 2018;8:995. [PMID: 29343795 DOI: 10.1038/s41598-018-19386-y] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
95 Stein RT, Bont LJ, Zar H, Polack FP, Park C, Claxton A, Borok G, Butylkova Y, Wegzyn C. Respiratory syncytial virus hospitalization and mortality: Systematic review and meta-analysis. Pediatr Pulmonol 2017;52:556-69. [PMID: 27740723 DOI: 10.1002/ppul.23570] [Cited by in Crossref: 106] [Cited by in F6Publishing: 101] [Article Influence: 17.7] [Reference Citation Analysis]
96 Sun Z, Pan Y, Jiang S, Lu L. Respiratory syncytial virus entry inhibitors targeting the F protein. Viruses 2013;5:211-25. [PMID: 23325327 DOI: 10.3390/v5010211] [Cited by in Crossref: 49] [Cited by in F6Publishing: 46] [Article Influence: 5.4] [Reference Citation Analysis]
97 Emukule GO, Khagayi S, McMorrow ML, Ochola R, Otieno N, Widdowson MA, Ochieng M, Feikin DR, Katz MA, Mott JA. The burden of influenza and RSV among inpatients and outpatients in rural western Kenya, 2009-2012. PLoS One 2014;9:e105543. [PMID: 25133576 DOI: 10.1371/journal.pone.0105543] [Cited by in Crossref: 51] [Cited by in F6Publishing: 50] [Article Influence: 6.4] [Reference Citation Analysis]
98 De Baets S, Schepens B, Sedeyn K, Schotsaert M, Roose K, Bogaert P, Fiers W, Saelens X. Recombinant influenza virus carrying the respiratory syncytial virus (RSV) F85-93 CTL epitope reduces RSV replication in mice. J Virol 2013;87:3314-23. [PMID: 23302879 DOI: 10.1128/JVI.03019-12] [Cited by in Crossref: 24] [Cited by in F6Publishing: 16] [Article Influence: 2.7] [Reference Citation Analysis]
99 Passmore C, Makidon PE, O'Konek JJ, Zahn JA, Pannu J, Hamouda T, Bitko V, Myc A, Lukacs NW, Fattom A, Baker JR Jr. Intranasal immunization with W 80 5EC adjuvanted recombinant RSV rF-ptn enhances clearance of respiratory syncytial virus in a mouse model. Hum Vaccin Immunother 2014;10:615-22. [PMID: 24326268 DOI: 10.4161/hv.27383] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.2] [Reference Citation Analysis]
100 Zomer-Kooijker K, van der Ent CK, Ermers MJ, Uiterwaal CS, Rovers MM, Bont LJ; RSV Corticosteroid Study Group. Increased risk of wheeze and decreased lung function after respiratory syncytial virus infection. PLoS One 2014;9:e87162. [PMID: 24498037 DOI: 10.1371/journal.pone.0087162] [Cited by in Crossref: 68] [Cited by in F6Publishing: 63] [Article Influence: 8.5] [Reference Citation Analysis]
101 Park S, Lee Y, Michelow IC, Choe YJ. Global Seasonality of Human Coronaviruses: A Systematic Review. Open Forum Infect Dis 2020;7:ofaa443. [PMID: 33204751 DOI: 10.1093/ofid/ofaa443] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
102 Touzelet O, Broadbent L, Armstrong SD, Aljabr W, Cloutman-Green E, Power UF, Hiscox JA. The Secretome Profiling of a Pediatric Airway Epithelium Infected with hRSV Identified Aberrant Apical/Basolateral Trafficking and Novel Immune Modulating (CXCL6, CXCL16, CSF3) and Antiviral (CEACAM1) Proteins. Mol Cell Proteomics 2020;19:793-807. [PMID: 32075873 DOI: 10.1074/mcp.RA119.001546] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
103 Banerji A, Panzov V, Young M, Lee BE, Mamdani M, Giles BL, Dennis M, Morel J, Bisson D, Paes BA, Hui C, Mahony J. The real-life effectiveness of palivizumab for reducing hospital admissions for respiratory syncytial virus in infants residing in Nunavut. Can Respir J 2014;21:185-9. [PMID: 24367792 DOI: 10.1155/2014/941367] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.2] [Reference Citation Analysis]
104 Lee YN, Hwang HS, Kim MC, Lee YT, Kim YJ, Lee FE, Kang SM. Protection against respiratory syncytial virus by inactivated influenza virus carrying a fusion protein neutralizing epitope in a chimeric hemagglutinin. Nanomedicine 2016;12:759-70. [PMID: 26656630 DOI: 10.1016/j.nano.2015.11.007] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
105 Xue M, Zhang Y, Wang H, Kairis EL, Lu M, Ahmad S, Attia Z, Harder O, Zhang Z, Wei J, Chen P, Gao Y, Peeples ME, Sharma A, Boyaka P, He C, Hur S, Niewiesk S, Li J. Viral RNA N6-methyladenosine modification modulates both innate and adaptive immune responses of human respiratory syncytial virus. PLoS Pathog 2021;17:e1010142. [PMID: 34929018 DOI: 10.1371/journal.ppat.1010142] [Reference Citation Analysis]
106 Karron RA, Thumar B, Schappell E, Buchholz UJ, Collins PL. Attenuation of live respiratory syncytial virus vaccines is associated with reductions in levels of nasal cytokines. J Infect Dis 2013;207:1773-9. [PMID: 23482643 DOI: 10.1093/infdis/jit089] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
107 Rudan I, O'Brien KL, Nair H, Liu L, Theodoratou E, Qazi S, Lukšić I, Fischer Walker CL, Black RE, Campbell H; Child Health Epidemiology Reference Group (CHERG). Epidemiology and etiology of childhood pneumonia in 2010: estimates of incidence, severe morbidity, mortality, underlying risk factors and causative pathogens for 192 countries. J Glob Health 2013;3:010401. [PMID: 23826505 DOI: 10.7189/jogh.03.010401] [Cited by in F6Publishing: 212] [Reference Citation Analysis]
108 Kamigaki T, Aldey PP, Mercado ES, Tan AG, Javier JB, Lupisan SP, Oshitani H, Tallo VL. Estimates of influenza and respiratory syncytial virus incidences with fraction modeling approach in Baguio City, the Philippines, 2012-2014. Influenza Other Respir Viruses 2017;11:311-8. [PMID: 28371393 DOI: 10.1111/irv.12453] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
109 Zohar T, Hsiao JC, Mehta N, Das J, Devadhasan A, Karpinski W, Callahan C, Citron MP, DiStefano DJ, Touch S, Wen Z, Sachs JR, Cejas PJ, Espeseth AS, Lauffenburger DA, Bett AJ, Alter G. Upper and lower respiratory tract correlates of protection against respiratory syncytial virus following vaccination of nonhuman primates. Cell Host Microbe 2021:S1931-3128(21)00512-6. [PMID: 34879230 DOI: 10.1016/j.chom.2021.11.006] [Reference Citation Analysis]
110 Niewiesk S. Maternal antibodies: clinical significance, mechanism of interference with immune responses, and possible vaccination strategies. Front Immunol 2014;5:446. [PMID: 25278941 DOI: 10.3389/fimmu.2014.00446] [Cited by in Crossref: 219] [Cited by in F6Publishing: 202] [Article Influence: 27.4] [Reference Citation Analysis]
111 Divarathne MVM, Ahamed RR, Noordeen F. The Impact of RSV-Associated Respiratory Disease on Children in Asia. J Pediatr Infect Dis 2019;14:79-88. [PMID: 32300274 DOI: 10.1055/s-0038-1637752] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
112 Makari D, Jensen KM, Harris B, Jafri HS. Randomized, Double-Blind Study of the Safety of the Liquid Versus Lyophilized Formulation of Palivizumab in Premature Infants and Children with Chronic Lung Disease of Prematurity. Infect Dis Ther 2014;3:339-47. [PMID: 25156956 DOI: 10.1007/s40121-014-0033-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
113 Nair H, Verma VR, Theodoratou E, Zgaga L, Huda T, Simões EA, Wright PF, Rudan I, Campbell H. An evaluation of the emerging interventions against Respiratory Syncytial Virus (RSV)-associated acute lower respiratory infections in children. BMC Public Health 2011;11 Suppl 3:S30. [PMID: 21501449 DOI: 10.1186/1471-2458-11-S3-S30] [Cited by in Crossref: 43] [Cited by in F6Publishing: 26] [Article Influence: 3.9] [Reference Citation Analysis]
114 Zhang D, Morse S, Kambhamptati U, Li B. Evolving Corporate Social Responsibility in China. Sustainability 2014;6:7646-65. [DOI: 10.3390/su6117646] [Cited by in Crossref: 11] [Article Influence: 1.4] [Reference Citation Analysis]
115 Weisshaar M, Cox R, Plemper RK. Blocking Respiratory Syncytial Virus Entry: A Story with Twists. DNA Cell Biol 2015;34:505-10. [PMID: 25961744 DOI: 10.1089/dna.2015.2896] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
116 Joyce MG, Bao A, Chen M, Georgiev IS, Ou L, Bylund T, Druz A, Kong WP, Peng D, Rundlet EJ, Van Galen JG, Wang S, Yang Y, Zhang B, Chuang GY, McLellan JS, Graham BS, Mascola JR, Kwong PD. Crystal Structure and Immunogenicity of the DS-Cav1-Stabilized Fusion Glycoprotein From Respiratory Syncytial Virus Subtype B. Pathog Immun 2019;4:294-323. [PMID: 31893251 DOI: 10.20411/pai.v4i2.338] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
117 Cox R, Plemper RK. Structure-guided design of small-molecule therapeutics against RSV disease. Expert Opin Drug Discov 2016;11:543-56. [PMID: 27046051 DOI: 10.1517/17460441.2016.1174212] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 2.7] [Reference Citation Analysis]
118 Komaravelli N, Ansar M, Garofalo RP, Casola A. Respiratory syncytial virus induces NRF2 degradation through a promyelocytic leukemia protein - ring finger protein 4 dependent pathway. Free Radic Biol Med 2017;113:494-504. [PMID: 29107745 DOI: 10.1016/j.freeradbiomed.2017.10.380] [Cited by in F6Publishing: 26] [Reference Citation Analysis]
119 Chen L, Shi M, Deng Q, Liu W, Li Q, Ye P, Yu X, Zhang B, Xu Y, Li X, Yang Y, Li M, Yan Y, Xu Z, Yu J, Xiang L, Tang X, Wan G, Cai Q, Wang L, Hu B, Xie L, Li G, Xie L, Liu X, Liu C, Li L, Chen L, Jiang X, Huang Y, Wang S, Guo J, Shi Y, Li L, Wang X, Zhao Z, Li Y, Liu Y, Fu Q, Zeng Y, Zou Y, Liu D, Wan D, Ai T, Liu H. A multi-center randomized prospective study on the treatment of infant bronchiolitis with interferon α1b nebulization. PLoS One 2020;15:e0228391. [PMID: 32084142 DOI: 10.1371/journal.pone.0228391] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
120 Marcink TC, Porotto M, Moscona A. Parainfluenza virus entry at the onset of infection. Adv Virus Res 2021;111:1-29. [PMID: 34663496 DOI: 10.1016/bs.aivir.2021.07.001] [Reference Citation Analysis]
121 Do LA, van Doorn HR, Bryant JE, Nghiem MN, Nguyen Van VC, Vo CK, Nguyen MD, Tran TH, Farrar J, de Jong MD. A sensitive real-time PCR for detection and subgrouping of human respiratory syncytial virus. J Virol Methods 2012;179:250-5. [PMID: 22119628 DOI: 10.1016/j.jviromet.2011.11.012] [Cited by in Crossref: 32] [Cited by in F6Publishing: 31] [Article Influence: 2.9] [Reference Citation Analysis]
122 Redondo-Bravo L, Delgado-Sanz C, Oliva J, Vega T, Lozano J, Larrauri A, The Spanish Influenza Sentinel Surveillance System. Transmissibility of influenza during the 21st-century epidemics, Spain, influenza seasons 2001/02 to 2017/18. Euro Surveill 2020;25. [PMID: 32489178 DOI: 10.2807/1560-7917.ES.2020.25.21.1900364] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
123 Bruden DJ, Singleton R, Hawk CS, Bulkow LR, Bentley S, Anderson LJ, Herrmann L, Chikoyak L, Hennessy TW. Eighteen Years of Respiratory Syncytial Virus Surveillance: Changes in Seasonality and Hospitalization Rates in Southwestern Alaska Native Children. Pediatr Infect Dis J 2015;34:945-50. [PMID: 26065863 DOI: 10.1097/INF.0000000000000772] [Cited by in Crossref: 21] [Cited by in F6Publishing: 10] [Article Influence: 3.5] [Reference Citation Analysis]
124 Le Nouën C, Hillyer P, Winter CC, McCarty T, Rabin RL, Collins PL, Buchholz UJ. Low CCR7-mediated migration of human monocyte derived dendritic cells in response to human respiratory syncytial virus and human metapneumovirus. PLoS Pathog 2011;7:e1002105. [PMID: 21731495 DOI: 10.1371/journal.ppat.1002105] [Cited by in Crossref: 36] [Cited by in F6Publishing: 29] [Article Influence: 3.3] [Reference Citation Analysis]
125 Liu H, Osterburg AR, Flury J, Huang S, McCormack FX, Cormier SA, Borchers MT. NKG2D Regulation of Lung Pathology and Dendritic Cell Function Following Respiratory Syncytial Virus Infection. J Infect Dis 2018;218:1822-32. [PMID: 29554301 DOI: 10.1093/infdis/jiy151] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
126 Battles MB, Langedijk JP, Furmanova-Hollenstein P, Chaiwatpongsakorn S, Costello HM, Kwanten L, Vranckx L, Vink P, Jaensch S, Jonckers TH, Koul A, Arnoult E, Peeples ME, Roymans D, McLellan JS. Molecular mechanism of respiratory syncytial virus fusion inhibitors. Nat Chem Biol 2016;12:87-93. [PMID: 26641933 DOI: 10.1038/nchembio.1982] [Cited by in Crossref: 81] [Cited by in F6Publishing: 74] [Article Influence: 11.6] [Reference Citation Analysis]
127 Shibata T, Makino A, Ogata R, Nakamura S, Ito T, Nagata K, Terauchi Y, Oishi T, Fujieda M, Takahashi Y, Ato M. Respiratory syncytial virus infection exacerbates pneumococcal pneumonia via Gas6/Axl-mediated macrophage polarization. J Clin Invest 2020;130:3021-37. [PMID: 32364537 DOI: 10.1172/JCI125505] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 8.0] [Reference Citation Analysis]
128 Rajan D, Chinnadurai R, O'Keefe EL, Boyoglu-Barnum S, Todd SO, Hartert TV, Galipeau J, Anderson LJ. Protective role of Indoleamine 2,3 dioxygenase in Respiratory Syncytial Virus associated immune response in airway epithelial cells. Virology 2017;512:144-50. [PMID: 28963880 DOI: 10.1016/j.virol.2017.09.007] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
129 Nicolas De Lamballerie C, Pizzorno A, Dubois J, Padey B, Julien T, Traversier A, Carbonneau J, Orcel E, Lina B, Hamelin ME, Roche M, Textoris J, Boivin G, Legras-Lachuer C, Terrier O, Rosa-Calatrava M. Human Respiratory Syncytial Virus-Induced Immune Signature of Infection Revealed by Transcriptome Analysis of Clinical Pediatric Nasopharyngeal Swab Samples. J Infect Dis 2021;223:1052-61. [PMID: 32726438 DOI: 10.1093/infdis/jiaa468] [Reference Citation Analysis]
130 Fuentes S, Crim RL, Beeler J, Teng MN, Golding H, Khurana S. Development of a simple, rapid, sensitive, high-throughput luciferase reporter based microneutralization test for measurement of virus neutralizing antibodies following Respiratory Syncytial Virus vaccination and infection. Vaccine 2013;31:3987-94. [PMID: 23742994 DOI: 10.1016/j.vaccine.2013.05.088] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 2.9] [Reference Citation Analysis]
131 Piras S, Sanna G, Carta A, Corona P, Ibba R, Loddo R, Madeddu S, Caria P, Aulic S, Laurini E, Fermeglia M, Pricl S. Dichloro-Phenyl-Benzotriazoles: A New Selective Class of Human Respiratory Syncytial Virus Entry Inhibitors. Front Chem 2019;7:247. [PMID: 31041309 DOI: 10.3389/fchem.2019.00247] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
132 Cesar RG, Bispo BRP, Felix PHCA, Modolo MCC, Souza AAF, Horigoshi NK, Rotta AT. High-Flow Nasal Cannula versus Continuous Positive Airway Pressure in Critical Bronchiolitis: A Randomized Controlled Pilot. J Pediatr Intensive Care 2020;9:248-55. [PMID: 33133739 DOI: 10.1055/s-0040-1709656] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
133 Krivitskaya V, Komissarova K, Pisareva M, Sverlova M, Fadeev A, Petrova E, Timonina V, Sominina A, Danilenko D. Respiratory Syncytial Virus G Protein Sequence Variability among Isolates from St. Petersburg, Russia, during the 2013-2014 Epidemic Season. Viruses 2021;13:119. [PMID: 33477301 DOI: 10.3390/v13010119] [Reference Citation Analysis]
134 Sajuthi SP, DeFord P, Li Y, Jackson ND, Montgomery MT, Everman JL, Rios CL, Pruesse E, Nolin JD, Plender EG, Wechsler ME, Mak ACY, Eng C, Salazar S, Medina V, Wohlford EM, Huntsman S, Nickerson DA, Germer S, Zody MC, Abecasis G, Kang HM, Rice KM, Kumar R, Oh S, Rodriguez-Santana J, Burchard EG, Seibold MA. Type 2 and interferon inflammation regulate SARS-CoV-2 entry factor expression in the airway epithelium. Nat Commun 2020;11:5139. [PMID: 33046696 DOI: 10.1038/s41467-020-18781-2] [Cited by in Crossref: 32] [Cited by in F6Publishing: 42] [Article Influence: 16.0] [Reference Citation Analysis]
135 Scaggs Huang F, Bernstein DI, Slobod KS, Portner A, Takimoto T, Russell CJ, Meagher M, Jones BG, Sealy RE, Coleclough C, Branum K, Dickey M, Buschle K, McNeal M, Makowski M, Nakamura A, Hurwitz JL. Safety and immunogenicity of an intranasal sendai virus-based vaccine for human parainfluenza virus type I and respiratory syncytial virus (SeVRSV) in adults. Hum Vaccin Immunother 2021;17:554-9. [PMID: 32750273 DOI: 10.1080/21645515.2020.1779517] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
136 Khuri-Bulos N, Lawrence L, Piya B, Wang L, Fonnesbeck C, Faouri S, Shehabi A, Vermund SH, Williams JV, Halasa NB. Severe outcomes associated with respiratory viruses in newborns and infants: a prospective viral surveillance study in Jordan. BMJ Open 2018;8:e021898. [PMID: 29780032 DOI: 10.1136/bmjopen-2018-021898] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 3.5] [Reference Citation Analysis]
137 Schmidt ME, Varga SM. The CD8 T Cell Response to Respiratory Virus Infections. Front Immunol 2018;9:678. [PMID: 29686673 DOI: 10.3389/fimmu.2018.00678] [Cited by in Crossref: 129] [Cited by in F6Publishing: 127] [Article Influence: 32.3] [Reference Citation Analysis]
138 Sande CJ, Mutunga MN, Okiro EA, Medley GF, Cane PA, Nokes DJ. Kinetics of the neutralizing antibody response to respiratory syncytial virus infections in a birth cohort. J Med Virol 2013;85:2020-5. [PMID: 23983183 DOI: 10.1002/jmv.23696] [Cited by in Crossref: 28] [Cited by in F6Publishing: 26] [Article Influence: 3.5] [Reference Citation Analysis]
139 Thomsen SF. The contribution of twin studies to the understanding of the aetiology of asthma and atopic diseases. Eur Clin Respir J 2015;2:27803. [PMID: 26672957 DOI: 10.3402/ecrj.v2.27803] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.1] [Reference Citation Analysis]
140 Moreno-Perez D, Calvo C; Five Study Group. Epidemiological and clinical data of hospitalizations associated with respiratory syncytial virus infection in children under 5 years of age in Spain: FIVE multicenter study. Influenza Other Respir Viruses 2014;8:209-16. [PMID: 24382343 DOI: 10.1111/irv.12224] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 2.1] [Reference Citation Analysis]
141 Jroundi I, Mahraoui C, Benmessaoud R, Moraleda C, Tligui H, Seffar M, Kettani SE, Benjelloun BS, Chaacho S, Muñoz-Almagro C, Ruiz J, Alonso PL, Bassat Q. Risk factors for a poor outcome among children admitted with clinically severe pneumonia to a university hospital in Rabat, Morocco. Int J Infect Dis 2014;28:164-70. [PMID: 25305555 DOI: 10.1016/j.ijid.2014.07.027] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 2.4] [Reference Citation Analysis]
142 Lukšić I, Kearns PK, Scott F, Rudan I, Campbell H, Nair H. Viral etiology of hospitalized acute lower respiratory infections in children under 5 years of age -- a systematic review and meta-analysis. Croat Med J 2013;54:122-34. [PMID: 23630140 DOI: 10.3325/cmj.2013.54.122] [Cited by in Crossref: 41] [Cited by in F6Publishing: 40] [Article Influence: 4.6] [Reference Citation Analysis]
143 Vareille M, Kieninger E, Edwards MR, Regamey N. The airway epithelium: soldier in the fight against respiratory viruses. Clin Microbiol Rev 2011;24:210-29. [PMID: 21233513 DOI: 10.1128/CMR.00014-10] [Cited by in Crossref: 338] [Cited by in F6Publishing: 221] [Article Influence: 30.7] [Reference Citation Analysis]
144 Lee J, Klenow L, Coyle EM, Golding H, Khurana S. Protective antigenic sites in respiratory syncytial virus G attachment protein outside the central conserved and cysteine noose domains. PLoS Pathog 2018;14:e1007262. [PMID: 30142227 DOI: 10.1371/journal.ppat.1007262] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 3.5] [Reference Citation Analysis]
145 González-Parra G, Dobrovolny HM. The rate of viral transfer between upper and lower respiratory tracts determines RSV illness duration. J Math Biol 2019;79:467-83. [PMID: 31011792 DOI: 10.1007/s00285-019-01364-1] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
146 Brown PM, Schneeberger DL, Piedimonte G. Biomarkers of respiratory syncytial virus (RSV) infection: specific neutrophil and cytokine levels provide increased accuracy in predicting disease severity. Paediatr Respir Rev 2015;16:232-40. [PMID: 26074450 DOI: 10.1016/j.prrv.2015.05.005] [Cited by in Crossref: 12] [Cited by in F6Publishing: 16] [Article Influence: 1.7] [Reference Citation Analysis]
147 Wang Y, Zhu N, Li Y, Lu R, Wang H, Liu G, Zou X, Xie Z, Tan W. Metagenomic analysis of viral genetic diversity in respiratory samples from children with severe acute respiratory infection in China. Clin Microbiol Infect 2016;22:458.e1-9. [PMID: 26802214 DOI: 10.1016/j.cmi.2016.01.006] [Cited by in Crossref: 40] [Cited by in F6Publishing: 36] [Article Influence: 6.7] [Reference Citation Analysis]
148 Papin JF, Wolf RF, Kosanke SD, Jenkins JD, Moore SN, Anderson MP, Welliver RC Sr. Infant baboons infected with respiratory syncytial virus develop clinical and pathological changes that parallel those of human infants. Am J Physiol Lung Cell Mol Physiol 2013;304:L530-9. [PMID: 23418091 DOI: 10.1152/ajplung.00173.2012] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 3.3] [Reference Citation Analysis]
149 Riffault S, Hägglund S, Guzman E, Näslund K, Jouneau L, Dubuquoy C, Pietralunga V, Laubreton D, Boulesteix O, Gauthier D, Remot A, Boukaridi A, Falk A, Shevchenko G, Lind SB, Vargmar K, Zhang B, Kwong PD, Rodriguez MJ, Duran MG, Schwartz-Cornil I, Eléouët JF, Taylor G, Valarcher JF. A Single Shot Pre-fusion-Stabilized Bovine RSV F Vaccine is Safe and Effective in Newborn Calves with Maternally Derived Antibodies. Vaccines (Basel) 2020;8:E231. [PMID: 32443437 DOI: 10.3390/vaccines8020231] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
150 Lakhani D, Muley P. The association of positive chest radiograph and laboratory parameters with community acquired pneumonia in children. J Clin Diagn Res 2013;7:1629-31. [PMID: 24086859 DOI: 10.7860/JCDR/2013/5132.3222] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
151 Etemadi MR, Sekawi Z, Othman N, Lye MS, Moghaddam FY. Circulation of human respiratory syncytial virus strains among hospitalized children with acute lower respiratory infection in malaysia. Evol Bioinform Online 2013;9:151-61. [PMID: 23641140 DOI: 10.4137/EBO.S10999] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
152 Sande CJ, Cane PA, Nokes DJ. The association between age and the development of respiratory syncytial virus neutralising antibody responses following natural infection in infants. Vaccine 2014;32:4726-9. [PMID: 25005882 DOI: 10.1016/j.vaccine.2014.05.038] [Cited by in Crossref: 32] [Cited by in F6Publishing: 27] [Article Influence: 4.0] [Reference Citation Analysis]
153 Stephens LM, Varga SM. Function and Modulation of Type I Interferons during Respiratory Syncytial Virus Infection. Vaccines (Basel) 2020;8:E177. [PMID: 32290326 DOI: 10.3390/vaccines8020177] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 5.5] [Reference Citation Analysis]
154 Deval J, Fung A, Stevens SK, Jordan PC, Gromova T, Taylor JS, Hong J, Meng J, Wang G, Dyatkina N, Prhavc M, Symons JA, Beigelman L. Biochemical Effect of Resistance Mutations against Synergistic Inhibitors of RSV RNA Polymerase. PLoS One 2016;11:e0154097. [PMID: 27163448 DOI: 10.1371/journal.pone.0154097] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 2.7] [Reference Citation Analysis]
155 Staadegaard L, Caini S, Wangchuk S, Thapa B, de Almeida WAF, de Carvalho FC, Njouom R, Fasce RA, Bustos P, Kyncl J, Novakova L, Caicedo AB, de Mora Coloma DJ, Meijer A, Hooiveld M, Huang S, Wood T, Guiomar R, Rodrigues AP, Danilenko D, Stolyarov K, Lee VJM, Ang LW, Cohen C, Moyes J, Larrauri A, Delgado-Sanz C, Le MQ, Hoang PVM, Demont C, Bangert M, van Summeren J, Dückers M, Paget J. The Global Epidemiology of RSV in Community and Hospitalized Care: Findings From 15 Countries. Open Forum Infect Dis 2021;8:ofab159. [PMID: 34337092 DOI: 10.1093/ofid/ofab159] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
156 Cortjens B, Yasuda E, Yu X, Wagner K, Claassen YB, Bakker AQ, van Woensel JBM, Beaumont T. Broadly Reactive Anti-Respiratory Syncytial Virus G Antibodies from Exposed Individuals Effectively Inhibit Infection of Primary Airway Epithelial Cells. J Virol 2017;91:e02357-16. [PMID: 28275185 DOI: 10.1128/JVI.02357-16] [Cited by in Crossref: 37] [Cited by in F6Publishing: 26] [Article Influence: 7.4] [Reference Citation Analysis]
157 Schmidt ME, Varga SM. Cytokines and CD8 T cell immunity during respiratory syncytial virus infection. Cytokine 2020;133:154481. [PMID: 30031680 DOI: 10.1016/j.cyto.2018.07.012] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
158 Jain S. Epidemiology of Viral Pneumonia. Clin Chest Med 2017;38:1-9. [PMID: 28159152 DOI: 10.1016/j.ccm.2016.11.012] [Cited by in Crossref: 35] [Cited by in F6Publishing: 32] [Article Influence: 5.8] [Reference Citation Analysis]
159 Ferronato ÂE, Gilio AE, Ferraro AA, Paulis Md, Vieira SE. Etiological diagnosis reduces the use of antibiotics in infants with bronchiolitis. Clinics (Sao Paulo) 2012;67:1001-6. [PMID: 23018294 DOI: 10.6061/clinics/2012(09)03] [Cited by in Crossref: 23] [Cited by in F6Publishing: 18] [Article Influence: 2.6] [Reference Citation Analysis]
160 Palgen JL, Jurgens EM, Moscona A, Porotto M, Palermo LM. Unity in diversity: shared mechanism of entry among paramyxoviruses. Prog Mol Biol Transl Sci 2015;129:1-32. [PMID: 25595799 DOI: 10.1016/bs.pmbts.2014.10.001] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 2.1] [Reference Citation Analysis]
161 Törmänen S, Teräsjärvi J, Lauhkonen E, Helminen M, Koponen P, Korppi M, Nuolivirta K, He Q. TLR5 rs5744174 gene polymorphism is associated with the virus etiology of infant bronchiolitis but not with post-bronchiolitis asthma. Health Sci Rep 2018;1:e38. [PMID: 30623075 DOI: 10.1002/hsr2.38] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
162 Jain R, Piramanayagam S. In silico approach towards designing virtual oligopeptides for HRSV. ScientificWorldJournal 2014;2014:613293. [PMID: 25525622 DOI: 10.1155/2014/613293] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
163 Gutfraind A, Galvani AP, Meyers LA. Efficacy and optimization of palivizumab injection regimens against respiratory syncytial virus infection. JAMA Pediatr 2015;169:341-8. [PMID: 25706618 DOI: 10.1001/jamapediatrics.2014.3804] [Cited by in Crossref: 29] [Cited by in F6Publishing: 24] [Article Influence: 4.1] [Reference Citation Analysis]
164 Zhang XY, Zhang XC, Yu HY, Wang Y, Chen J, Wang Y, Yu L, Zhu GX, Cao XJ, Huang SH. Respiratory syncytial virus infection of microglia exacerbates SH-SY5Y neuronal cell injury by inducing the secretion of inflammatory cytokines: A Transwell in vitro study. Iran J Basic Med Sci 2021;24:213-21. [PMID: 33953861 DOI: 10.22038/ijbms.2020.49193.11263] [Reference Citation Analysis]
165 Kellar GG, Barrow KA, Rich LM, Debley JS, Wight TN, Ziegler SF, Reeves SR. Loss of versican and production of hyaluronan in lung epithelial cells are associated with airway inflammation during RSV infection. J Biol Chem 2021;296:100076. [PMID: 33187989 DOI: 10.1074/jbc.RA120.016196] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
166 Buchwald AG, Tamboura B, Tennant SM, Haidara FC, Coulibaly F, Doumbia M, Diallo F, Keita AM, Sow SO, Kotloff KL, Levine MM, Tapia MD. Epidemiology, Risk Factors, and Outcomes of Respiratory Syncytial Virus Infections in Newborns in Bamako, Mali. Clin Infect Dis 2020;70:59-66. [PMID: 30810160 DOI: 10.1093/cid/ciz157] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 7.0] [Reference Citation Analysis]
167 Habibi MS, Jozwik A, Makris S, Dunning J, Paras A, DeVincenzo JP, de Haan CA, Wrammert J, Openshaw PJ, Chiu C; Mechanisms of Severe Acute Influenza Consortium Investigators. Impaired Antibody-mediated Protection and Defective IgA B-Cell Memory in Experimental Infection of Adults with Respiratory Syncytial Virus. Am J Respir Crit Care Med 2015;191:1040-9. [PMID: 25730467 DOI: 10.1164/rccm.201412-2256OC] [Cited by in Crossref: 147] [Cited by in F6Publishing: 84] [Article Influence: 21.0] [Reference Citation Analysis]
168 McGill JL, Guerra-Maupome M, Schneider S. Prophylactic digoxin treatment reduces IL-17 production in vivo in the neonatal calf and moderates RSV-associated disease. PLoS One 2019;14:e0214407. [PMID: 30908540 DOI: 10.1371/journal.pone.0214407] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
169 Graham BS, Anderson LJ. Challenges and opportunities for respiratory syncytial virus vaccines. Curr Top Microbiol Immunol 2013;372:391-404. [PMID: 24362701 DOI: 10.1007/978-3-642-38919-1_20] [Cited by in Crossref: 9] [Cited by in F6Publishing: 31] [Article Influence: 1.1] [Reference Citation Analysis]
170 Canedo-Marroquín G, Acevedo-Acevedo O, Rey-Jurado E, Saavedra JM, Lay MK, Bueno SM, Riedel CA, Kalergis AM. Modulation of Host Immunity by Human Respiratory Syncytial Virus Virulence Factors: A Synergic Inhibition of Both Innate and Adaptive Immunity. Front Cell Infect Microbiol 2017;7:367. [PMID: 28861397 DOI: 10.3389/fcimb.2017.00367] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 2.6] [Reference Citation Analysis]
171 Procario MC, Levine RE, McCarthy MK, Kim E, Zhu L, Chang CH, Hershenson MB, Weinberg JB. Susceptibility to acute mouse adenovirus type 1 respiratory infection and establishment of protective immunity in neonatal mice. J Virol 2012;86:4194-203. [PMID: 22345470 DOI: 10.1128/JVI.06967-11] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 1.9] [Reference Citation Analysis]
172 Mella C, Suarez-Arrabal MC, Lopez S, Stephens J, Fernandez S, Hall MW, Ramilo O, Mejias A. Innate immune dysfunction is associated with enhanced disease severity in infants with severe respiratory syncytial virus bronchiolitis. J Infect Dis 2013;207:564-73. [PMID: 23204162 DOI: 10.1093/infdis/jis721] [Cited by in Crossref: 80] [Cited by in F6Publishing: 73] [Article Influence: 8.0] [Reference Citation Analysis]
173 Chirkova T, Boyoglu-Barnum S, Gaston KA, Malik FM, Trau SP, Oomens AG, Anderson LJ. Respiratory syncytial virus G protein CX3C motif impairs human airway epithelial and immune cell responses. J Virol 2013;87:13466-79. [PMID: 24089561 DOI: 10.1128/JVI.01741-13] [Cited by in Crossref: 59] [Cited by in F6Publishing: 41] [Article Influence: 6.6] [Reference Citation Analysis]
174 Doucette A, Jiang X, Fryzek J, Coalson J, McLaurin K, Ambrose CS. Trends in Respiratory Syncytial Virus and Bronchiolitis Hospitalization Rates in High-Risk Infants in a United States Nationally Representative Database, 1997-2012. PLoS One 2016;11:e0152208. [PMID: 27050095 DOI: 10.1371/journal.pone.0152208] [Cited by in Crossref: 41] [Cited by in F6Publishing: 35] [Article Influence: 6.8] [Reference Citation Analysis]
175 Galván JM, Rajas O, Aspa J. Review of Non-Bacterial Infections in Respiratory Medicine: Viral Pneumonia. Arch Bronconeumol 2015;51:590-7. [PMID: 25957460 DOI: 10.1016/j.arbres.2015.02.015] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
176 Piedra FA, Mei M, Avadhanula V, Mehta R, Aideyan L, Garofalo RP, Piedra PA. The interdependencies of viral load, the innate immune response, and clinical outcome in children presenting to the emergency department with respiratory syncytial virus-associated bronchiolitis. PLoS One 2017;12:e0172953. [PMID: 28267794 DOI: 10.1371/journal.pone.0172953] [Cited by in Crossref: 28] [Cited by in F6Publishing: 29] [Article Influence: 5.6] [Reference Citation Analysis]
177 Phan SI, Zengel JR, Wei H, Li Z, Wang D, He B. Parainfluenza Virus 5 Expressing Wild-Type or Prefusion Respiratory Syncytial Virus (RSV) Fusion Protein Protects Mice and Cotton Rats from RSV Challenge. J Virol 2017;91:e00560-17. [PMID: 28747496 DOI: 10.1128/JVI.00560-17] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 2.6] [Reference Citation Analysis]
178 Meng J, Hotard AL, Currier MG, Lee S, Stobart CC, Moore ML. Respiratory Syncytial Virus Attachment Glycoprotein Contribution to Infection Depends on the Specific Fusion Protein. J Virol 2016;90:245-53. [PMID: 26468535 DOI: 10.1128/JVI.02140-15] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 2.6] [Reference Citation Analysis]
179 O'Callaghan-Gordo C, Bassat Q, Díez-Padrisa N, Morais L, Machevo S, Nhampossa T, Quintó L, Alonso PL, Roca A. Lower respiratory tract infections associated with rhinovirus during infancy and increased risk of wheezing during childhood. A cohort study. PLoS One 2013;8:e69370. [PMID: 23935997 DOI: 10.1371/journal.pone.0069370] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 1.8] [Reference Citation Analysis]
180 Higdon MM, Le T, O'Brien KL, Murdoch DR, Prosperi C, Baggett HC, Brooks WA, Feikin DR, Hammitt LL, Howie SRC, Kotloff KL, Levine OS, Scott JAG, Thea DM, Awori JO, Baillie VL, Cascio S, Chuananon S, DeLuca AN, Driscoll AJ, Ebruke BE, Endtz HP, Kaewpan A, Kahn G, Karani A, Karron RA, Moore DP, Park DE, Rahman MZ, Salaudeen R, Seidenberg P, Somwe SW, Sylla M, Tapia MD, Zeger SL, Deloria Knoll M, Madhi SA; PERCH Study Group . Association of C-Reactive Protein With Bacterial and Respiratory Syncytial Virus-Associated Pneumonia Among Children Aged <5 Years in the PERCH Study. Clin Infect Dis 2017;64:S378-86. [PMID: 28575375 DOI: 10.1093/cid/cix150] [Cited by in Crossref: 40] [Cited by in F6Publishing: 40] [Article Influence: 10.0] [Reference Citation Analysis]
181 Mejias A, Dimo B, Suarez NM, Garcia C, Suarez-Arrabal MC, Jartti T, Blankenship D, Jordan-Villegas A, Ardura MI, Xu Z, Banchereau J, Chaussabel D, Ramilo O. Whole blood gene expression profiles to assess pathogenesis and disease severity in infants with respiratory syncytial virus infection. PLoS Med 2013;10:e1001549. [PMID: 24265599 DOI: 10.1371/journal.pmed.1001549] [Cited by in Crossref: 203] [Cited by in F6Publishing: 190] [Article Influence: 22.6] [Reference Citation Analysis]
182 Vandini S, Biagi C, Lanari M. Respiratory Syncytial Virus: The Influence of Serotype and Genotype Variability on Clinical Course of Infection. Int J Mol Sci 2017;18:E1717. [PMID: 28783078 DOI: 10.3390/ijms18081717] [Cited by in Crossref: 55] [Cited by in F6Publishing: 50] [Article Influence: 11.0] [Reference Citation Analysis]
183 Salisch NC, Izquierdo Gil A, Czapska-Casey DN, Vorthoren L, Serroyen J, Tolboom J, Saeland E, Schuitemaker H, Zahn RC. Adenovectors encoding RSV-F protein induce durable and mucosal immunity in macaques after two intramuscular administrations. NPJ Vaccines 2019;4:54. [PMID: 31885877 DOI: 10.1038/s41541-019-0150-4] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 5.7] [Reference Citation Analysis]
184 Baral S, Antia R, Dixit NM. A dynamical motif comprising the interactions between antigens and CD8 T cells may underlie the outcomes of viral infections. Proc Natl Acad Sci U S A 2019;116:17393-8. [PMID: 31413198 DOI: 10.1073/pnas.1902178116] [Cited by in Crossref: 18] [Cited by in F6Publishing: 11] [Article Influence: 6.0] [Reference Citation Analysis]
185 Sampson DL, Fox BA, Yager TD, Bhide S, Cermelli S, McHugh LC, Seldon TA, Brandon RA, Sullivan E, Zimmerman JJ, Noursadeghi M, Brandon RB. A Four-Biomarker Blood Signature Discriminates Systemic Inflammation Due to Viral Infection Versus Other Etiologies. Sci Rep 2017;7:2914. [PMID: 28588308 DOI: 10.1038/s41598-017-02325-8] [Cited by in Crossref: 30] [Cited by in F6Publishing: 27] [Article Influence: 6.0] [Reference Citation Analysis]
186 Clementi N, Ghosh S, De Santis M, Castelli M, Criscuolo E, Zanoni I, Clementi M, Mancini N. Viral Respiratory Pathogens and Lung Injury. Clin Microbiol Rev 2021;34:e00103-20. [PMID: 33789928 DOI: 10.1128/CMR.00103-20] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
187 Kim J, Nam J, Jang W, Lim CS. Clinical Performance of the AllplexTM Respiratory Panel 1 Test Compared to SimplexaTM Flu A/B and RSV for Detection of Influenza Virus and Respiratory Syncytial Virus Infection Including Their Subtyping. Med Princ Pract 2019;28:380-6. [PMID: 30831570 DOI: 10.1159/000499313] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
188 Souza C, Zanchin NI, Krieger MA, Ludwig A. In silico analysis of amino acid variation in human respiratory syncytial virus: insights into immunodiagnostics. Mem Inst Oswaldo Cruz 2017;112:655-63. [PMID: 28953993 DOI: 10.1590/0074-02760170013] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
189 Wrotek A, Badyda A, Czechowski PO, Owczarek T, Dąbrowiecki P, Jackowska T. Air Pollutants' Concentrations Are Associated with Increased Number of RSV Hospitalizations in Polish Children. J Clin Med 2021;10:3224. [PMID: 34362009 DOI: 10.3390/jcm10153224] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
190 Edwards CL, Zhang V, Werder RB, Best SE, Sebina I, James KR, Faleiro RJ, de Labastida Rivera F, Amante FH, Engwerda CR, Phipps S, Haque A. Coinfection with Blood-Stage Plasmodium Promotes Systemic Type I Interferon Production during Pneumovirus Infection but Impairs Inflammation and Viral Control in the Lung. Clin Vaccine Immunol 2015;22:477-83. [PMID: 25716232 DOI: 10.1128/CVI.00051-15] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
191 Shi W, Jiang Z, He H, Xiao F, Lin F, Sun Y, Hou L, Shen L, Han L, Zeng M, Lai K, Gu Z, Chen X, Zhao T, Guo L, Yang C, Li J, Chen S. Discovery of 3,3'-Spiro[Azetidine]-2-oxo-indoline Derivatives as Fusion Inhibitors for Treatment of RSV Infection. ACS Med Chem Lett 2018;9:94-7. [PMID: 29456794 DOI: 10.1021/acsmedchemlett.7b00418] [Cited by in Crossref: 19] [Cited by in F6Publishing: 14] [Article Influence: 4.8] [Reference Citation Analysis]
192 Geskey JM, Cyran SE. Managing the morbidity associated with respiratory viral infections in children with congenital heart disease. Int J Pediatr 2012;2012:646780. [PMID: 22518179 DOI: 10.1155/2012/646780] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.2] [Reference Citation Analysis]
193 Schobel SA, Stucker KM, Moore ML, Anderson LJ, Larkin EK, Shankar J, Bera J, Puri V, Shilts MH, Rosas-Salazar C, Halpin RA, Fedorova N, Shrivastava S, Stockwell TB, Peebles RS, Hartert TV, Das SR. Respiratory Syncytial Virus whole-genome sequencing identifies convergent evolution of sequence duplication in the C-terminus of the G gene. Sci Rep 2016;6:26311. [PMID: 27212633 DOI: 10.1038/srep26311] [Cited by in Crossref: 43] [Cited by in F6Publishing: 41] [Article Influence: 7.2] [Reference Citation Analysis]
194 Komaravelli N, Casola A. Respiratory Viral Infections and Subversion of Cellular Antioxidant Defenses. J Pharmacogenomics Pharmacoproteomics 2014;5:1000141. [PMID: 25584194 DOI: 10.4172/2153-0645.1000141] [Cited by in Crossref: 11] [Cited by in F6Publishing: 31] [Article Influence: 1.4] [Reference Citation Analysis]
195 Zhao Y, Jamaluddin M, Zhang Y, Sun H, Ivanciuc T, Garofalo RP, Brasier AR. Systematic Analysis of Cell-Type Differences in the Epithelial Secretome Reveals Insights into the Pathogenesis of Respiratory Syncytial Virus-Induced Lower Respiratory Tract Infections. J Immunol 2017;198:3345-64. [PMID: 28258195 DOI: 10.4049/jimmunol.1601291] [Cited by in Crossref: 30] [Cited by in F6Publishing: 33] [Article Influence: 6.0] [Reference Citation Analysis]
196 Trevisan M, Di Antonio V, Radeghieri A, Palù G, Ghildyal R, Alvisi G. Molecular Requirements for Self-Interaction of the Respiratory Syncytial Virus Matrix Protein in Living Mammalian Cells. Viruses 2018;10:E109. [PMID: 29510513 DOI: 10.3390/v10030109] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
197 Pangesti KNA, El Ghany MA, Kesson AM, Hill-Cawthorne GA. Respiratory syncytial virus in the Western Pacific Region: a systematic review and meta-analysis. J Glob Health 2019;9:020431. [PMID: 31893034 DOI: 10.7189/jogh.09.020431] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
198 Hurt AC, Hui DS, Hay A, Hayden FG. Overview of the 3rd isirv-Antiviral Group Conference--advances in clinical management. Influenza Other Respir Viruses 2015;9:20-31. [PMID: 25399715 DOI: 10.1111/irv.12293] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 1.8] [Reference Citation Analysis]
199 López D, Barriga A, Lorente E, Mir C. Immunoproteomic Lessons for Human Respiratory Syncytial Virus Vaccine Design. J Clin Med 2019;8:E486. [PMID: 30974886 DOI: 10.3390/jcm8040486] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
200 Xing Y, Proesmans M. New therapies for acute RSV infections: where are we? Eur J Pediatr 2019;178:131-8. [PMID: 30610420 DOI: 10.1007/s00431-018-03310-7] [Cited by in Crossref: 27] [Cited by in F6Publishing: 23] [Article Influence: 9.0] [Reference Citation Analysis]
201 Raiden S, Sananez I, Remes-Lenicov F, Pandolfi J, Romero C, De Lillo L, Ceballos A, Geffner J, Arruvito L. Respiratory Syncytial Virus (RSV) Infects CD4+ T Cells: Frequency of Circulating CD4+ RSV+ T Cells as a Marker of Disease Severity in Young Children. J Infect Dis 2017;215:1049-58. [PMID: 28199704 DOI: 10.1093/infdis/jix070] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 4.2] [Reference Citation Analysis]
202 Choi EJ, Ren Y, Chen Y, Liu S, Wu W, Ren J, Wang P, Garofalo RP, Zhou J, Bao X. Exchange Proteins Directly Activated by cAMP and Their Roles in Respiratory Syncytial Virus Infection. J Virol 2018;92:e01200-18. [PMID: 30185593 DOI: 10.1128/JVI.01200-18] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
203 Bénet T, Picot VS, Awasthi S, Pandey N, Bavdekar A, Kawade A, Robinson A, Rakoto-Andrianarivelo M, Sylla M, Diallo S, Russomando G, Basualdo W, Komurian-Pradel F, Endtz H, Vanhems P, Paranhos-Baccalà G, For The Gabriel Network. Severity of Pneumonia in Under 5-Year-Old Children from Developing Countries: A Multicenter, Prospective, Observational Study. Am J Trop Med Hyg 2017;97:68-76. [PMID: 28719310 DOI: 10.4269/ajtmh.16-0733] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 4.0] [Reference Citation Analysis]
204 Wansaula Z, Olsen SJ, Casal MG, Golenko C, Erhart LM, Kammerer P, Whitfield N, McCotter OZ. Surveillance for severe acute respiratory infections in Southern Arizona, 2010-2014. Influenza Other Respir Viruses 2016;10:161-9. [PMID: 26590069 DOI: 10.1111/irv.12360] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 3.3] [Reference Citation Analysis]
205 Rajapaksa AE, Do LAH, Suryawijaya Ong D, Sourial M, Veysey D, Beare R, Hughes W, Yang W, Bischof RJ, McDonnell A, Eu P, Yeo LY, Licciardi PV, Mulholland EK. Pulmonary Deposition of Radionucleotide-Labeled Palivizumab: Proof-of-Concept Study. Front Pharmacol 2020;11:1291. [PMID: 32973520 DOI: 10.3389/fphar.2020.01291] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
206 Hamza A, Shafat Z, Parray ZA, Hisamuddin M, Khan WH, Ahmed A, Almajhdi FN, Farrag MA, Mohammed AA, Islam A, Parveen S. Structural Characterization and Binding Studies of the Ectodomain G Protein of Respiratory Syncytial Virus Reveal the Crucial Role of pH with Possible Implications in Host-Pathogen Interactions. ACS Omega 2021;6:10403-14. [PMID: 34056193 DOI: 10.1021/acsomega.1c00800] [Reference Citation Analysis]
207 Green CA, Scarselli E, Voysey M, Capone S, Vitelli A, Nicosia A, Cortese R, Thompson AJ, Sande CS, de Lara C, Klenerman P, Pollard AJ. Safety and immunogenicity of novel respiratory syncytial virus (RSV) vaccines based on the RSV viral proteins F, N and M2-1 encoded by simian adenovirus (PanAd3-RSV) and MVA (MVA-RSV); protocol for an open-label, dose-escalation, single-centre, phase 1 clinical trial in healthy adults. BMJ Open 2015;5:e008748. [PMID: 26510727 DOI: 10.1136/bmjopen-2015-008748] [Cited by in Crossref: 34] [Cited by in F6Publishing: 34] [Article Influence: 4.9] [Reference Citation Analysis]
208 Cetinkaya M, Oral TK, Karatekin S, Cebeci B, Babayigit A, Yesil Y. Efficacy of palivizumab prophylaxis on the frequency of RSV-associated lower respiratory tract infections in preterm infants: determination of the ideal target population for prophylaxis. Eur J Clin Microbiol Infect Dis 2017;36:1629-34. [PMID: 28391538 DOI: 10.1007/s10096-017-2976-x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
209 Harding JN, Siefker D, Vu L, You D, DeVincenzo J, Pierre JF, Cormier SA. Altered gut microbiota in infants is associated with respiratory syncytial virus disease severity. BMC Microbiol 2020;20:140. [PMID: 32487019 DOI: 10.1186/s12866-020-01816-5] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
210 Christiaansen AF, Syed MA, Ten Eyck PP, Hartwig SM, Durairaj L, Kamath SS, Varga SM. Altered Treg and cytokine responses in RSV-infected infants. Pediatr Res 2016;80:702-9. [PMID: 27486703 DOI: 10.1038/pr.2016.130] [Cited by in Crossref: 31] [Cited by in F6Publishing: 31] [Article Influence: 5.2] [Reference Citation Analysis]
211 Gomi R, Sharma A, Wu W, Worgall S. Neonatal Genetic Delivery of Anti-Respiratory Syncytial Virus (RSV) Antibody by Non-Human Primate-Based Adenoviral Vector to Provide Protection against RSV. Vaccines (Basel) 2018;7:E3. [PMID: 30597977 DOI: 10.3390/vaccines7010003] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
212 Hosakote YM, Jantzi PD, Esham DL, Spratt H, Kurosky A, Casola A, Garofalo RP. Viral-mediated inhibition of antioxidant enzymes contributes to the pathogenesis of severe respiratory syncytial virus bronchiolitis. Am J Respir Crit Care Med 2011;183:1550-60. [PMID: 21471094 DOI: 10.1164/rccm.201010-1755OC] [Cited by in F6Publishing: 56] [Reference Citation Analysis]
213 Zar HJ, Barnett W, Stadler A, Gardner-Lubbe S, Myer L, Nicol MP. Aetiology of childhood pneumonia in a well vaccinated South African birth cohort: a nested case-control study of the Drakenstein Child Health Study. Lancet Respir Med 2016;4:463-72. [PMID: 27117547 DOI: 10.1016/S2213-2600(16)00096-5] [Cited by in Crossref: 85] [Cited by in F6Publishing: 59] [Article Influence: 14.2] [Reference Citation Analysis]
214 Chambliss JM, Ansar M, Kelley JP, Spratt H, Garofalo RP, Casola A. A Polymorphism in the Catalase Gene Promoter Confers Protection against Severe RSV Bronchiolitis. Viruses 2020;12:E57. [PMID: 31947722 DOI: 10.3390/v12010057] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
215 Whelan B, Musters E, Murray A, Moore E, Lievaart L, Visser S, Toxopeus E, van Veen A, Notario G, Campbell FJ. Review of the home care programmes for respiratory syncytial virus (RSV) prophylaxis in Ireland and The Netherlands. Drugs Ther Perspect 2016;32:119-30. [PMID: 26924927 DOI: 10.1007/s40267-015-0275-0] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
216 Chida-Nagai A, Sato H, Sato I, Shiraishi M, Sasaki D, Izumi G, Yamazawa H, Cho K, Manabe A, Takeda A. Risk factors for hospitalisation due to respiratory syncytial virus infection in children receiving prophylactic palivizumab. Eur J Pediatr 2021. [PMID: 34417646 DOI: 10.1007/s00431-021-04216-7] [Reference Citation Analysis]
217 Jepsen MT, Trebbien R, Emborg HD, Krause TG, Schønning K, Voldstedlund M, Nielsen J, Fischer TK. Incidence and seasonality of respiratory syncytial virus hospitalisations in young children in Denmark, 2010 to 2015. Euro Surveill 2018;23. [PMID: 29386093 DOI: 10.2807/1560-7917.ES.2018.23.3.17-00163] [Cited by in Crossref: 17] [Cited by in F6Publishing: 8] [Article Influence: 5.7] [Reference Citation Analysis]
218 Yin GQ, Zeng HX, Li ZL, Chen C, Zhong JY, Xiao MS, Zeng Q, Jiang WH, Wu PQ, Zeng JM, Hu XY, Chen HH, Ruo-Hu, Zhao HJ, Gao L, Liu C, Cai SX. Differential proteomic analysis of children infected with respiratory syncytial virus. Braz J Med Biol Res 2021;54:e9850. [PMID: 33656056 DOI: 10.1590/1414-431X20209850] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
219 Taylor JR, Skeate JG, Kast WM. Annexin A2 in Virus Infection. Front Microbiol. 2018;9:2954. [PMID: 30568638 DOI: 10.3389/fmicb.2018.02954] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 3.3] [Reference Citation Analysis]
220 Smith RJ, Hogan AB, Mercer GN. Unexpected Infection Spikes in a Model of Respiratory Syncytial Virus Vaccination. Vaccines (Basel) 2017;5:E12. [PMID: 28524109 DOI: 10.3390/vaccines5020012] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
221 Grim SA, Reid GE, Clark NM. Update in the treatment of non-influenza respiratory virus infection in solid organ transplant recipients. Expert Opin Pharmacother 2017;18:767-79. [PMID: 28425766 DOI: 10.1080/14656566.2017.1322063] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
222 Rey-Ares L, Irazola V, Althabe F, Sobrino E, Mazzoni A, Serón P, Lanas F, Calandreli M, Rubinstein A. Lower tract respiratory infection in children younger than 5 years of age and adverse pregnancy outcomes related to household air pollution in Bariloche (Argentina) and Temuco (Chile). Indoor Air 2016;26:964-75. [PMID: 26615053 DOI: 10.1111/ina.12274] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
223 Tjernberg AR, Ludvigsson JF. Children with celiac disease are more likely to have attended hospital for prior respiratory syncytial virus infection. Dig Dis Sci 2014;59:1502-8. [PMID: 24510390 DOI: 10.1007/s10620-014-3046-1] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
224 Wagatsuma K, Koolhof IS, Shobugawa Y, Saito R. Decreased human respiratory syncytial virus activity during the COVID-19 pandemic in Japan: an ecological time-series analysis. BMC Infect Dis 2021;21:734. [PMID: 34344351 DOI: 10.1186/s12879-021-06461-5] [Reference Citation Analysis]
225 Lee S, Stokes KL, Currier MG, Sakamoto K, Lukacs NW, Celis E, Moore ML. Vaccine-elicited CD8+ T cells protect against respiratory syncytial virus strain A2-line19F-induced pathogenesis in BALB/c mice. J Virol 2012;86:13016-24. [PMID: 23015695 DOI: 10.1128/JVI.01770-12] [Cited by in Crossref: 41] [Cited by in F6Publishing: 25] [Article Influence: 4.1] [Reference Citation Analysis]
226 Sobrinho FLDV, Aragon DC, Carlotti APCP. Epidemiology and factors associated with the severity of viral acute lower respiratory infection in children hospitalized in Manaus, Amazonas, in 2017-2018: An observational study. Medicine (Baltimore) 2021;100:e25799. [PMID: 33950979 DOI: 10.1097/MD.0000000000025799] [Reference Citation Analysis]
227 Yoshida I, Arikawa K, Honma Y, Inatani S, Yoshinaga M, Sugiyama H. Pharmacological Characterization of TP0591816, a Novel Macrocyclic Respiratory Syncytial Virus Fusion Inhibitor with Antiviral Activity against F Protein Mutants. Antimicrob Agents Chemother 2020;65:e01407-20. [PMID: 33046486 DOI: 10.1128/AAC.01407-20] [Reference Citation Analysis]
228 Stewart CJ, Mansbach JM, Ajami NJ, Petrosino JF, Zhu Z, Liang L, Camargo CA, Hasegawa K. Serum Metabolome Is Associated With the Nasopharyngeal Microbiota and Disease Severity Among Infants With Bronchiolitis. J Infect Dis 2019;219:2005-14. [PMID: 30629185 DOI: 10.1093/infdis/jiz021] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
229 Eroglu E, Singh A, Bawage S, Tiwari PM, Vig K, Pillai SR, Dennis VA, Singh SR. Immunogenicity of RSV F DNA Vaccine in BALB/c Mice. Adv Virol 2016;2016:7971847. [PMID: 27688769 DOI: 10.1155/2016/7971847] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
230 Rezaee F, DeSando SA, Ivanov AI, Chapman TJ, Knowlden SA, Beck LA, Georas SN. Sustained protein kinase D activation mediates respiratory syncytial virus-induced airway barrier disruption. J Virol 2013;87:11088-95. [PMID: 23926335 DOI: 10.1128/JVI.01573-13] [Cited by in Crossref: 50] [Cited by in F6Publishing: 41] [Article Influence: 5.6] [Reference Citation Analysis]
231 Munywoki PK, Koech DC, Agoti CN, Kibirige N, Kipkoech J, Cane PA, Medley GF, Nokes DJ. Influence of age, severity of infection, and co-infection on the duration of respiratory syncytial virus (RSV) shedding. Epidemiol Infect 2015;143:804-12. [PMID: 24901443 DOI: 10.1017/S0950268814001393] [Cited by in Crossref: 49] [Cited by in F6Publishing: 35] [Article Influence: 6.1] [Reference Citation Analysis]
232 Farrag MA, Amer HM, Öhlschläger P, Hamad ME, Almajhdi FN. Novel recombinant DNA vaccine candidates for human respiratory syncytial virus: Preclinical evaluation of immunogenicity and protection efficiency. Hum Vaccin Immunother 2017;13:1586-97. [PMID: 28272978 DOI: 10.1080/21645515.2017.1295190] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
233 Ruckwardt TJ, Morabito KM, Graham BS. Determinants of early life immune responses to RSV infection. Curr Opin Virol 2016;16:151-7. [PMID: 26986236 DOI: 10.1016/j.coviro.2016.01.003] [Cited by in Crossref: 34] [Cited by in F6Publishing: 32] [Article Influence: 5.7] [Reference Citation Analysis]
234 Nolan T, Borja-Tabora C, Lopez P, Weckx L, Ulloa-Gutierrez R, Lazcano-Ponce E, Kerdpanich A, Weber MA, Mascareñas de Los Santos A, Tinoco JC, Safadi MA, Seng LF, Hernandez-de Mezerville M, Faingezicht I, Cruz-Valdez A, Feng Y, Li P, Durviaux S, Haars G, Roy-Ghanta S, Vaughn DW, Taylor S. Prevalence and Incidence of Respiratory Syncytial Virus and Other Respiratory Viral Infections in Children Aged 6 Months to 10 Years With Influenza-like Illness Enrolled in a Randomized Trial. Clin Infect Dis 2015;60:e80-9. [PMID: 25673560 DOI: 10.1093/cid/civ065] [Cited by in Crossref: 28] [Cited by in F6Publishing: 27] [Article Influence: 4.0] [Reference Citation Analysis]
235 Portugal CAA, de Araújo Castro Í, Prates MCM, Gagliardi TB, Martins RB, de Jesus BLS, de Souza Cardoso R, da Silva MVG, Aragon DC, Arruda Neto E, Alves Filho JCF, Cunha FQ, Carlotti APCP. IL-33 and ST2 as predictors of disease severity in children with viral acute lower respiratory infection. Cytokine 2020;127:154965. [PMID: 31901762 DOI: 10.1016/j.cyto.2019.154965] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
236 Fang L, Choudhary S, Tian B, Boldogh I, Yang C, Ivanciuc T, Ma Y, Garofalo RP, Brasier AR. Ataxia telangiectasia mutated kinase mediates NF-κB serine 276 phosphorylation and interferon expression via the IRF7-RIG-I amplification loop in paramyxovirus infection. J Virol 2015;89:2628-42. [PMID: 25520509 DOI: 10.1128/JVI.02458-14] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 2.6] [Reference Citation Analysis]
237 Ezzat K, Pernemalm M, Pålsson S, Roberts TC, Järver P, Dondalska A, Bestas B, Sobkowiak MJ, Levänen B, Sköld M, Thompson EA, Saher O, Kari OK, Lajunen T, Sverremark Ekström E, Nilsson C, Ishchenko Y, Malm T, Wood MJA, Power UF, Masich S, Lindén A, Sandberg JK, Lehtiö J, Spetz AL, El Andaloussi S. The viral protein corona directs viral pathogenesis and amyloid aggregation. Nat Commun 2019;10:2331. [PMID: 31133680 DOI: 10.1038/s41467-019-10192-2] [Cited by in Crossref: 70] [Cited by in F6Publishing: 64] [Article Influence: 23.3] [Reference Citation Analysis]
238 Brüggmann D, Köster C, Klingelhöfer D, Bauer J, Ohlendorf D, Bundschuh M, Groneberg DA. Respiratory syncytial virus: a systematic scientometric analysis of the global publication output and the gender distribution of publishing authors. BMJ Open 2017;7:e013615. [PMID: 28751483 DOI: 10.1136/bmjopen-2016-013615] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
239 Jones BG, Sealy RE, Surman SL, Portner A, Russell CJ, Slobod KS, Dormitzer PR, DeVincenzo J, Hurwitz JL. Sendai virus-based RSV vaccine protects against RSV challenge in an in vivo maternal antibody model. Vaccine 2014;32:3264-73. [PMID: 24721531 DOI: 10.1016/j.vaccine.2014.03.088] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.9] [Reference Citation Analysis]
240 Komoyo GF, Yambiyo BM, Manirakiza A, Gody JC, Muller CP, Hübschen JM, Nakoune E, Snoeck CJ. Epidemiology and genetic characterization of respiratory syncytial virus in children with acute respiratory infections: Findings from the influenza sentinel surveillance network in Central African Republic, 2015 to 2018. Health Sci Rep 2021;4:e298. [PMID: 34013070 DOI: 10.1002/hsr2.298] [Reference Citation Analysis]
241 Pereira N, Cardone C, Lassoued S, Galloux M, Fix J, Assrir N, Lescop E, Bontems F, Eléouët JF, Sizun C. New Insights into Structural Disorder in Human Respiratory Syncytial Virus Phosphoprotein and Implications for Binding of Protein Partners. J Biol Chem 2017;292:2120-31. [PMID: 28031463 DOI: 10.1074/jbc.M116.765958] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 3.5] [Reference Citation Analysis]
242 Huntjens DRH, Ouwerkerk-Mahadevan S, Brochot A, Rusch S, Stevens M, Verloes R. Population Pharmacokinetic Modeling of JNJ-53718678, a Novel Fusion Inhibitor for the Treatment of Respiratory Syncytial Virus: Results from a Phase I, Double-Blind, Randomized, Placebo-Controlled First-in-Human Study in Healthy Adult Subjects. Clin Pharmacokinet 2017;56:1331-42. [PMID: 28238203 DOI: 10.1007/s40262-017-0522-8] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
243 Carter MJ, Mitchell RM, Meyer Sauteur PM, Kelly DF, Trück J. The Antibody-Secreting Cell Response to Infection: Kinetics and Clinical Applications. Front Immunol 2017;8:630. [PMID: 28620385 DOI: 10.3389/fimmu.2017.00630] [Cited by in Crossref: 35] [Cited by in F6Publishing: 32] [Article Influence: 7.0] [Reference Citation Analysis]
244 Chan M, Park JJ, Shi T, Martinón-Torres F, Bont L, Nair H; Respiratory Syncytial Virus Network (ReSViNET). The burden of respiratory syncytial virus (RSV) associated acute lower respiratory infections in children with Down syndrome: A systematic review and meta-analysis. J Glob Health 2017;7:020413. [PMID: 29302319 DOI: 10.7189/jogh.07.020413] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 5.5] [Reference Citation Analysis]
245 Kiti MC, Kinyanjui TM, Koech DC, Munywoki PK, Medley GF, Nokes DJ. Quantifying age-related rates of social contact using diaries in a rural coastal population of Kenya. PLoS One 2014;9:e104786. [PMID: 25127257 DOI: 10.1371/journal.pone.0104786] [Cited by in Crossref: 86] [Cited by in F6Publishing: 65] [Article Influence: 10.8] [Reference Citation Analysis]
246 Feiler MO, Caserta MT, van Wijngaarden E, Thevenet-Morrison K, Hardy DJ, Zhang YV, Dozier AM, Lawrence BP, Jusko TA. Environmental Lead Exposure and Influenza and Respiratory Syncytial Virus Diagnoses in Young Children: A Test-Negative Case-Control Study. Int J Environ Res Public Health 2020;17:E7625. [PMID: 33086756 DOI: 10.3390/ijerph17207625] [Reference Citation Analysis]
247 McFarlane AJ, McSorley HJ, Davidson DJ, Fitch PM, Errington C, Mackenzie KJ, Gollwitzer ES, Johnston CJC, MacDonald AS, Edwards MR, Harris NL, Marsland BJ, Maizels RM, Schwarze J. Enteric helminth-induced type I interferon signaling protects against pulmonary virus infection through interaction with the microbiota. J Allergy Clin Immunol 2017;140:1068-1078.e6. [PMID: 28196762 DOI: 10.1016/j.jaci.2017.01.016] [Cited by in Crossref: 53] [Cited by in F6Publishing: 55] [Article Influence: 10.6] [Reference Citation Analysis]
248 Bianchini S, Silvestri E, Argentiero A, Fainardi V, Pisi G, Esposito S. Role of Respiratory Syncytial Virus in Pediatric Pneumonia. Microorganisms 2020;8:E2048. [PMID: 33371276 DOI: 10.3390/microorganisms8122048] [Reference Citation Analysis]
249 Liang B, Ngwuta JO, Surman S, Kabatova B, Liu X, Lingemann M, Liu X, Yang L, Herbert R, Swerczek J, Chen M, Moin SM, Kumar A, McLellan JS, Kwong PD, Graham BS, Collins PL, Munir S. Improved Prefusion Stability, Optimized Codon Usage, and Augmented Virion Packaging Enhance the Immunogenicity of Respiratory Syncytial Virus Fusion Protein in a Vectored-Vaccine Candidate. J Virol 2017;91:e00189-17. [PMID: 28539444 DOI: 10.1128/JVI.00189-17] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 3.6] [Reference Citation Analysis]
250 Cressey TN, Noton SL, Nagendra K, Braun MR, Fearns R. Mechanism for de novo initiation at two sites in the respiratory syncytial virus promoter. Nucleic Acids Res 2018;46:6785-96. [PMID: 29873775 DOI: 10.1093/nar/gky480] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
251 Ohuma EO, Okiro EA, Ochola R, Sande CJ, Cane PA, Medley GF, Bottomley C, Nokes DJ. The natural history of respiratory syncytial virus in a birth cohort: the influence of age and previous infection on reinfection and disease. Am J Epidemiol 2012;176:794-802. [PMID: 23059788 DOI: 10.1093/aje/kws257] [Cited by in Crossref: 71] [Cited by in F6Publishing: 63] [Article Influence: 7.1] [Reference Citation Analysis]
252 Liljeroos L, Krzyzaniak MA, Helenius A, Butcher SJ. Architecture of respiratory syncytial virus revealed by electron cryotomography. Proc Natl Acad Sci U S A 2013;110:11133-8. [PMID: 23776214 DOI: 10.1073/pnas.1309070110] [Cited by in Crossref: 123] [Cited by in F6Publishing: 113] [Article Influence: 13.7] [Reference Citation Analysis]
253 Reeves SR, Barrow KA, Rich LM, White MP, Shubin NJ, Chan CK, Kang I, Ziegler SF, Piliponsky AM, Wight TN, Debley JS. Respiratory Syncytial Virus Infection of Human Lung Fibroblasts Induces a Hyaluronan-Enriched Extracellular Matrix That Binds Mast Cells and Enhances Expression of Mast Cell Proteases. Front Immunol 2019;10:3159. [PMID: 32047499 DOI: 10.3389/fimmu.2019.03159] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
254 Machado D, Hoffmann J, Moroso M, Rosa-Calatrava M, Endtz H, Terrier O, Paranhos-Baccalà G. RSV Infection in Human Macrophages Promotes CXCL10/IP-10 Expression during Bacterial Co-Infection. Int J Mol Sci 2017;18:E2654. [PMID: 29215596 DOI: 10.3390/ijms18122654] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
255 Freitas AR, Donalisio MR. Respiratory syncytial virus seasonality in Brazil: implications for the immunisation policy for at-risk populations. Mem Inst Oswaldo Cruz 2016;111:294-301. [PMID: 27120006 DOI: 10.1590/0074-02760150341] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.3] [Reference Citation Analysis]
256 O'Konek JJ, Makidon PE, Landers JJ, Cao Z, Malinczak CA, Pannu J, Sun J, Bitko V, Ciotti S, Hamouda T, Wojcinski ZW, Lukacs NW, Fattom A, Baker JR Jr. Intranasal nanoemulsion-based inactivated respiratory syncytial virus vaccines protect against viral challenge in cotton rats. Hum Vaccin Immunother 2015;11:2904-12. [PMID: 26307915 DOI: 10.1080/21645515.2015.1075680] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 2.3] [Reference Citation Analysis]
257 den Hartog G, Jacobino S, Bont L, Cox L, Ulfman LH, Leusen JH, van Neerven RJ. Specificity and Effector Functions of Human RSV-Specific IgG from Bovine Milk. PLoS One 2014;9:e112047. [PMID: 25375837 DOI: 10.1371/journal.pone.0112047] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 2.1] [Reference Citation Analysis]
258 Gamiño-Arroyo AE, Moreno-Espinosa S, Llamosas-Gallardo B, Ortiz-Hernández AA, Guerrero ML, Galindo-Fraga A, Galán-Herrera JF, Prado-Galbarro FJ, Beigel JH, Ruiz-Palacios GM, Noyola DE; Mexico Emerging Infectious Diseases Clinical Research Network (La Red). Epidemiology and clinical characteristics of respiratory syncytial virus infections among children and adults in Mexico. Influenza Other Respir Viruses 2017;11:48-56. [PMID: 27439650 DOI: 10.1111/irv.12414] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.2] [Reference Citation Analysis]
259 Richard CA, Rincheval V, Lassoued S, Fix J, Cardone C, Esneau C, Nekhai S, Galloux M, Rameix-Welti MA, Sizun C, Eléouët JF. RSV hijacks cellular protein phosphatase 1 to regulate M2-1 phosphorylation and viral transcription. PLoS Pathog 2018;14:e1006920. [PMID: 29489893 DOI: 10.1371/journal.ppat.1006920] [Cited by in Crossref: 29] [Cited by in F6Publishing: 24] [Article Influence: 7.3] [Reference Citation Analysis]
260 Chi H, Chung CH, Lin YJ, Lin CH. Seasonal peaks and risk factors of respiratory syncytial virus infections related hospitalization of preterm infants in Taiwan. PLoS One 2018;13:e0197410. [PMID: 29746578 DOI: 10.1371/journal.pone.0197410] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
261 Eguchi K, Fujitani N, Nakagawa H, Miyazaki T. Prevention of respiratory syncytial virus infection with probiotic lactic acid bacterium Lactobacillus gasseri SBT2055. Sci Rep. 2019;9:4812. [PMID: 30886158 DOI: 10.1038/s41598-019-39602-7] [Cited by in Crossref: 43] [Cited by in F6Publishing: 41] [Article Influence: 14.3] [Reference Citation Analysis]
262 Weng K, Zhang J, Mei X, Wu A, Zhang B, Cai M, Zheng Y, Ke Z. Lower number of plasmacytoid dendritic cells in peripheral blood of children with bronchiolitis following respiratory syncytial virus infection. Influenza Other Respir Viruses 2014;8:469-73. [PMID: 24528606 DOI: 10.1111/irv.12242] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.5] [Reference Citation Analysis]
263 Perk Y, Özdil M. Respiratory syncytial virüs infections in neonates and infants. Turk Pediatri Ars 2018;53:63-70. [PMID: 30116126 DOI: 10.5152/TurkPediatriArs.2018.6939] [Cited by in Crossref: 9] [Cited by in F6Publishing: 3] [Article Influence: 2.3] [Reference Citation Analysis]
264 Tian D, Battles MB, Moin SM, Chen M, Modjarrad K, Kumar A, Kanekiyo M, Graepel KW, Taher NM, Hotard AL, Moore ML, Zhao M, Zheng ZZ, Xia NS, McLellan JS, Graham BS. Structural basis of respiratory syncytial virus subtype-dependent neutralization by an antibody targeting the fusion glycoprotein. Nat Commun 2017;8:1877. [PMID: 29187732 DOI: 10.1038/s41467-017-01858-w] [Cited by in Crossref: 30] [Cited by in F6Publishing: 29] [Article Influence: 6.0] [Reference Citation Analysis]
265 Boonyaratanakornkit J, Englund JA, Magaret AS, Bu Y, Tielsch JM, Khatry SK, Katz J, Kuypers J, Shrestha L, LeClerq SC, Steinhoff MC, Chu HY. Primary and Repeated Respiratory Viral Infections Among Infants in Rural Nepal. J Pediatric Infect Dis Soc 2020;9:21-9. [PMID: 30423150 DOI: 10.1093/jpids/piy107] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
266 Chen X, Zhu Y, Wang W, Li C, An S, Lu G, Jin R, Xu B, Zhou Y, Chen A, Li L, Zhang M, Xie Z. A multi-center study on Molecular Epidemiology of Human Respiratory Syncytial Virus from Children with Acute Lower Respiratory Tract Infections in the Mainland of China between 2015 and 2019. Virol Sin 2021. [PMID: 34398429 DOI: 10.1007/s12250-021-00430-7] [Reference Citation Analysis]
267 Manti S, Cuppari C, Lanzafame A, Salpietro C, Betta P, Leonardi S, Perez MK, Piedimonte G. Detection of respiratory syncytial virus (RSV) at birth in a newborn with respiratory distress. Pediatr Pulmonol 2017;52:E81-4. [PMID: 28834426 DOI: 10.1002/ppul.23775] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
268 Kinder JT, Moncman CL, Barrett C, Jin H, Kallewaard N, Dutch RE. Respiratory Syncytial Virus and Human Metapneumovirus Infections in Three-Dimensional Human Airway Tissues Expose an Interesting Dichotomy in Viral Replication, Spread, and Inhibition by Neutralizing Antibodies. J Virol 2020;94:e01068-20. [PMID: 32759319 DOI: 10.1128/JVI.01068-20] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
269 Manzoni P, Figueras-Aloy J, Simões EAF, Checchia PA, Fauroux B, Bont L, Paes B, Carbonell-Estrany X. Defining the Incidence and Associated Morbidity and Mortality of Severe Respiratory Syncytial Virus Infection Among Children with Chronic Diseases. Infect Dis Ther 2017;6:383-411. [PMID: 28653300 DOI: 10.1007/s40121-017-0160-3] [Cited by in Crossref: 32] [Cited by in F6Publishing: 30] [Article Influence: 6.4] [Reference Citation Analysis]
270 Liu M, Li Z, Liu M, Zhu Y, Liu Y, Kuetche MWN, Wang J, Wang X, Liu X, Li X, Wang W, Guo X, Tao L. Association between temperature and COVID-19 transmission in 153 countries. Environ Sci Pollut Res Int 2021. [PMID: 34637125 DOI: 10.1007/s11356-021-16666-5] [Reference Citation Analysis]
271 Hattoufi K, Tligui H, Obtel M, El Ftouh S, Kharbach A, Barkat A. Molecular Diagnosis of Pneumonia Using Multiplex Real-Time PCR Assay RespiFinder® SMART 22 FAST in a Group of Moroccan Infants. Adv Virol 2020;2020:6212643. [PMID: 32148499 DOI: 10.1155/2020/6212643] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
272 Sharma A, Wendland R, Sung B, Wu W, Grunwald T, Worgall S. Maternal immunization with chimpanzee adenovirus expressing RSV fusion protein protects against neonatal RSV pulmonary infection. Vaccine 2014;32:5761-8. [PMID: 25171847 DOI: 10.1016/j.vaccine.2014.08.049] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 1.9] [Reference Citation Analysis]
273 Roggeri DP, Roggeri A, Rossi E, Cataudella S, Martini N. Impact of hospitalizations for bronchiolitis in preterm infants on long-term health care costs in Italy: a retrospective case-control study. Clinicoecon Outcomes Res 2016;8:407-12. [PMID: 27536151 DOI: 10.2147/CEOR.S111535] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
274 Juliana AE, Tang MJ, Kemps L, Noort AC, Hermelijn S, Plötz FB, Zonneveld R, Wilschut JC. Viral causes of severe acute respiratory infection in hospitalized children and association with outcomes: A two-year prospective surveillance study in Suriname. PLoS One 2021;16:e0247000. [PMID: 33606795 DOI: 10.1371/journal.pone.0247000] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
275 Hibino A, Saito R, Taniguchi K, Zaraket H, Shobugawa Y, Matsui T, Suzuki H; Japanese HRSV Collaborative Study Group. Molecular epidemiology of human respiratory syncytial virus among children in Japan during three seasons and hospitalization risk of genotype ON1. PLoS One 2018;13:e0192085. [PMID: 29377949 DOI: 10.1371/journal.pone.0192085] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
276 Maheden K, Todd B, Gordon CJ, Tchesnokov EP, Götte M. Inhibition of viral RNA-dependent RNA polymerases with clinically relevant nucleotide analogs. Enzymes 2021;49:315-54. [PMID: 34696837 DOI: 10.1016/bs.enz.2021.07.002] [Reference Citation Analysis]
277 Sloan C, Moore ML, Hartert T. Impact of pollution, climate, and sociodemographic factors on spatiotemporal dynamics of seasonal respiratory viruses. Clin Transl Sci 2011;4:48-54. [PMID: 21348956 DOI: 10.1111/j.1752-8062.2010.00257.x] [Cited by in Crossref: 52] [Cited by in F6Publishing: 44] [Article Influence: 4.7] [Reference Citation Analysis]
278 Verani JR, McCracken J, Arvelo W, Estevez A, Lopez MR, Reyes L, Moir JC, Bernart C, Moscoso F, Gray J, Olsen SJ, Lindblade KA. Surveillance for hospitalized acute respiratory infection in Guatemala. PLoS One 2013;8:e83600. [PMID: 24391792 DOI: 10.1371/journal.pone.0083600] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 3.0] [Reference Citation Analysis]
279 Koch T, Fathi A, Addo MM. The COVID-19 Vaccine Landscape. Adv Exp Med Biol 2021;1318:549-73. [PMID: 33973199 DOI: 10.1007/978-3-030-63761-3_31] [Reference Citation Analysis]
280 Abbas AT, El-Kafrawy SA, Sohrab SS, Azhar EIA. IgY antibodies for the immunoprophylaxis and therapy of respiratory infections.Hum Vaccin Immunother. 2019;15:264-275. [PMID: 30230944 DOI: 10.1080/21645515.2018.1514224] [Cited by in Crossref: 27] [Cited by in F6Publishing: 23] [Article Influence: 6.8] [Reference Citation Analysis]
281 Citron MP, McAnulty J, Callahan C, Knapp W, Fontenot J, Morales P, Flynn JA, Douglas CM, Espeseth AS. Transplacental Antibody Transfer of Respiratory Syncytial Virus Specific IgG in Non-Human Primate Mother-Infant Pairs. Pathogens 2021;10:1441. [PMID: 34832599 DOI: 10.3390/pathogens10111441] [Reference Citation Analysis]
282 Martens A, Amann G, Schmidt K, Gaupmann R, Böhm B, Dehlink E, Szépfalusi Z, Förster-Waldl E, Berger A, Fyhrquist N, Alenius H, Wisgrill L. An optimized, robust and reproducible protocol to generate well-differentiated primary nasal epithelial models from extremely premature infants. Sci Rep 2019;9:20069. [PMID: 31882915 DOI: 10.1038/s41598-019-56737-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
283 Thuy Tien TT, Park H, Tuong HT, Yu ST, Choi DY, Yeo SJ. Development of a Rapid Fluorescent Immunochromatographic Test to Detect Respiratory Syncytial Virus. Int J Mol Sci 2018;19:E3013. [PMID: 30279406 DOI: 10.3390/ijms19103013] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
284 Laursen RP, Hojsak I. Probiotics for respiratory tract infections in children attending day care centers-a systematic review. Eur J Pediatr 2018;177:979-94. [PMID: 29752587 DOI: 10.1007/s00431-018-3167-1] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 6.8] [Reference Citation Analysis]
285 Vissers M, Habets MN, Ahout IM, Jans J, de Jonge MI, Diavatopoulos DA, Ferwerda G. An in vitro model to study immune responses of human peripheral blood mononuclear cells to human respiratory syncytial virus infection. J Vis Exp 2013;:e50766. [PMID: 24379004 DOI: 10.3791/50766] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
286 de Souza AP, de Freitas DN, Antuntes Fernandes KE, D'Avila da Cunha M, Antunes Fernandes JL, Benetti Gassen R, Fazolo T, Pinto LA, Scotta M, Mattiello R, Pitrez PM, Bonorino C, Stein RT. Respiratory syncytial virus induces phosphorylation of mTOR at ser2448 in CD8 T cells from nasal washes of infected infants. Clin Exp Immunol 2016;183:248-57. [PMID: 26437614 DOI: 10.1111/cei.12720] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.9] [Reference Citation Analysis]
287 Lee YN, Suk Hwang H, Kim MC, Lee YT, Cho MK, Kwon YM, Seok Lee J, Plemper RK, Kang SM. Recombinant influenza virus carrying the conserved domain of respiratory syncytial virus (RSV) G protein confers protection against RSV without inflammatory disease. Virology 2015;476:217-25. [PMID: 25553517 DOI: 10.1016/j.virol.2014.12.004] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
288 Kubale J, Kuan G, Gresh L, Ojeda S, Azziz-Baumgartner E, Sanchez N, Lopez R, Harris E, Balmaseda A, Gordon A. Assessing the Incidence of Symptomatic Respiratory Syncytial Virus Illness Within a Prospective Birth Cohort in Managua, Nicaragua. Clin Infect Dis 2020;70:2029-35. [PMID: 31257406 DOI: 10.1093/cid/ciz585] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
289 Saha S, Pandey BG, Choudekar A, Krishnan A, Gerber SI, Rai SK, Singh P, Chadha M, Lal RB, Broor S. Evaluation of case definitions for estimation of respiratory syncytial virus associated hospitalizations among children in a rural community of northern India. J Glob Health 2015;5:010419. [PMID: 26649172 DOI: 10.7189/jogh.05.020419] [Cited by in Crossref: 21] [Cited by in F6Publishing: 25] [Article Influence: 3.5] [Reference Citation Analysis]
290 Tahamtan A, Inchley CS, Marzban M, Tavakoli-Yaraki M, Teymoori-Rad M, Nakstad B, Salimi V. The role of microRNAs in respiratory viral infection: friend or foe? Rev Med Virol 2016;26:389-407. [PMID: 27373545 DOI: 10.1002/rmv.1894] [Cited by in Crossref: 20] [Cited by in F6Publishing: 26] [Article Influence: 3.3] [Reference Citation Analysis]
291 Paiva TM, Ishida MA, Benega MA, Constantino CR, Silva DB, Santos KC, Oliveira MI, Barbosa HA, Carvalhanas TR, Schuck-Paim C, Alonso WJ. Shift in the timing of respiratory syncytial virus circulation in a subtropical megalopolis: implications for immunoprophylaxis. J Med Virol 2012;84:1825-30. [PMID: 22997087 DOI: 10.1002/jmv.23347] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
292 Pusch E, Renz H, Skevaki C. Respiratory virus-induced heterologous immunity: Part of the problem or part of the solution? Allergo J Int 2018;27:79-96. [PMID: 32226720 DOI: 10.1007/s40629-018-0056-0] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
293 Naja Z, Fayad D, Khafaja S, Chamseddine S, Dbaibo G, Hanna-Wakim R. Bronchiolitis Admissions in a Lebanese Tertiary Medical Center: A 10 Years' Experience. Front Pediatr 2019;7:189. [PMID: 31157192 DOI: 10.3389/fped.2019.00189] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
294 Drazdienė N, Laan M, Zaikauskienė J, Usonis V. Respiratory syncytial virus infection in a selected sample of infants hospitalized for lower respiratory tract infection in Lithuania and Estonia. Acta Med Litu 2017;24:191-8. [PMID: 29487482 DOI: 10.6001/actamedica.v24i4.3614] [Reference Citation Analysis]
295 Alonso WJ, Laranjeira BJ, Pereira SA, Florencio CM, Moreno EC, Miller MA, Giglio R, Schuck-Paim C, Moura FE. Comparative dynamics, morbidity and mortality burden of pediatric viral respiratory infections in an equatorial city. Pediatr Infect Dis J 2012;31:e9-14. [PMID: 22001966 DOI: 10.1097/INF.0b013e31823883be] [Cited by in Crossref: 41] [Cited by in F6Publishing: 20] [Article Influence: 4.1] [Reference Citation Analysis]
296 Ravi LI, Li L, Sutejo R, Chen H, Wong PS, Tan BH, Sugrue RJ. A systems-based approach to analyse the host response in murine lung macrophages challenged with respiratory syncytial virus. BMC Genomics. 2013;14:190. [PMID: 23506210 DOI: 10.1186/1471-2164-14-190] [Cited by in Crossref: 20] [Cited by in F6Publishing: 24] [Article Influence: 2.2] [Reference Citation Analysis]
297 Lederhofer J, van Lent J, Bhoelan F, Karneva Z, de Haan A, Wilschut JC, Stegmann T. Development of a Virosomal RSV Vaccine Containing 3D-PHAD® Adjuvant: Formulation, Composition, and Long-Term Stability. Pharm Res 2018;35:172. [PMID: 29971500 DOI: 10.1007/s11095-018-2453-y] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
298 Nguyen VH, Dubot-Pérès A, Russell FM, Dance DAB, Vilivong K, Phommachan S, Syladeth C, Lai J, Lim R, Morpeth M, Mayxay M, Newton PN, Richet H, De Lamballerie X. Acute respiratory infections in hospitalized children in Vientiane, Lao PDR - the importance of Respiratory Syncytial Virus. Sci Rep 2017;7:9318. [PMID: 28839157 DOI: 10.1038/s41598-017-09006-6] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.2] [Reference Citation Analysis]
299 Buendía JA, Acuña-Cordero R. The cost-effectiveness of hypertonic saline inhalations for infant bronchiolitis. BMC Health Serv Res 2020;20:1001. [PMID: 33138807 DOI: 10.1186/s12913-020-05814-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
300 Janet S, Broad J, Snape MD. Respiratory syncytial virus seasonality and its implications on prevention strategies. Hum Vaccin Immunother 2018;14:234-44. [PMID: 29194014 DOI: 10.1080/21645515.2017.1403707] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.8] [Reference Citation Analysis]
301 Hasegawa K, Mansbach JM, Ajami NJ, Espinola JA, Henke DM, Petrosino JF, Piedra PA, Shaw CA, Sullivan AF, Camargo CA Jr; the MARC-35 Investigators. Association of nasopharyngeal microbiota profiles with bronchiolitis severity in infants hospitalised for bronchiolitis. Eur Respir J 2016;48:1329-39. [PMID: 27799386 DOI: 10.1183/13993003.00152-2016] [Cited by in Crossref: 84] [Cited by in F6Publishing: 85] [Article Influence: 14.0] [Reference Citation Analysis]
302 Kong AM, Krilov LR, Fergie J, Goldstein M, Diakun D, Wade SW, Pavilack M, McLaurin KK. The 2014-2015 National Impact of the 2014 American Academy of Pediatrics Guidance for Respiratory Syncytial Virus Immunoprophylaxis on Preterm Infants Born in the United States. Am J Perinatol 2018;35:192-200. [PMID: 28881376 DOI: 10.1055/s-0037-1606352] [Cited by in Crossref: 25] [Cited by in F6Publishing: 20] [Article Influence: 5.0] [Reference Citation Analysis]
303 Rigter A, Widjaja I, Versantvoort H, Coenjaerts FE, van Roosmalen M, Leenhouts K, Rottier PJ, Haijema BJ, de Haan CA. A protective and safe intranasal RSV vaccine based on a recombinant prefusion-like form of the F protein bound to bacterium-like particles. PLoS One 2013;8:e71072. [PMID: 23951084 DOI: 10.1371/journal.pone.0071072] [Cited by in Crossref: 51] [Cited by in F6Publishing: 53] [Article Influence: 5.7] [Reference Citation Analysis]
304 Céspedes PF, Bueno SM, Ramírez BA, Gomez RS, Riquelme SA, Palavecino CE, Mackern-Oberti JP, Mora JE, Depoil D, Sacristán C, Cammer M, Creneguy A, Nguyen TH, Riedel CA, Dustin ML, Kalergis AM. Surface expression of the hRSV nucleoprotein impairs immunological synapse formation with T cells. Proc Natl Acad Sci U S A 2014;111:E3214-23. [PMID: 25056968 DOI: 10.1073/pnas.1400760111] [Cited by in Crossref: 42] [Cited by in F6Publishing: 40] [Article Influence: 5.3] [Reference Citation Analysis]
305 Al-Zayadneh E, Mohammad Abu Assab D, Adeeb Arabiat E, Al-Iede M, Ahmad Kayed H, Daher A. The burden of influenza and other respiratory viruses in hospitalized infants and children in a university hospital, Jordan. Multidiscip Respir Med 2021;16:763. [PMID: 34900252 DOI: 10.4081/mrm.2021.763] [Reference Citation Analysis]
306 McGill JL, Rusk RA, Guerra-Maupome M, Briggs RE, Sacco RE. Bovine Gamma Delta T Cells Contribute to Exacerbated IL-17 Production in Response to Co-Infection with Bovine RSV and Mannheimia haemolytica. PLoS One 2016;11:e0151083. [PMID: 26942409 DOI: 10.1371/journal.pone.0151083] [Cited by in Crossref: 31] [Cited by in F6Publishing: 29] [Article Influence: 5.2] [Reference Citation Analysis]
307 Buchholz UJ, Cunningham CK, Muresan P, Gnanashanmugam D, Sato P, Siberry GK, Rexroad V, Valentine M, Perlowski C, Schappell E, Thumar B, Luongo C, Barr E, Aziz M, Yogev R, Spector SA, Collins PL, McFarland EJ, Karron RA; International Maternal Pediatric Adolescent AIDS Clinical Trials (IMPAACT) P1114 Study Team. Live Respiratory Syncytial Virus (RSV) Vaccine Candidate Containing Stabilized Temperature-Sensitivity Mutations Is Highly Attenuated in RSV-Seronegative Infants and Children. J Infect Dis 2018;217:1338-46. [PMID: 29509929 DOI: 10.1093/infdis/jiy066] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 8.3] [Reference Citation Analysis]
308 Om C, Daily F, Vlieghe E, McLaughlin JC, McLaws ML. Pervasive antibiotic misuse in the Cambodian community: antibiotic-seeking behaviour with unrestricted access. Antimicrob Resist Infect Control 2017;6:30. [PMID: 28352463 DOI: 10.1186/s13756-017-0187-y] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 2.6] [Reference Citation Analysis]
309 Kassem E, Na'amnih W, Bdair-Amsha A, Zahalkah H, Muhsen K. Comparisons between ethnic groups in hospitalizations for respiratory syncytial virus bronchiolitis in Israel. PLoS One 2019;14:e0214197. [PMID: 30933992 DOI: 10.1371/journal.pone.0214197] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
310 Nagasawa K, Ishiwada N. Disease burden of respiratory syncytial virus infection in the pediatric population in Japan. J Infect Chemother 2021:S1341-321X(21)00318-4. [PMID: 34952776 DOI: 10.1016/j.jiac.2021.11.007] [Reference Citation Analysis]
311 Ning G, Wang X, Wu D, Yin Z, Li Y, Wang H, Yang W. The etiology of community-acquired pneumonia among children under 5 years of age in mainland China, 2001-2015: A systematic review. Hum Vaccin Immunother 2017;13:2742-50. [PMID: 28922613 DOI: 10.1080/21645515.2017.1371381] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 4.4] [Reference Citation Analysis]
312 Zhao X, Qin Q, Zhang X. Outcomes of High-Flow Nasal Cannula Vs. Nasal Continuous Positive Airway Pressure in Young Children With Respiratory Distress: A Systematic Review and Meta-Analysis. Front Pediatr 2021;9:759297. [PMID: 34805049 DOI: 10.3389/fped.2021.759297] [Reference Citation Analysis]
313 Gao Y, Cao J, Xing P, Altmeyer R, Zhang Y. Evaluation of Small Molecule Combinations against Respiratory Syncytial Virus In Vitro. Molecules 2021;26:2607. [PMID: 33946996 DOI: 10.3390/molecules26092607] [Reference Citation Analysis]
314 Hurwitz JL, Jones BG, Penkert RR, Gansebom S, Sun Y, Tang L, Bramley AM, Jain S, McCullers JA, Arnold SR. Low Retinol-Binding Protein and Vitamin D Levels Are Associated with Severe Outcomes in Children Hospitalized with Lower Respiratory Tract Infection and Respiratory Syncytial Virus or Human Metapneumovirus Detection. J Pediatr 2017;187:323-7. [PMID: 28578159 DOI: 10.1016/j.jpeds.2017.04.061] [Cited by in Crossref: 27] [Cited by in F6Publishing: 22] [Article Influence: 5.4] [Reference Citation Analysis]
315 Mehta S, Shin H, Burnett R, North T, Cohen AJ. Ambient particulate air pollution and acute lower respiratory infections: a systematic review and implications for estimating the global burden of disease. Air Qual Atmos Health 2013;6:69-83. [PMID: 23450182 DOI: 10.1007/s11869-011-0146-3] [Cited by in Crossref: 136] [Cited by in F6Publishing: 116] [Article Influence: 12.4] [Reference Citation Analysis]
316 Rudan I, Theodoratou E, Zgaga L, Nair H, Chan KY, Tomlinson M, Tsai A, Biloglav Z, Huda T, El Arifeen S, Chopra M, Campbell H. Setting priorities for development of emerging interventions against childhood pneumonia, meningitis and influenza. J Glob Health 2012;2:010304. [PMID: 23198129 DOI: 10.7189/jogh.02.010304] [Cited by in F6Publishing: 13] [Reference Citation Analysis]
317 Mousa JJ, Sauer MF, Sevy AM, Finn JA, Bates JT, Alvarado G, King HG, Loerinc LB, Fong RH, Doranz BJ, Correia BE, Kalyuzhniy O, Wen X, Jardetzky TS, Schief WR, Ohi MD, Meiler J, Crowe JE Jr. Structural basis for nonneutralizing antibody competition at antigenic site II of the respiratory syncytial virus fusion protein. Proc Natl Acad Sci U S A 2016;113:E6849-58. [PMID: 27791117 DOI: 10.1073/pnas.1609449113] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 4.5] [Reference Citation Analysis]
318 Groves HT, Cuthbertson L, James P, Moffatt MF, Cox MJ, Tregoning JS. Respiratory Disease following Viral Lung Infection Alters the Murine Gut Microbiota. Front Immunol. 2018;9:182. [PMID: 29483910 DOI: 10.3389/fimmu.2018.00182] [Cited by in Crossref: 88] [Cited by in F6Publishing: 83] [Article Influence: 22.0] [Reference Citation Analysis]
319 Feldman AS, He Y, Moore ML, Hershenson MB, Hartert TV. Toward primary prevention of asthma. Reviewing the evidence for early-life respiratory viral infections as modifiable risk factors to prevent childhood asthma. Am J Respir Crit Care Med 2015;191:34-44. [PMID: 25369458 DOI: 10.1164/rccm.201405-0901PP] [Cited by in Crossref: 114] [Cited by in F6Publishing: 79] [Article Influence: 16.3] [Reference Citation Analysis]
320 Yoshihara K, Le MN, Okamoto M, Wadagni AC, Nguyen HA, Toizumi M, Pham E, Suzuki M, Nguyen AT, Oshitani H, Ariyoshi K, Moriuchi H, Hashizume M, Dang DA, Yoshida LM. Association of RSV-A ON1 genotype with Increased Pediatric Acute Lower Respiratory Tract Infection in Vietnam. Sci Rep 2016;6:27856. [PMID: 27306333 DOI: 10.1038/srep27856] [Cited by in Crossref: 34] [Cited by in F6Publishing: 31] [Article Influence: 5.7] [Reference Citation Analysis]
321 Stephens LM, Varga SM. Nanoparticle vaccines against respiratory syncytial virus. Future Virol 2020;15:763-78. [PMID: 33343684 DOI: 10.2217/fvl-2020-0174] [Reference Citation Analysis]
322 Tran LC, Tournus C, Dina J, Morello R, Brouard J, Vabret A. SOFIA®RSV: prospective laboratory evaluation and implementation of a rapid diagnostic test in a pediatric emergency ward. BMC Infect Dis 2017;17:452. [PMID: 28651525 DOI: 10.1186/s12879-017-2557-8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
323 Samuel D, Xing W, Niedziela-Majka A, Wong JS, Hung M, Brendza KM, Perron M, Jordan R, Sperandio D, Liu X, Mackman R, Sakowicz R. GS-5806 inhibits pre- to postfusion conformational changes of the respiratory syncytial virus fusion protein. Antimicrob Agents Chemother 2015;59:7109-12. [PMID: 26324264 DOI: 10.1128/AAC.00761-15] [Cited by in Crossref: 27] [Cited by in F6Publishing: 18] [Article Influence: 3.9] [Reference Citation Analysis]
324 Midgley CM, Haynes AK, Baumgardner JL, Chommanard C, Demas SW, Prill MM, Abedi GR, Curns AT, Watson JT, Gerber SI. Determining the Seasonality of Respiratory Syncytial Virus in the United States: The Impact of Increased Molecular Testing. J Infect Dis 2017;216:345-55. [PMID: 28859428 DOI: 10.1093/infdis/jix275] [Cited by in Crossref: 27] [Cited by in F6Publishing: 22] [Article Influence: 5.4] [Reference Citation Analysis]
325 Turi KN, Romick-Rosendale L, Gebretsadik T, Watanabe M, Brunwasser S, Anderson LJ, Moore ML, Larkin EK, Peebles RS Jr, Hartert TV. Using urine metabolomics to understand the pathogenesis of infant respiratory syncytial virus (RSV) infection and its role in childhood wheezing. Metabolomics 2018;14:135. [PMID: 30830453 DOI: 10.1007/s11306-018-1431-z] [Cited by in Crossref: 15] [Cited by in F6Publishing: 18] [Article Influence: 3.8] [Reference Citation Analysis]
326 McMorrow ML, Tempia S, Walaza S, Treurnicht FK, Moyes J, Cohen AL, Pretorius M, Hellferscee O, Wolter N, von Gottberg A, Nguweneza A, McAnerney JM, Naby F, Mekgoe O, Venter M, Madhi SA, Cohen C. The Role of Human Immunodeficiency Virus in Influenza- and Respiratory Syncytial Virus-associated Hospitalizations in South African Children, 2011-2016. Clin Infect Dis 2019;68:773-80. [PMID: 29961814 DOI: 10.1093/cid/ciy532] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 7.5] [Reference Citation Analysis]
327 Banerji A, Ng K, Moraes TJ, Panzov V, Robinson J, Lee BE. Cost-effectiveness of palivizumab compared to no prophylaxis in term infants residing in the Canadian Arctic. CMAJ Open 2016;4:E623-33. [PMID: 28443266 DOI: 10.9778/cmajo.20150052] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
328 Wang Q, Li W, Qu D, Xin T, Gao P. Fatal pulmonary infection with respiratory syncytial virus in an immunocompromised adult patient: A case report. Medicine (Baltimore) 2018;97:e11528. [PMID: 30024538 DOI: 10.1097/MD.0000000000011528] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
329 Li H, Callahan C, Citron M, Wen Z, Touch S, Monslow MA, Cox KS, DiStefano DJ, Vora KA, Bett A, Espeseth A. Respiratory syncytial virus elicits enriched CD8+ T lymphocyte responses in lung compared with blood in African green monkeys. PLoS One 2017;12:e0187642. [PMID: 29121080 DOI: 10.1371/journal.pone.0187642] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
330 Murray J, Bottle A, Sharland M, Modi N, Aylin P, Majeed A, Saxena S; Medicines for Neonates Investigator Group. Risk factors for hospital admission with RSV bronchiolitis in England: a population-based birth cohort study. PLoS One 2014;9:e89186. [PMID: 24586581 DOI: 10.1371/journal.pone.0089186] [Cited by in Crossref: 106] [Cited by in F6Publishing: 100] [Article Influence: 13.3] [Reference Citation Analysis]
331 Zhang Y, Brooks WA, Goswami D, Rahman M, Luby SP, Erdman DD. A duplex recombinant viral nucleoprotein microbead immunoassay for simultaneous detection of seroresponses to human respiratory syncytial virus and metapneumovirus infections. J Virol Methods 2014;206:55-62. [PMID: 24859050 DOI: 10.1016/j.jviromet.2014.05.008] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
332 Park S, Lee Y, Kwon YM, Lee YT, Kim KH, Ko EJ, Jung JH, Song M, Graham B, Prausnitz MR, Kang SM. Vaccination by microneedle patch with inactivated respiratory syncytial virus and monophosphoryl lipid A enhances the protective efficacy and diminishes inflammatory disease after challenge. PLoS One 2018;13:e0205071. [PMID: 30365561 DOI: 10.1371/journal.pone.0205071] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
333 Stockman LJ, Brooks WA, Streatfield PK, Rahman M, Goswami D, Nahar K, Rahman MZ, Luby SP, Anderson LJ. Challenges to evaluating respiratory syncytial virus mortality in Bangladesh, 2004-2008. PLoS One 2013;8:e53857. [PMID: 23365643 DOI: 10.1371/journal.pone.0053857] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 1.9] [Reference Citation Analysis]
334 Yue C, Kang Z, Ai K, Xu D, Wu J, Pan Y, Yan J, Liu M, Liu Q. Virus infection facilitates the development of severe pneumonia in transplant patients with hematologic malignancies. Oncotarget 2016;7:53930-40. [PMID: 27340772 DOI: 10.18632/oncotarget.10182] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
335 Naqvi STQ, Yasmeen M, Ismail M, Muhammad SA, Nawazish-I-Husain S, Ali A, Munir F, Zhang Q. Designing of Potential Polyvalent Vaccine Model for Respiratory Syncytial Virus by System Level Immunoinformatics Approaches. Biomed Res Int 2021;2021:9940010. [PMID: 34136576 DOI: 10.1155/2021/9940010] [Reference Citation Analysis]
336 Gervassi AL, Horton H. Is Infant Immunity Actively Suppressed or Immature? Virology (Auckl) 2014;2014:1-9. [PMID: 25429207 DOI: 10.4137/VRT.S12248] [Cited by in Crossref: 11] [Cited by in F6Publishing: 20] [Article Influence: 1.4] [Reference Citation Analysis]
337 Hirsch HH. Spatiotemporal Virus Surveillance for Severe Acute Respiratory Infections in Resource-limited Settings: How Deep Need We Go? Clin Infect Dis 2019;68:1126-8. [PMID: 30099498 DOI: 10.1093/cid/ciy663] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
338 Brookes DW, Coates M, Allen H, Daly L, Constant S, Huang S, Hows M, Davis A, Cass L, Ayrton J, Knowles I, Strong P, Rapeport G, Ito K. Late therapeutic intervention with a respiratory syncytial virus L-protein polymerase inhibitor, PC786, on respiratory syncytial virus infection in human airway epithelium. Br J Pharmacol 2018;175:2520-34. [PMID: 29579332 DOI: 10.1111/bph.14221] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
339 Buendía JA, Patiño DG. Costs of Respiratory Syncytial Virus Hospitalizations in Colombia. Pharmacoecon Open 2021;5:71-6. [PMID: 32418086 DOI: 10.1007/s41669-020-00218-7] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 3.5] [Reference Citation Analysis]
340 Cho HJ, Shim SY, Son DW, Sun YH, Tchah H, Jeon IS. Respiratory viruses in neonates hospitalized with acute lower respiratory tract infections. Pediatr Int 2013;55:49-53. [PMID: 22978535 DOI: 10.1111/j.1442-200X.2012.03727.x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
341 Rey-Jurado E, Bohmwald K, Correa HG, Kalergis AM. TCR Repertoire Characterization for T Cells Expanded in Response to hRSV Infection in Mice Immunized with a Recombinant BCG Vaccine. Viruses 2020;12:E233. [PMID: 32093256 DOI: 10.3390/v12020233] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
342 Martínez-Pérez B, de la Torre-Díez I, López-Coronado M, Sainz-De-Abajo B. Comparison of mobile apps for the leading causes of death among different income zones: a review of the literature and app stores. JMIR Mhealth Uhealth 2014;2:e1. [PMID: 25099695 DOI: 10.2196/mhealth.2779] [Cited by in Crossref: 33] [Cited by in F6Publishing: 25] [Article Influence: 4.1] [Reference Citation Analysis]
343 Tokuhara D, Hikita N. Cord Blood-Based Approach to Assess Candidate Vaccine Adjuvants Designed for Neonates and Infants. Vaccines (Basel) 2021;9:95. [PMID: 33514054 DOI: 10.3390/vaccines9020095] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
344 Monteiro AI, Bellei NC, Sousa AR, dos Santos AM, Weckx LY. Respiratory infections in children up to two years of age on prophylaxis with palivizumab. Rev Paul Pediatr 2014;32:152-8. [PMID: 25119744 DOI: 10.1590/0103-0582201432214813] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
345 Bont L, Checchia PA, Fauroux B, Figueras-Aloy J, Manzoni P, Paes B, Simões EA, Carbonell-Estrany X. Defining the Epidemiology and Burden of Severe Respiratory Syncytial Virus Infection Among Infants and Children in Western Countries. Infect Dis Ther 2016;5:271-98. [PMID: 27480325 DOI: 10.1007/s40121-016-0123-0] [Cited by in Crossref: 119] [Cited by in F6Publishing: 109] [Article Influence: 19.8] [Reference Citation Analysis]
346 Turti TV, Baibarina EN, Degtiareva EA, Keshishyan ES, Lobzin YV, Namazova-Вaranova LS, Prodeus AP, Gudkov KM, Kruglova AI, Schulz GA, Notario GF. A prospective, open-label, non-comparative study of palivizumab prophylaxis in children at high risk of serious respiratory syncytial virus disease in the Russian Federation. BMC Res Notes 2012;5:484. [PMID: 22943074 DOI: 10.1186/1756-0500-5-484] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
347 Mackow N, Amaro-Carambot E, Liang B, Surman S, Lingemann M, Yang L, Collins PL, Munir S. Attenuated Human Parainfluenza Virus Type 1 (HPIV1) Expressing the Fusion Glycoprotein of Human Respiratory Syncytial Virus (RSV) as a Bivalent HPIV1/RSV Vaccine. J Virol 2015;89:10319-32. [PMID: 26223633 DOI: 10.1128/JVI.01380-15] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
348 Torres J, Surya W, Li Y, Liu DX. Protein-Protein Interactions of Viroporins in Coronaviruses and Paramyxoviruses: New Targets for Antivirals? Viruses 2015;7:2858-83. [PMID: 26053927 DOI: 10.3390/v7062750] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 2.7] [Reference Citation Analysis]
349 Wadman M. Animal rights: Chimpanzee research on trial. Nature 2011;474:268-71. [PMID: 21677722 DOI: 10.1038/474268a] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
350 Outlaw VK, Lemke JT, Zhu Y, Gellman SH, Porotto M, Moscona A. Structure-Guided Improvement of a Dual HPIV3/RSV Fusion Inhibitor. J Am Chem Soc 2020;142:2140-4. [PMID: 31951396 DOI: 10.1021/jacs.9b11548] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
351 Abarca K, Rey-Jurado E, Muñoz-Durango N, Vázquez Y, Soto JA, Gálvez NMS, Valdés-Ferrada J, Iturriaga C, Urzúa M, Borzutzky A, Cerda J, Villarroel L, Madrid V, González PA, González-Aramundiz JV, Bueno SM, Kalergis AM. Safety and immunogenicity evaluation of recombinant BCG vaccine against respiratory syncytial virus in a randomized, double-blind, placebo-controlled phase I clinical trial. EClinicalMedicine 2020;27:100517. [PMID: 33073219 DOI: 10.1016/j.eclinm.2020.100517] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
352 Tahir Ul Qamar M, Shokat Z, Muneer I, Ashfaq UA, Javed H, Anwar F, Bari A, Zahid B, Saari N. Multiepitope-Based Subunit Vaccine Design and Evaluation against Respiratory Syncytial Virus Using Reverse Vaccinology Approach. Vaccines (Basel) 2020;8:E288. [PMID: 32521680 DOI: 10.3390/vaccines8020288] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 9.0] [Reference Citation Analysis]
353 Anderson EJ, Carbonell-Estrany X, Blanken M, Lanari M, Sheridan-Pereira M, Rodgers-Gray B, Fullarton J, Rouffiac E, Vo P, Notario G, Campbell F, Paes B. Burden of Severe Respiratory Syncytial Virus Disease Among 33-35 Weeks' Gestational Age Infants Born During Multiple Respiratory Syncytial Virus Seasons. Pediatr Infect Dis J 2017;36:160-7. [PMID: 27755464 DOI: 10.1097/INF.0000000000001377] [Cited by in Crossref: 18] [Cited by in F6Publishing: 10] [Article Influence: 3.6] [Reference Citation Analysis]
354 Lee SY, Noh Y, Goo JH, Rho S, Kim MJ, Kang CY, Song M, Kim JO. Natural killer T cell sensitization during neonatal respiratory syncytial virus infection induces eosinophilic lung disease in re-infected adult mice. PLoS One 2017;12:e0176940. [PMID: 28570692 DOI: 10.1371/journal.pone.0176940] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
355 Nickbakhsh S, Thorburn F, VON Wissmann B, McMENAMIN J, Gunson RN, Murcia PR. Extensive multiplex PCR diagnostics reveal new insights into the epidemiology of viral respiratory infections. Epidemiol Infect 2016;144:2064-76. [PMID: 26931455 DOI: 10.1017/S0950268816000339] [Cited by in Crossref: 29] [Cited by in F6Publishing: 19] [Article Influence: 4.8] [Reference Citation Analysis]
356 Yoon BW, Lee SH. Possible therapeutic effect of orally administered ribavirin for respiratory syncytial virus-induced acute respiratory distress syndrome in an immunocompetent patient: a case report. J Med Case Rep 2017;11:353. [PMID: 29258592 DOI: 10.1186/s13256-017-1514-x] [Reference Citation Analysis]
357 Piedimonte G, Perez MK. Respiratory syncytial virus infection and bronchiolitis. Pediatr Rev 2014;35:519-30. [PMID: 25452661 DOI: 10.1542/pir.35-12-519] [Cited by in Crossref: 88] [Cited by in F6Publishing: 79] [Article Influence: 12.6] [Reference Citation Analysis]
358 Martín-Vicente M, González-Riaño C, Barbas C, Jiménez-Sousa MÁ, Brochado-Kith O, Resino S, Martínez I. Metabolic changes during respiratory syncytial virus infection of epithelial cells. PLoS One 2020;15:e0230844. [PMID: 32214395 DOI: 10.1371/journal.pone.0230844] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 5.5] [Reference Citation Analysis]
359 Martín-Vicente M, Resino S, Martínez I. siRNA-Mediated Simultaneous Regulation of the Cellular Innate Immune Response and Human Respiratory Syncytial Virus Replication. Biomolecules 2019;9:E165. [PMID: 31035368 DOI: 10.3390/biom9050165] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
360 You HL, Chang SJ, Yu HR, Li CC, Chen CH, Liao WT. Simultaneous detection of respiratory syncytial virus and human metapneumovirus by one-step multiplex real-time RT-PCR in patients with respiratory symptoms. BMC Pediatr 2017;17:89. [PMID: 28347279 DOI: 10.1186/s12887-017-0843-7] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 2.4] [Reference Citation Analysis]
361 Mastrangelo P, Hegele RG. RSV fusion: time for a new model. Viruses 2013;5:873-85. [PMID: 23518574 DOI: 10.3390/v5030873] [Cited by in Crossref: 32] [Cited by in F6Publishing: 29] [Article Influence: 3.6] [Reference Citation Analysis]
362 Peters RM, Schnee SV, Tabatabai J, Schnitzler P, Pfeil J. Evaluation of Alere i RSV for Rapid Detection of Respiratory Syncytial Virus in Children Hospitalized with Acute Respiratory Tract Infection. J Clin Microbiol 2017;55:1032-6. [PMID: 28077700 DOI: 10.1128/JCM.02433-16] [Cited by in Crossref: 22] [Cited by in F6Publishing: 9] [Article Influence: 4.4] [Reference Citation Analysis]
363 Sakala IG, Eichinger KM, Petrovsky N. Neonatal vaccine effectiveness and the role of adjuvants. Expert Rev Clin Immunol 2019;15:869-78. [PMID: 31293189 DOI: 10.1080/1744666X.2019.1642748] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
364 Lambert L, Sagfors AM, Openshaw PJ, Culley FJ. Immunity to RSV in Early-Life. Front Immunol 2014;5:466. [PMID: 25324843 DOI: 10.3389/fimmu.2014.00466] [Cited by in Crossref: 97] [Cited by in F6Publishing: 98] [Article Influence: 12.1] [Reference Citation Analysis]
365 Maunder HE, Taylor G, Leppard KN, Easton AJ. Intranasal immunisation with recombinant adenovirus vaccines protects against a lethal challenge with pneumonia virus of mice. Vaccine 2015;33:6641-9. [PMID: 26529077 DOI: 10.1016/j.vaccine.2015.10.105] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
366 Poletti P, Merler S, Ajelli M, Manfredi P, Munywoki PK, Nokes D, Melegaro A. Evaluating vaccination strategies for reducing infant respiratory syncytial virus infection in low-income settings. BMC Med 2015;13:49. [PMID: 25857701 DOI: 10.1186/s12916-015-0283-x] [Cited by in Crossref: 46] [Cited by in F6Publishing: 41] [Article Influence: 6.6] [Reference Citation Analysis]
367 Vecino-Ortiz AI, Goldenberg SD, Douthwaite ST, Cheng CY, Glover RE, Mak C, Adams EJ. Impact of a multiplex PCR point-of-care test for influenza A/B and respiratory syncytial virus on an acute pediatric hospital ward. Diagn Microbiol Infect Dis 2018;91:331-5. [PMID: 29706478 DOI: 10.1016/j.diagmicrobio.2018.03.013] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
368 Mohammed NI, Everard ML, Ayres JG, Barker NJ, Litchfield IJ. A Preliminary Assessment of the Role of Ambient Nitric Oxide Exposure in Hospitalization with Respiratory Syncytial Virus Bronchiolitis. Int J Environ Res Public Health 2016;13:E578. [PMID: 27294948 DOI: 10.3390/ijerph13060578] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
369 Schmidt AC, Schaap-Nutt A, Bartlett EJ, Schomacker H, Boonyaratanakornkit J, Karron RA, Collins PL. Progress in the development of human parainfluenza virus vaccines. Expert Rev Respir Med 2011;5:515-26. [PMID: 21859271 DOI: 10.1586/ers.11.32] [Cited by in Crossref: 68] [Cited by in F6Publishing: 63] [Article Influence: 6.2] [Reference Citation Analysis]
370 Tuan TA, Thanh TT, Hai Nt, Tinh le BB, Kim le TN, Do LA, Chinh B'Krong Nt, Tham NT, Hang Vt, Merson L, Farrar J, Thuong TC, de Jong MD, Schultsz C, van Doorn HR. Characterization of hospital and community-acquired respiratory syncytial virus in children with severe lower respiratory tract infections in Ho Chi Minh City, Vietnam, 2010. Influenza Other Respir Viruses 2015;9:110-9. [PMID: 25702707 DOI: 10.1111/irv.12307] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
371 Liang B, Matsuoka Y, Le Nouën C, Liu X, Herbert R, Swerczek J, Santos C, Paneru M, Collins PL, Buchholz UJ, Munir S. A Parainfluenza Virus Vector Expressing the Respiratory Syncytial Virus (RSV) Prefusion F Protein Is More Effective than RSV for Boosting a Primary Immunization with RSV. J Virol 2020;95:e01512-20. [PMID: 33115876 DOI: 10.1128/JVI.01512-20] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
372 Sow FB, Gallup JM, Krishnan S, Patera AC, Suzich J, Ackermann MR. Respiratory syncytial virus infection is associated with an altered innate immunity and a heightened pro-inflammatory response in the lungs of preterm lambs. Respir Res 2011;12:106. [PMID: 21827668 DOI: 10.1186/1465-9921-12-106] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 1.9] [Reference Citation Analysis]
373 Wurzel DF, Ranganathan S. No evidence that heliox inhalation therapy improves important outcomes for infants with bronchiolitis: Heliox inhalation therapy outcomes in infant. J Paediatr Child Health 2016;52:1114-6. [DOI: 10.1111/jpc.13413] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
374 Connelly AR, Jeong BM, Coden ME, Cao JY, Chirkova T, Rosas-Salazar C, Cephus JY, Anderson LJ, Newcomb DC, Hartert TV, Berdnikovs S. Metabolic Reprogramming of Nasal Airway Epithelial Cells Following Infant Respiratory Syncytial Virus Infection. Viruses 2021;13:2055. [PMID: 34696488 DOI: 10.3390/v13102055] [Reference Citation Analysis]
375 Boyoglu-Barnum S, Todd SO, Chirkova T, Barnum TR, Gaston KA, Haynes LM, Tripp RA, Moore ML, Anderson LJ. An anti-G protein monoclonal antibody treats RSV disease more effectively than an anti-F monoclonal antibody in BALB/c mice. Virology 2015;483:117-25. [PMID: 25965801 DOI: 10.1016/j.virol.2015.02.035] [Cited by in Crossref: 44] [Cited by in F6Publishing: 39] [Article Influence: 6.3] [Reference Citation Analysis]
376 de Souza RP, Ribeiro ALR, de Menezes SAF, Machado LFA. Incidence of respiratory syncytial virus infection in children with congenital heart disease undergoing immunoprophylaxis with palivizumab in Pará state, north region of Brazil. BMC Pediatr 2019;19:299. [PMID: 31462289 DOI: 10.1186/s12887-019-1681-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
377 Levitz R, Gao Y, Dozmorov I, Song R, Wakeland EK, Kahn JS. Distinct patterns of innate immune activation by clinical isolates of respiratory syncytial virus. PLoS One 2017;12:e0184318. [PMID: 28877226 DOI: 10.1371/journal.pone.0184318] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 3.2] [Reference Citation Analysis]
378 McGill JL, Kelly SM, Kumar P, Speckhart S, Haughney SL, Henningson J, Narasimhan B, Sacco RE. Efficacy of mucosal polyanhydride nanovaccine against respiratory syncytial virus infection in the neonatal calf. Sci Rep 2018;8:3021. [PMID: 29445124 DOI: 10.1038/s41598-018-21292-2] [Cited by in Crossref: 30] [Cited by in F6Publishing: 27] [Article Influence: 7.5] [Reference Citation Analysis]
379 Lanza K, Perez LG, Costa LB, Cordeiro TM, Palmeira VA, Ribeiro VT, Simões E Silva AC. Covid-19: the renin-angiotensin system imbalance hypothesis. Clin Sci (Lond) 2020;134:1259-64. [PMID: 32507883 DOI: 10.1042/CS20200492] [Cited by in Crossref: 33] [Cited by in F6Publishing: 17] [Article Influence: 16.5] [Reference Citation Analysis]
380 Wang S, Ling Y, Yao Y, Zheng G, Chen W. Luteolin inhibits respiratory syncytial virus replication by regulating the MiR-155/SOCS1/STAT1 signaling pathway. Virol J 2020;17:187. [PMID: 33239033 DOI: 10.1186/s12985-020-01451-6] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 2.5] [Reference Citation Analysis]
381 Noor A, Fiorito T, Krilov LR. Cold Weather Viruses. Pediatr Rev 2019;40:497-507. [PMID: 31575801 DOI: 10.1542/pir.2018-0237] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
382 Huang G, Yu D, Mao N, Zhu Z, Zhang H, Jiang Z, Li H, Zhang Y, Shi J, Zhang S, Wang X, Xu W. Viral etiology of acute respiratory infection in Gansu Province, China, 2011. PLoS One 2013;8:e64254. [PMID: 23691184 DOI: 10.1371/journal.pone.0064254] [Cited by in Crossref: 33] [Cited by in F6Publishing: 29] [Article Influence: 3.7] [Reference Citation Analysis]
383 Phan SI, Adam CM, Chen Z, Citron M, Liang X, Espeseth AS, Wang D, He B. Genetic Stability of Parainfluenza Virus 5-Vectored Human Respiratory Syncytial Virus Vaccine Candidates after In Vitro and In Vivo Passage. J Virol 2017;91:e00559-17. [PMID: 28747497 DOI: 10.1128/JVI.00559-17] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 1.6] [Reference Citation Analysis]
384 Brakel KA, Binjawadagi B, French-Kim K, Watts M, Harder O, Ma Y, Li J, Niewiesk S. Coexpression of respiratory syncytial virus (RSV) fusion (F) protein and attachment glycoprotein (G) in a vesicular stomatitis virus (VSV) vector system provides synergistic effects against RSV infection in a cotton rat model. Vaccine 2021;39:6817-28. [PMID: 34702618 DOI: 10.1016/j.vaccine.2021.10.042] [Reference Citation Analysis]
385 Mejias A, Rodríguez-Fernández R, Oliva S, Peeples ME, Ramilo O. The journey to a respiratory syncytial virus vaccine. Ann Allergy Asthma Immunol 2020;125:36-46. [PMID: 32217187 DOI: 10.1016/j.anai.2020.03.017] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 5.5] [Reference Citation Analysis]
386 Martín-Vicente M, González-Sanz R, Cuesta I, Monzón S, Resino S, Martínez I. Downregulation of A20 Expression Increases the Immune Response and Apoptosis and Reduces Virus Production in Cells Infected by the Human Respiratory Syncytial Virus. Vaccines (Basel) 2020;8:E100. [PMID: 32102364 DOI: 10.3390/vaccines8010100] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
387 Munywoki PK, Hamid F, Mutunga M, Welch S, Cane P, Nokes DJ. Improved detection of respiratory viruses in pediatric outpatients with acute respiratory illness by real-time PCR using nasopharyngeal flocked swabs. J Clin Microbiol 2011;49:3365-7. [PMID: 21775539 DOI: 10.1128/JCM.02231-10] [Cited by in Crossref: 33] [Cited by in F6Publishing: 25] [Article Influence: 3.0] [Reference Citation Analysis]
388 Zhang D, Feng Z, Zhao M, Wang H, Wang L, Yang S, Li G, Lu L, Ma X. Clinical Evaluation of a Single-Tube Multiple RT-PCR Assay for the Detection of 13 Common Virus Types/Subtypes Associated with Acute Respiratory Infection. PLoS One 2016;11:e0152702. [PMID: 27043208 DOI: 10.1371/journal.pone.0152702] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
389 Brunwasser SM, Slavich GM, Newcomb DC, Gebretsadik T, Turi KN, Stone C Jr, Anderson LJ, Hartert TV. Sex-specific association between prenatal life stress exposure and infant pro-inflammatory cytokine levels during acute respiratory infection. Brain Behav Immun 2019;76:275-9. [PMID: 30550928 DOI: 10.1016/j.bbi.2018.12.002] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
390 Schmidt AC. Progress in respiratory virus vaccine development. Semin Respir Crit Care Med 2011;32:527-40. [PMID: 21858754 DOI: 10.1055/s-0031-1283289] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 1.7] [Reference Citation Analysis]
391 Matharu DS, Flaherty DP, Simpson DS, Schroeder CE, Chung D, Yan D, Noah JW, Jonsson CB, White EL, Aubé J, Plemper RK, Severson WE, Golden JE. Optimization of potent and selective quinazolinediones: inhibitors of respiratory syncytial virus that block RNA-dependent RNA-polymerase complex activity. J Med Chem 2014;57:10314-28. [PMID: 25399509 DOI: 10.1021/jm500902x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 2.1] [Reference Citation Analysis]
392 Tang A, Chen Z, Cox KS, Su HP, Callahan C, Fridman A, Zhang L, Patel SB, Cejas PJ, Swoyer R, Touch S, Citron MP, Govindarajan D, Luo B, Eddins M, Reid JC, Soisson SM, Galli J, Wang D, Wen Z, Heidecker GJ, Casimiro DR, DiStefano DJ, Vora KA. A potent broadly neutralizing human RSV antibody targets conserved site IV of the fusion glycoprotein. Nat Commun 2019;10:4153. [PMID: 31515478 DOI: 10.1038/s41467-019-12137-1] [Cited by in Crossref: 25] [Cited by in F6Publishing: 28] [Article Influence: 8.3] [Reference Citation Analysis]
393 Shin HB, Choi MS, Ryu B, Lee NR, Kim HI, Choi HE, Chang J, Lee KT, Jang DS, Inn KS. Antiviral activity of carnosic acid against respiratory syncytial virus. Virol J 2013;10:303. [PMID: 24103432 DOI: 10.1186/1743-422X-10-303] [Cited by in Crossref: 36] [Cited by in F6Publishing: 15] [Article Influence: 4.0] [Reference Citation Analysis]
394 Zhang Y, Yuan L, Zhang Y, Zhang X, Zheng M, Kyaw MH. Burden of respiratory syncytial virus infections in China: Systematic review and meta-analysis. J Glob Health 2015;5:020417. [PMID: 26682049 DOI: 10.7189/jogh.05.020417] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 4.2] [Reference Citation Analysis]
395 Abubakar A, Barakat A, Ahmed A, El Kholy A, Alsawalh L, Al Ariqi L, Rahman Malik M, Obtel M, Sahak M, Mrad P, Triki S, Al Awaidy S, Khan WM. Fourth meeting of the Eastern Mediterranean Acute Respiratory Infection Surveillance (EMARIS) network and first scientific conference on acute respiratory infections in the Eastern Mediterranean Region, 11-14 December, 2017, Amman, Jordan. J Infect Public Health 2020;13:451-6. [PMID: 32144017 DOI: 10.1016/j.jiph.2020.02.031] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
396 Wang D, Chen L, Ding Y, Zhang J, Hua J, Geng Q, Ya X, Zeng S, Wu J, Jiang Y, Zhang T, Zhao G. Viral etiology of medically attended influenza-like illnesses in children less than five years old in Suzhou, China, 2011-2014. J Med Virol 2016;88:1334-40. [PMID: 26792409 DOI: 10.1002/jmv.24480] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 2.5] [Reference Citation Analysis]
397 Barr R, Green CA, Sande CJ, Drysdale SB. Respiratory syncytial virus: diagnosis, prevention and management. Ther Adv Infect Dis 2019;6:2049936119865798. [PMID: 31384456 DOI: 10.1177/2049936119865798] [Cited by in Crossref: 8] [Cited by in F6Publishing: 13] [Article Influence: 2.7] [Reference Citation Analysis]
398 Barton SJ, Murray R, Lillycrop KA, Inskip HM, Harvey NC, Cooper C, Karnani N, Zolezzi IS, Sprenger N, Godfrey KM, Binia A. FUT2 Genetic Variants and Reported Respiratory and Gastrointestinal Illnesses During Infancy. J Infect Dis 2019;219:836-43. [PMID: 30376117 DOI: 10.1093/infdis/jiy582] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
399 Kirin BK, Topić RZ, Dodig S. Hepatitis during respiratory syncytial virus infection--a case report. Biochem Med (Zagreb) 2013;23:112-6. [PMID: 23457772 DOI: 10.11613/bm.2013.014] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
400 Nyiro JU, Sande CJ, Mutunga M, Kiyuka PK, Munywoki PK, Scott JA, Nokes DJ. Absence of Association between Cord Specific Antibody Levels and Severe Respiratory Syncytial Virus (RSV) Disease in Early Infants: A Case Control Study from Coastal Kenya. PLoS One 2016;11:e0166706. [PMID: 27851799 DOI: 10.1371/journal.pone.0166706] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 2.5] [Reference Citation Analysis]
401 van der Fits L, Bolder R, Heemskerk-van der Meer M, Drijver J, van Polanen Y, Serroyen J, Langedijk JPM, Schuitemaker H, Saeland E, Zahn R. Adenovector 26 encoded prefusion conformation stabilized RSV-F protein induces long-lasting Th1-biased immunity in neonatal mice. NPJ Vaccines 2020;5:49. [PMID: 32566260 DOI: 10.1038/s41541-020-0200-y] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
402 Ban J, Lee NR, Lee NJ, Lee JK, Quan FS, Inn KS. Human Respiratory Syncytial Virus NS 1 Targets TRIM25 to Suppress RIG-I Ubiquitination and Subsequent RIG-I-Mediated Antiviral Signaling. Viruses 2018;10:E716. [PMID: 30558248 DOI: 10.3390/v10120716] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 4.8] [Reference Citation Analysis]
403 Mammas IN, Drysdale SB, Rath B, Theodoridou M, Papaioannou G, Papatheodoropoulou A, Koutsounaki E, Koutsaftiki C, Kozanidou E, Achtsidis V, Korovessi P, Chrousos GP, Spandidos DA. Update on current views and advances on RSV infection (Review). Int J Mol Med 2020;46:509-20. [PMID: 32626981 DOI: 10.3892/ijmm.2020.4641] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
404 Nguyen TK, Tran TH, Roberts CL, Graham SM, Marais BJ. Child pneumonia - focus on the Western Pacific Region. Paediatr Respir Rev 2017;21:102-10. [PMID: 27569107 DOI: 10.1016/j.prrv.2016.07.004] [Cited by in Crossref: 5] [Cited by in F6Publishing: 12] [Article Influence: 0.8] [Reference Citation Analysis]
405 Lafond KE, Nair H, Rasooly MH, Valente F, Booy R, Rahman M, Kitsutani P, Yu H, Guzman G, Coulibaly D, Armero J, Jima D, Howie SR, Ampofo W, Mena R, Chadha M, Sampurno OD, Emukule GO, Nurmatov Z, Corwin A, Heraud JM, Noyola DE, Cojocaru R, Nymadawa P, Barakat A, Adedeji A, von Horoch M, Olveda R, Nyatanyi T, Venter M, Mmbaga V, Chittaganpitch M, Nguyen TH, Theo A, Whaley M, Azziz-Baumgartner E, Bresee J, Campbell H, Widdowson MA; Global Respiratory Hospitalizations—Influenza Proportion Positive (GRIPP) Working Group. Global Role and Burden of Influenza in Pediatric Respiratory Hospitalizations, 1982-2012: A Systematic Analysis. PLoS Med 2016;13:e1001977. [PMID: 27011229 DOI: 10.1371/journal.pmed.1001977] [Cited by in Crossref: 175] [Cited by in F6Publishing: 167] [Article Influence: 29.2] [Reference Citation Analysis]
406 Učakar V, Sočan M, Trilar KP. The impact of influenza and respiratory syncytial virus on hospitalizations for lower respiratory tract infections in young children: Slovenia, 2006-2011. Influenza Other Respir Viruses 2013;7:1093-102. [PMID: 23782430 DOI: 10.1111/irv.12134] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
407 Edwards L, Boisson E, Nathaniel-Girdharrie S, Morris-Glasgow V. Distribution of influenza and other acute respiratory viruses during the first year after the 2009-2010 influenza pandemic in the English- and Dutch-speaking Caribbean countries. Influenza Other Respir Viruses 2013;7:1062-9. [PMID: 23745666 DOI: 10.1111/irv.12126] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
408 Roy Mukherjee T, Chanda S, Mullick S, De P, Dey-Sarkar M, Chawla-Sarkar M. Spectrum of respiratory viruses circulating in eastern India: prospective surveillance among patients with influenza-like illness during 2010-2011. J Med Virol 2013;85:1459-65. [PMID: 23765782 DOI: 10.1002/jmv.23607] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
409 Chu HY, Tielsch J, Katz J, Magaret AS, Khatry S, LeClerq SC, Shrestha L, Kuypers J, Steinhoff MC, Englund JA. Transplacental transfer of maternal respiratory syncytial virus (RSV) antibody and protection against RSV disease in infants in rural Nepal. J Clin Virol 2017;95:90-5. [PMID: 28903080 DOI: 10.1016/j.jcv.2017.08.017] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 5.4] [Reference Citation Analysis]
410 Otieno JR, Kamau EM, Agoti CN, Lewa C, Otieno G, Bett A, Ngama M, Cane PA, Nokes DJ. Spread and Evolution of Respiratory Syncytial Virus A Genotype ON1, Coastal Kenya, 2010-2015. Emerg Infect Dis 2017;23:264-71. [PMID: 28098528 DOI: 10.3201/eid2302.161149] [Cited by in Crossref: 36] [Cited by in F6Publishing: 31] [Article Influence: 9.0] [Reference Citation Analysis]
411 Abubakar A, Barakat A, Ahmed A, El Kholy A, Alsawalh L, Al Ariqi L, Malik MR, Obtel M, Sahak M, Mrad P, Triki S, Al Awaidy S, Khan WM. Fourth meeting of the Eastern Mediterranean Acute Respiratory Infection Surveillance (EMARIS) network and first scientific conference on acute respiratory infections in the Eastern Mediterranean Region, 11-14 December, 2017, Amman, Jordan. J Infect Public Health 2019;12:534-9. [PMID: 30733047 DOI: 10.1016/j.jiph.2019.01.062] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
412 Stephens LM, Ross KA, Waldstein KA, Legge KL, McLellan JS, Narasimhan B, Varga SM. Prefusion F-Based Polyanhydride Nanovaccine Induces Both Humoral and Cell-Mediated Immunity Resulting in Long-Lasting Protection against Respiratory Syncytial Virus. J Immunol 2021;206:2122-34. [PMID: 33827894 DOI: 10.4049/jimmunol.2100018] [Reference Citation Analysis]
413 Groothuis JR, Hoopes JM, Jessie VG. Prevention of serious respiratory syncytial virus-related illness. I: Disease pathogenesis and early attempts at prevention. Adv Ther 2011;28:91-109. [PMID: 21318606 DOI: 10.1007/s12325-010-0100-z] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 2.1] [Reference Citation Analysis]
414 Galanti M, Birger R, Ud-Dean M, Filip I, Morita H, Comito D, Anthony S, Freyer GA, Ibrahim S, Lane B, Ligon C, Rabadan R, Shittu A, Tagne E, Shaman J. Longitudinal active sampling for respiratory viral infections across age groups. Influenza Other Respir Viruses 2019;13:226-32. [PMID: 30770641 DOI: 10.1111/irv.12629] [Cited by in Crossref: 17] [Cited by in F6Publishing: 22] [Article Influence: 5.7] [Reference Citation Analysis]
415 Zandi M, Soltani S, Fani M, Abbasi S, Ebrahimi S, Ramezani A. Severe acute respiratory syndrome coronavirus 2 and respiratory syncytial virus coinfection in children. Osong Public Health Res Perspect 2021;12:286-92. [PMID: 34719220 DOI: 10.24171/j.phrp.2021.0140] [Reference Citation Analysis]
416 Russell CJ, Simões EAF, Hurwitz JL. Vaccines for the Paramyxoviruses and Pneumoviruses: Successes, Candidates, and Hurdles. Viral Immunol 2018;31:133-41. [PMID: 29323621 DOI: 10.1089/vim.2017.0137] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
417 Coates M, Brookes D, Kim YI, Allen H, Fordyce EAF, Meals EA, Colley T, Ciana CL, Parra GF, Sherbukhin V, Stockwell JA, Thomas JC, Hunt SF, Anderson-Dring L, Onions ST, Cass L, Murray PJ, Ito K, Strong P, DeVincenzo JP, Rapeport G. Preclinical Characterization of PC786, an Inhaled Small-Molecule Respiratory Syncytial Virus L Protein Polymerase Inhibitor. Antimicrob Agents Chemother 2017;61:e00737-17. [PMID: 28652242 DOI: 10.1128/AAC.00737-17] [Cited by in Crossref: 20] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
418 Pitzer VE, Viboud C, Alonso WJ, Wilcox T, Metcalf CJ, Steiner CA, Haynes AK, Grenfell BT. Environmental drivers of the spatiotemporal dynamics of respiratory syncytial virus in the United States. PLoS Pathog 2015;11:e1004591. [PMID: 25569275 DOI: 10.1371/journal.ppat.1004591] [Cited by in Crossref: 70] [Cited by in F6Publishing: 53] [Article Influence: 10.0] [Reference Citation Analysis]
419 Atwell JE, Thumar B, Robinson LJ, Tobby R, Yambo P, Ome-Kaius M, Siba PM, Unger HW, Rogerson SJ, King CL, Karron RA. Impact of Placental Malaria and Hypergammaglobulinemia on Transplacental Transfer of Respiratory Syncytial Virus Antibody in Papua New Guinea. J Infect Dis 2016;213:423-31. [PMID: 26238686 DOI: 10.1093/infdis/jiv401] [Cited by in Crossref: 25] [Cited by in F6Publishing: 28] [Article Influence: 3.6] [Reference Citation Analysis]
420 Kimura D, Saravia J, Jaligama S, McNamara I, Vu LD, Sullivan RD, Mancarella S, You D, Cormier SA. New mouse model of pulmonary hypertension induced by respiratory syncytial virus bronchiolitis. Am J Physiol Heart Circ Physiol 2018;315:H581-9. [PMID: 29906223 DOI: 10.1152/ajpheart.00627.2017] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
421 Oren E, Frere J, Yom-Tov E, Yom-Tov E. Respiratory syncytial virus tracking using internet search engine data. BMC Public Health 2018;18:445. [PMID: 29615018 DOI: 10.1186/s12889-018-5367-z] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 2.8] [Reference Citation Analysis]
422 To J, Surya W, Torres J. Targeting the Channel Activity of Viroporins. Adv Protein Chem Struct Biol 2016;104:307-55. [PMID: 27038378 DOI: 10.1016/bs.apcsb.2015.12.003] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.7] [Reference Citation Analysis]
423 Kebede TT, Svensson M, Addissie A, Trollfors B, Andersson R. Cost-effectiveness of childhood pneumococcal vaccination program in Ethiopia: results from a quasi-experimental evaluation. BMC Public Health 2019;19:1078. [PMID: 31399030 DOI: 10.1186/s12889-019-7423-8] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
424 Sakthivel SK, Whitaker B, Lu X, Oliveira DB, Stockman LJ, Kamili S, Oberste MS, Erdman DD. Comparison of fast-track diagnostics respiratory pathogens multiplex real-time RT-PCR assay with in-house singleplex assays for comprehensive detection of human respiratory viruses. J Virol Methods 2012;185:259-66. [PMID: 22796035 DOI: 10.1016/j.jviromet.2012.07.010] [Cited by in Crossref: 58] [Cited by in F6Publishing: 53] [Article Influence: 5.8] [Reference Citation Analysis]
425 Lee YT, Kwon YM, Kang SM. Do recombinant-engineered nanoparticle vaccines hold promise for the prevention of respiratory syncytial virus? Nanomedicine (Lond) 2016;11:439-42. [PMID: 26893211 DOI: 10.2217/nnm.16.2] [Reference Citation Analysis]
426 Schmidt ME, Varga SM. Modulation of the host immune response by respiratory syncytial virus proteins. J Microbiol 2017;55:161-71. [PMID: 28243940 DOI: 10.1007/s12275-017-7045-8] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 2.6] [Reference Citation Analysis]
427 Trento A, Ábrego L, Rodriguez-Fernandez R, González-Sánchez MI, González-Martínez F, Delfraro A, Pascale JM, Arbiza J, Melero JA. Conservation of G-Protein Epitopes in Respiratory Syncytial Virus (Group A) Despite Broad Genetic Diversity: Is Antibody Selection Involved in Virus Evolution? J Virol 2015;89:7776-85. [PMID: 25995258 DOI: 10.1128/JVI.00467-15] [Cited by in Crossref: 49] [Cited by in F6Publishing: 26] [Article Influence: 7.0] [Reference Citation Analysis]
428 Milne G, Hames T, Scotton C, Gent N, Johnsen A, Anderson RM, Ward T. Does infection with or vaccination against SARS-CoV-2 lead to lasting immunity? Lancet Respir Med 2021:S2213-2600(21)00407-0. [PMID: 34688434 DOI: 10.1016/S2213-2600(21)00407-0] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
429 Capella C, Chaiwatpongsakorn S, Gorrell E, Risch ZA, Ye F, Mertz SE, Johnson SM, Moore-Clingenpeel M, Ramilo O, Mejias A, Peeples ME. Prefusion F, Postfusion F, G Antibodies, and Disease Severity in Infants and Young Children With Acute Respiratory Syncytial Virus Infection. J Infect Dis 2017;216:1398-406. [PMID: 29029312 DOI: 10.1093/infdis/jix489] [Cited by in Crossref: 57] [Cited by in F6Publishing: 55] [Article Influence: 11.4] [Reference Citation Analysis]
430 Elgizouli M, Logan C, Nieters A, Brenner H, Rothenbacher D. Cord blood PRF1 methylation patterns and risk of lower respiratory tract infections in infants: findings from the Ulm Birth Cohort. Medicine (Baltimore) 2015;94:e332. [PMID: 25569648 DOI: 10.1097/MD.0000000000000332] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
431 Zar HJ, Madhi SA, Aston SJ, Gordon SB. Pneumonia in low and middle income countries: progress and challenges. Thorax 2013;68:1052-6. [PMID: 23956020 DOI: 10.1136/thoraxjnl-2013-204247] [Cited by in Crossref: 62] [Cited by in F6Publishing: 57] [Article Influence: 6.9] [Reference Citation Analysis]
432 Tian B, Zhao Y, Kalita M, Edeh CB, Paessler S, Casola A, Teng MN, Garofalo RP, Brasier AR. CDK9-dependent transcriptional elongation in the innate interferon-stimulated gene response to respiratory syncytial virus infection in airway epithelial cells. J Virol 2013;87:7075-92. [PMID: 23596302 DOI: 10.1128/JVI.03399-12] [Cited by in Crossref: 45] [Cited by in F6Publishing: 39] [Article Influence: 5.0] [Reference Citation Analysis]
433 Liesman RM, Buchholz UJ, Luongo CL, Yang L, Proia AD, DeVincenzo JP, Collins PL, Pickles RJ. RSV-encoded NS2 promotes epithelial cell shedding and distal airway obstruction. J Clin Invest 2014;124:2219-33. [PMID: 24713657 DOI: 10.1172/JCI72948] [Cited by in Crossref: 69] [Cited by in F6Publishing: 51] [Article Influence: 8.6] [Reference Citation Analysis]
434 Anderson LJ, Dormitzer PR, Nokes DJ, Rappuoli R, Roca A, Graham BS. Strategic priorities for respiratory syncytial virus (RSV) vaccine development. Vaccine 2013;31 Suppl 2:B209-15. [PMID: 23598484 DOI: 10.1016/j.vaccine.2012.11.106] [Cited by in Crossref: 168] [Cited by in F6Publishing: 149] [Article Influence: 21.0] [Reference Citation Analysis]
435 Villamil JPS, Polack FP, Buendía JA. Disability-adjusted life years for respiratory syncytial virus in children under 2 years. BMC Public Health 2020;20:1679. [PMID: 33167966 DOI: 10.1186/s12889-020-09796-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
436 Jung JW. Respiratory syncytial virus infection in children with congenital heart disease: global data and interim results of Korean RSV-CHD survey. Korean J Pediatr 2011;54:192-6. [PMID: 21829409 DOI: 10.3345/kjp.2011.54.5.192] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 1.5] [Reference Citation Analysis]
437 Siefker DT, Vu L, You D, McBride A, Taylor R, Jones TL, DeVincenzo J, Cormier SA. Respiratory Syncytial Virus Disease Severity Is Associated with Distinct CD8+ T-Cell Profiles. Am J Respir Crit Care Med 2020;201:325-34. [PMID: 31644878 DOI: 10.1164/rccm.201903-0588OC] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 5.5] [Reference Citation Analysis]
438 Wangui J, Nokes DJ, Mobegi VA, Otieno JR, Agoti CN, Ngeranwa JJN, Bulimo WD. Spatial-temporal distribution and sequence diversity of group a human respiratory syncytial viruses in Kenya preceding the emergence of ON1 genotype. Influenza Other Respir Viruses 2021. [PMID: 34962085 DOI: 10.1111/irv.12948] [Reference Citation Analysis]
439 Semple MG, Taylor-Robinson DC, Lane S, Smyth RL. Household tobacco smoke and admission weight predict severe bronchiolitis in infants independent of deprivation: prospective cohort study. PLoS One 2011;6:e22425. [PMID: 21811609 DOI: 10.1371/journal.pone.0022425] [Cited by in Crossref: 37] [Cited by in F6Publishing: 32] [Article Influence: 3.4] [Reference Citation Analysis]
440 Liu Z, Ma N, Zhong Y, Yang ZQ. Antiviral effect of emodin from Rheum palmatum against coxsakievirus B5 and human respiratory syncytial virus in vitro. J Huazhong Univ Sci Technolog Med Sci. 2015;35:916-922. [PMID: 26670446 DOI: 10.1007/s11596-015-1528-9] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
441 Colvin JM, Jaffe DM, Muenzer JT. Evaluation of the precision of emergency department diagnoses in young children with fever. Clin Pediatr (Phila) 2012;51:51-7. [PMID: 21868591 DOI: 10.1177/0009922811417295] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
442 Noton SL, Deflubé LR, Tremaglio CZ, Fearns R. The respiratory syncytial virus polymerase has multiple RNA synthesis activities at the promoter. PLoS Pathog 2012;8:e1002980. [PMID: 23093940 DOI: 10.1371/journal.ppat.1002980] [Cited by in Crossref: 57] [Cited by in F6Publishing: 54] [Article Influence: 5.7] [Reference Citation Analysis]
443 Berbers G, Mollema L, van der Klis F, den Hartog G, Schepp R. Antibody Responses to Respiratory Syncytial Virus: A Cross-Sectional Serosurveillance Study in the Dutch Population Focusing on Infants Younger Than 2 Years. J Infect Dis 2021;224:269-78. [PMID: 32964923 DOI: 10.1093/infdis/jiaa483] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
444 Kinyanjui T, Pan-Ngum W, Saralamba S, Taylor S, White L, Nokes DJ. Model evaluation of target product profiles of an infant vaccine against respiratory syncytial virus (RSV) in a developed country setting. Vaccine X 2020;4:100055. [PMID: 32123865 DOI: 10.1016/j.jvacx.2020.100055] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
445 Cevigney R, Leary C, Gonik B. Adjustable Algorithmic Tool for Assessing the Effectiveness of Maternal Respiratory Syncytial Virus (RSV) Vaccination on Infant Mortality in Developing Countries. Infect Dis Obstet Gynecol 2021;2021:5536633. [PMID: 34121834 DOI: 10.1155/2021/5536633] [Reference Citation Analysis]
446 Yurtseven A, Turan C, Erseven E, Saz EU. Comparison of heated humidified high-flow nasal cannula flow rates (1-L·kg·min-1 vs 2-L·kg·min -1 ) in the management of acute bronchiolitis. Pediatr Pulmonol 2019;54:894-900. [PMID: 30887731 DOI: 10.1002/ppul.24318] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
447 Rudan I, Nair H, Marušić A, Campbell H. Reducing mortality from childhood pneumonia and diarrhoea: The leading priority is also the greatest opportunity. J Glob Health 2013;3:010101. [PMID: 23826497 DOI: 10.7189/jogh.03.010101] [Cited by in Crossref: 89] [Cited by in F6Publishing: 25] [Article Influence: 9.9] [Reference Citation Analysis]
448 Schmidt MR, McGinnes LW, Kenward SA, Willems KN, Woodland RT, Morrison TG. Long-term and memory immune responses in mice against Newcastle disease virus-like particles containing respiratory syncytial virus glycoprotein ectodomains. J Virol 2012;86:11654-62. [PMID: 22896618 DOI: 10.1128/JVI.01510-12] [Cited by in Crossref: 38] [Cited by in F6Publishing: 18] [Article Influence: 3.8] [Reference Citation Analysis]
449 Schmidt ME, Oomens AGP, Varga SM. Vaccination with a Single-Cycle Respiratory Syncytial Virus Is Immunogenic and Protective in Mice. J Immunol 2019;202:3234-45. [PMID: 31004010 DOI: 10.4049/jimmunol.1900050] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
450 Schmidt MR, McGinnes-Cullen LW, Kenward SA, Willems KN, Woodland RT, Morrison TG. Modification of the respiratory syncytial virus f protein in virus-like particles impacts generation of B cell memory. J Virol 2014;88:10165-76. [PMID: 24965456 DOI: 10.1128/JVI.01250-14] [Cited by in Crossref: 17] [Cited by in F6Publishing: 11] [Article Influence: 2.1] [Reference Citation Analysis]
451 Papenburg J, Carbonneau J, Hamelin MÈ, Isabel S, Bouhy X, Ohoumanne N, Déry P, Paes BA, Corbeil J, Bergeron MG, De Serres G, Boivin G. Molecular evolution of respiratory syncytial virus fusion gene, Canada, 2006-2010. Emerg Infect Dis 2012;18:120-4. [PMID: 22264682 DOI: 10.3201/eid1801.110515] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 2.6] [Reference Citation Analysis]
452 Díez-Domingo J, Pérez-Yarza EG, Melero JA, Sánchez-Luna M, Aguilar MD, Blasco AJ, Alfaro N, Lázaro P. Social, economic, and health impact of the respiratory syncytial virus: a systematic search. BMC Infect Dis 2014;14:544. [PMID: 25358423 DOI: 10.1186/s12879-014-0544-x] [Cited by in Crossref: 49] [Cited by in F6Publishing: 44] [Article Influence: 6.1] [Reference Citation Analysis]
453 Goritzka M, Pereira C, Makris S, Durant LR, Johansson C. T cell responses are elicited against Respiratory Syncytial Virus in the absence of signalling through TLRs, RLRs and IL-1R/IL-18R. Sci Rep 2015;5:18533. [PMID: 26688048 DOI: 10.1038/srep18533] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 2.3] [Reference Citation Analysis]
454 You D, Siefker DT, Shrestha B, Saravia J, Cormier SA. Building a better neonatal mouse model to understand infant respiratory syncytial virus disease. Respir Res 2015;16:91. [PMID: 26231396 DOI: 10.1186/s12931-015-0244-0] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
455 Lam TT, Tang JW, Lai FY, Zaraket H, Dbaibo G, Bialasiewicz S, Tozer S, Heraud JM, Drews SJ, Hachette T, Chan PK, Koay ES, Lee HK, Tee KK, Liu Y, Fraaij P, Jennings L, Waris M, Krajden M, Corriveau A, Jalal H, Nishimura H, Nymadawa P, Badarch D, Watanabe A, Kabanda A, Sloots T, Kok J, Dwyer DE, Koopmans M; INSPIRE (International Network for the Sequencing of Respiratory Viruses). Comparative global epidemiology of influenza, respiratory syncytial and parainfluenza viruses, 2010-2015. J Infect 2019;79:373-82. [PMID: 31323249 DOI: 10.1016/j.jinf.2019.07.008] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 9.3] [Reference Citation Analysis]
456 Nederend M, van Stigt AH, Jansen JHM, Jacobino SR, Brugman S, de Haan CAM, Bont LJ, van Neerven RJJ, Leusen JHW. Bovine IgG Prevents Experimental Infection With RSV and Facilitates Human T Cell Responses to RSV. Front Immunol 2020;11:1701. [DOI: 10.3389/fimmu.2020.01701] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
457 de Steenhuijsen Piters WA, Heinonen S, Hasrat R, Bunsow E, Smith B, Suarez-Arrabal MC, Chaussabel D, Cohen DM, Sanders EA, Ramilo O, Bogaert D, Mejias A. Nasopharyngeal Microbiota, Host Transcriptome, and Disease Severity in Children with Respiratory Syncytial Virus Infection. Am J Respir Crit Care Med 2016;194:1104-15. [PMID: 27135599 DOI: 10.1164/rccm.201602-0220OC] [Cited by in Crossref: 207] [Cited by in F6Publishing: 127] [Article Influence: 41.4] [Reference Citation Analysis]
458 Tian B, Yang J, Zhao Y, Ivanciuc T, Sun H, Wakamiya M, Garofalo RP, Brasier AR. Central Role of the NF-κB Pathway in the Scgb1a1-Expressing Epithelium in Mediating Respiratory Syncytial Virus-Induced Airway Inflammation. J Virol 2018;92:e00441-18. [PMID: 29593031 DOI: 10.1128/JVI.00441-18] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 4.8] [Reference Citation Analysis]
459 Rostad CA, Stobart CC, Gilbert BE, Pickles RJ, Hotard AL, Meng J, Blanco JCG, Moin SM, Graham BS, Piedra PA, Moore ML. A Recombinant Respiratory Syncytial Virus Vaccine Candidate Attenuated by a Low-Fusion F Protein Is Immunogenic and Protective against Challenge in Cotton Rats. J Virol 2016;90:7508-18. [PMID: 27279612 DOI: 10.1128/JVI.00012-16] [Cited by in Crossref: 37] [Cited by in F6Publishing: 25] [Article Influence: 6.2] [Reference Citation Analysis]
460 Obodai E, Asmah R, Boamah I, Goka B, Odoom JK, Adiku T. Respiratory syncytial virus genotypes circulating in urban Ghana: February to November 2006. Pan Afr Med J 2014;19:128. [PMID: 25745535 DOI: 10.11604/pamj.2014.19.128.4749] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
461 Rehder KJ, Wilson EA, Zimmerman KO, Cunningham CK, Turner DA. Detection of Multiple Respiratory Viruses Associated With Mortality and Severity of Illness in Children. Pediatr Crit Care Med 2015;16:e201-6. [PMID: 26121097 DOI: 10.1097/PCC.0000000000000492] [Cited by in Crossref: 12] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
462 Kamphuis T, Meijerhof T, Stegmann T, Lederhofer J, Wilschut J, de Haan A. Immunogenicity and protective capacity of a virosomal respiratory syncytial virus vaccine adjuvanted with monophosphoryl lipid A in mice. PLoS One 2012;7:e36812. [PMID: 22590614 DOI: 10.1371/journal.pone.0036812] [Cited by in Crossref: 56] [Cited by in F6Publishing: 54] [Article Influence: 5.6] [Reference Citation Analysis]
463 Currier MG, Lee S, Stobart CC, Hotard AL, Villenave R, Meng J, Pretto CD, Shields MD, Nguyen MT, Todd SO, Chi MH, Hammonds J, Krumm SA, Spearman P, Plemper RK, Sakamoto K, Peebles RS Jr, Power UF, Moore ML. EGFR Interacts with the Fusion Protein of Respiratory Syncytial Virus Strain 2-20 and Mediates Infection and Mucin Expression. PLoS Pathog 2016;12:e1005622. [PMID: 27152417 DOI: 10.1371/journal.ppat.1005622] [Cited by in Crossref: 29] [Cited by in F6Publishing: 27] [Article Influence: 4.8] [Reference Citation Analysis]
464 Luo X, Liu T, Wang Y, Jia H, Zhang Y, Caballero D, Du J, Wang RE, Wang D, Schultz PG, Wang F. An Epitope-Specific Respiratory Syncytial Virus Vaccine Based on an Antibody Scaffold. Angew Chem Int Ed Engl 2015;54:14531-4. [PMID: 26434555 DOI: 10.1002/anie.201507928] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
465 Yamaji Y, Sawada A, Yasui Y, Ito T, Nakayama T. Simultaneous Administration of Recombinant Measles Viruses Expressing Respiratory Syncytial Virus Fusion (F) and Nucleo (N) Proteins Induced Humoral and Cellular Immune Responses in Cotton Rats. Vaccines (Basel) 2019;7:E27. [PMID: 30836661 DOI: 10.3390/vaccines7010027] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
466 Fall A, Dia N, Cisse el HA, Kiori DE, Sarr FD, Sy S, Goudiaby D, Richard V, Niang MN. Epidemiology and Molecular Characterization of Human Respiratory Syncytial Virus in Senegal after Four Consecutive Years of Surveillance, 2012-2015. PLoS One. 2016;11:e0157163. [PMID: 27315120 DOI: 10.1371/journal.pone.0157163] [Cited by in Crossref: 34] [Cited by in F6Publishing: 31] [Article Influence: 5.7] [Reference Citation Analysis]
467 Crow R, Mutyara K, Agustian D, Kartasasmita CB, Simões EAF. Risk Factors for Respiratory Syncytial Virus Lower Respiratory Tract Infections: Evidence from an Indonesian Cohort. Viruses 2021;13:331. [PMID: 33669911 DOI: 10.3390/v13020331] [Reference Citation Analysis]
468 Nair H, Simões EA, Rudan I, Gessner BD, Azziz-Baumgartner E, Zhang JSF, Feikin DR, Mackenzie GA, Moiïsi JC, Roca A, Baggett HC, Zaman SM, Singleton RJ, Lucero MG, Chandran A, Gentile A, Cohen C, Krishnan A, Bhutta ZA, Arguedas A, Clara AW, Andrade AL, Ope M, Ruvinsky RO, Hortal M, McCracken JP, Madhi SA, Bruce N, Qazi SA, Morris SS, El Arifeen S, Weber MW, Scott JAG, Brooks WA, Breiman RF, Campbell H; Severe Acute Lower Respiratory Infections Working Group. Global and regional burden of hospital admissions for severe acute lower respiratory infections in young children in 2010: a systematic analysis. Lancet 2013;381:1380-90. [PMID: 23369797 DOI: 10.1016/S0140-6736(12)61901-1] [Cited by in Crossref: 378] [Cited by in F6Publishing: 253] [Article Influence: 42.0] [Reference Citation Analysis]
469 Soto JA, Gálvez NMS, Pacheco GA, Bueno SM, Kalergis AM. Antibody development for preventing the human respiratory syncytial virus pathology. Mol Med 2020;26:35. [PMID: 32303184 DOI: 10.1186/s10020-020-00162-6] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 7.0] [Reference Citation Analysis]
470 Carroll KN, Gebretsadik T, Larkin EK, Dupont WD, Liu Z, Van Driest S, Hartert TV. Relationship of maternal vitamin D level with maternal and infant respiratory disease. Am J Obstet Gynecol 2011;205:215.e1-7. [PMID: 21658670 DOI: 10.1016/j.ajog.2011.04.002] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 2.3] [Reference Citation Analysis]
471 Bawage SS, Tiwari PM, Pillai S, Dennis VA, Singh SR. Antibiotic Minocycline Prevents Respiratory Syncytial Virus Infection. Viruses 2019;11:E739. [PMID: 31405261 DOI: 10.3390/v11080739] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
472 Lin LL, Shan JJ, Xie T, Xu JY, Shen CS, Di LQ, Chen JB, Wang SC. Application of Traditional Chinese Medical Herbs in Prevention and Treatment of Respiratory Syncytial Virus. Evid Based Complement Alternat Med 2016;2016:6082729. [PMID: 27688789 DOI: 10.1155/2016/6082729] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
473 Campbell H, Bont L, Nair H. Respiratory syncytial virus (RSV) disease - new data needed to guide future policy. J Glob Health 2015;5:020101. [PMID: 26755941 DOI: 10.7189/jogh.05.020101] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.3] [Reference Citation Analysis]
474 Efstathiou C, Abidi SH, Harker J, Stevenson NJ. Revisiting respiratory syncytial virus's interaction with host immunity, towards novel therapeutics. Cell Mol Life Sci 2020;77:5045-58. [PMID: 32556372 DOI: 10.1007/s00018-020-03557-0] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
475 Wang L, Piedra PA, Avadhanula V, Durigon EL, Machablishvili A, López MR, Thornburg NJ, Peret TCT. Duplex real-time RT-PCR assay for detection and subgroup-specific identification of human respiratory syncytial virus. J Virol Methods 2019;271:113676. [PMID: 31181218 DOI: 10.1016/j.jviromet.2019.113676] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
476 Thongpan I, Mauleekoonphairoj J, Vichiwattana P, Korkong S, Wasitthankasem R, Vongpunsawad S, Poovorawan Y. Respiratory syncytial virus genotypes NA1, ON1, and BA9 are prevalent in Thailand, 2012-2015. PeerJ 2017;5:e3970. [PMID: 29085762 DOI: 10.7717/peerj.3970] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
477 Noveroske DB, Warren JL, Pitzer VE, Weinberger DM. Local variations in the timing of RSV epidemics. BMC Infect Dis 2016;16:674. [PMID: 27835988 DOI: 10.1186/s12879-016-2004-2] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
478 Noton SL, Nagendra K, Dunn EF, Mawhorter ME, Yu Q, Fearns R. Respiratory Syncytial Virus Inhibitor AZ-27 Differentially Inhibits Different Polymerase Activities at the Promoter. J Virol 2015;89:7786-98. [PMID: 25995255 DOI: 10.1128/JVI.00530-15] [Cited by in Crossref: 36] [Cited by in F6Publishing: 21] [Article Influence: 5.1] [Reference Citation Analysis]
479 Caballero MT, Polack FP. Respiratory syncytial virus is an "opportunistic" killer. Pediatr Pulmonol 2018;53:664-7. [PMID: 29461021 DOI: 10.1002/ppul.23963] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 2.8] [Reference Citation Analysis]
480 Green CA, Scarselli E, Sande CJ, Thompson AJ, de Lara CM, Taylor KS, Haworth K, Del Sorbo M, Angus B, Siani L, Di Marco S, Traboni C, Folgori A, Colloca S, Capone S, Vitelli A, Cortese R, Klenerman P, Nicosia A, Pollard AJ. Chimpanzee adenovirus- and MVA-vectored respiratory syncytial virus vaccine is safe and immunogenic in adults. Sci Transl Med 2015;7:300ra126. [PMID: 26268313 DOI: 10.1126/scitranslmed.aac5745] [Cited by in Crossref: 88] [Cited by in F6Publishing: 79] [Article Influence: 14.7] [Reference Citation Analysis]
481 Rostad CA, Maillis AN, Lai K, Bakshi N, Jerris RC, Lane PA, Yee ME, Yildirim I. The burden of respiratory syncytial virus infections among children with sickle cell disease. Pediatr Blood Cancer 2021;68:e28759. [PMID: 33034160 DOI: 10.1002/pbc.28759] [Reference Citation Analysis]
482 Rallabhandi P, Phillips RL, Boukhvalova MS, Pletneva LM, Shirey KA, Gioannini TL, Weiss JP, Chow JC, Hawkins LD, Vogel SN, Blanco JC. Respiratory syncytial virus fusion protein-induced toll-like receptor 4 (TLR4) signaling is inhibited by the TLR4 antagonists Rhodobacter sphaeroides lipopolysaccharide and eritoran (E5564) and requires direct interaction with MD-2. mBio 2012;3:e00218-12. [PMID: 22872782 DOI: 10.1128/mBio.00218-12] [Cited by in Crossref: 74] [Cited by in F6Publishing: 48] [Article Influence: 7.4] [Reference Citation Analysis]
483 Haider MSH, Khan WH, Deeba F, Ali S, Ahmed A, Naqvi IH, Dohare R, Alsenaidy HA, Alsenaidy AM, Broor S, Parveen S. BA9 lineage of respiratory syncytial virus from across the globe and its evolutionary dynamics. PLoS One 2018;13:e0193525. [PMID: 29694383 DOI: 10.1371/journal.pone.0193525] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 4.0] [Reference Citation Analysis]
484 Owczarczyk AB, Schaller MA, Reed M, Rasky AJ, Lombard DB, Lukacs NW. Sirtuin 1 Regulates Dendritic Cell Activation and Autophagy during Respiratory Syncytial Virus-Induced Immune Responses. J Immunol 2015;195:1637-46. [PMID: 26157176 DOI: 10.4049/jimmunol.1500326] [Cited by in Crossref: 38] [Cited by in F6Publishing: 37] [Article Influence: 5.4] [Reference Citation Analysis]
485 Ramezannia Z, Sadeghi J, Abdoli Oskouie S, Ahangarzadeh Rezaee M, Bannazadeh Baghi H, Azadi A, Ahangar Oskouee M. Evaluation of Human Respiratory Syncytial Virus and Human Parainfluenza Virus Type 3 among Hospitalized Children in Northwest of Iran. Can J Infect Dis Med Microbiol 2021;2021:2270307. [PMID: 34603564 DOI: 10.1155/2021/2270307] [Reference Citation Analysis]
486 Garegnani L, Styrmisdóttir L, Roson Rodriguez P, Escobar Liquitay CM, Esteban I, Franco JV. Palivizumab for preventing severe respiratory syncytial virus (RSV) infection in children. Cochrane Database Syst Rev 2021;11:CD013757. [PMID: 34783356 DOI: 10.1002/14651858.CD013757.pub2] [Reference Citation Analysis]
487 Breiman RF, Cosmas L, Njenga M, Williamson J, Mott JA, Katz MA, Erdman DD, Schneider E, Oberste M, Neatherlin JC, Njuguna H, Ondari DM, Odero K, Okoth GO, Olack B, Wamola N, Montgomery JM, Fields BS, Feikin DR. Severe acute respiratory infection in children in a densely populated urban slum in Kenya, 2007-2011. BMC Infect Dis 2015;15:95. [PMID: 25879805 DOI: 10.1186/s12879-015-0827-x] [Cited by in Crossref: 35] [Cited by in F6Publishing: 37] [Article Influence: 5.0] [Reference Citation Analysis]
488 Taleb SA, Al Thani AA, Al Ansari K, Yassine HM. Human respiratory syncytial virus: pathogenesis, immune responses, and current vaccine approaches. Eur J Clin Microbiol Infect Dis 2018;37:1817-27. [PMID: 29876771 DOI: 10.1007/s10096-018-3289-4] [Cited by in Crossref: 30] [Cited by in F6Publishing: 25] [Article Influence: 7.5] [Reference Citation Analysis]
489 Hsu CH, Lin CY, Chi H, Chang JH, Hung HY, Kao HA, Peng CC, Jim WT. Prolonged seasonality of respiratory syncytial virus infection among preterm infants in a subtropical climate. PLoS One 2014;9:e110166. [PMID: 25333346 DOI: 10.1371/journal.pone.0110166] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 2.1] [Reference Citation Analysis]
490 Lukacs NW, Malinczak CA. Harnessing Cellular Immunity for Vaccination against Respiratory Viruses. Vaccines (Basel) 2020;8:783. [PMID: 33371275 DOI: 10.3390/vaccines8040783] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
491 Rey-Jurado E, Bohmwald K, Gálvez NMS, Becerra D, Porcelli SA, Carreño LJ, Kalergis AM. Contribution of NKT cells to the immune response and pathogenesis triggered by respiratory viruses. Virulence 2020;11:580-93. [PMID: 32463330 DOI: 10.1080/21505594.2020.1770492] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
492 Dayakar S, Pillai HR, Thulasi VP, Nair RR. Development of a multiplex RT-PCR for simultaneous diagnosis of human metapneumovirus (HMPV) and human respiratory syncytial virus (HRSV) from clinical specimens. Virusdisease 2016;27:375-81. [PMID: 28004017 DOI: 10.1007/s13337-016-0348-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
493 Ali A, Yousafzai MT, Waris R, Jafri F, Aziz F, Abbasi IN, Zaidi A. RSV associated hospitalizations in children in Karachi, Pakistan: Implications for vaccine prevention strategies. J Med Virol 2017;89:1151-7. [PMID: 28092107 DOI: 10.1002/jmv.24768] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
494 Schepens B, Sedeyn K, Vande Ginste L, De Baets S, Schotsaert M, Roose K, Houspie L, Van Ranst M, Gilbert B, van Rooijen N, Fiers W, Piedra P, Saelens X. Protection and mechanism of action of a novel human respiratory syncytial virus vaccine candidate based on the extracellular domain of small hydrophobic protein. EMBO Mol Med 2014;6:1436-54. [PMID: 25298406 DOI: 10.15252/emmm.201404005] [Cited by in Crossref: 36] [Cited by in F6Publishing: 35] [Article Influence: 5.1] [Reference Citation Analysis]
495 Johnson SM, McNally BA, Ioannidis I, Flano E, Teng MN, Oomens AG, Walsh EE, Peeples ME. Respiratory Syncytial Virus Uses CX3CR1 as a Receptor on Primary Human Airway Epithelial Cultures. PLoS Pathog 2015;11:e1005318. [PMID: 26658574 DOI: 10.1371/journal.ppat.1005318] [Cited by in Crossref: 129] [Cited by in F6Publishing: 115] [Article Influence: 18.4] [Reference Citation Analysis]
496 Fonceca AM, Chopra A, Levy A, Noakes PS, Poh MW, Bear NL, Prescott S, Everard ML. Infective respiratory syncytial virus is present in human cord blood samples and most prevalent during winter months. PLoS One 2017;12:e0173738. [PMID: 28437435 DOI: 10.1371/journal.pone.0173738] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
497 Razanajatovo NH, Richard V, Hoffmann J, Reynes JM, Razafitrimo GM, Randremanana RV, Heraud JM. Viral etiology of influenza-like illnesses in Antananarivo, Madagascar, July 2008 to June 2009. PLoS One 2011;6:e17579. [PMID: 21390235 DOI: 10.1371/journal.pone.0017579] [Cited by in Crossref: 54] [Cited by in F6Publishing: 57] [Article Influence: 4.9] [Reference Citation Analysis]
498 Shi T, McLean K, Campbell H, Nair H. Aetiological role of common respiratory viruses in acute lower respiratory infections in children under five years: A systematic review and meta-analysis. J Glob Health 2015;5:010408. [PMID: 26445672 DOI: 10.7189/jogh.05.010408] [Cited by in Crossref: 48] [Cited by in F6Publishing: 88] [Article Influence: 6.9] [Reference Citation Analysis]
499 Nam HH, Ison MG. Respiratory Syncytial Virus. Semin Respir Crit Care Med 2021;42:788-99. [PMID: 34918321 DOI: 10.1055/s-0041-1736182] [Reference Citation Analysis]
500 Dapat C, Kumaki S, Sakurai H, Nishimura H, Labayo HKM, Okamoto M, Saito M, Oshitani H. Gene signature of children with severe respiratory syncytial virus infection. Pediatr Res 2021;89:1664-72. [PMID: 33510411 DOI: 10.1038/s41390-020-01347-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
501 Yun MR, Kim AR, Lee HS, Kim DW, Lee WJ, Kim K, Kim SS, Kim YJ. Complete genome sequences of human respiratory syncytial virus genotype a and B isolates from South Korea. Genome Announc 2015;3:e00332-15. [PMID: 25908140 DOI: 10.1128/genomeA.00332-15] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
502 Ang LW, Mak TM, Cui L, Leo YS, Lee VJM, Lin RT. Characterisation of respiratory syncytial virus activity in children and adults presenting with acute respiratory illness at primary care clinics in Singapore, 2014-2018. Influenza Other Respir Viruses 2020;14:412-9. [PMID: 32090482 DOI: 10.1111/irv.12730] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
503 Hasegawa K, Jartti T, Mansbach JM, Laham FR, Jewell AM, Espinola JA, Piedra PA, Camargo CA Jr. Respiratory syncytial virus genomic load and disease severity among children hospitalized with bronchiolitis: multicenter cohort studies in the United States and Finland. J Infect Dis 2015;211:1550-9. [PMID: 25425699 DOI: 10.1093/infdis/jiu658] [Cited by in Crossref: 88] [Cited by in F6Publishing: 87] [Article Influence: 11.0] [Reference Citation Analysis]
504 Banerjee D, Kanwar N, Hassan F, Essmyer C, Selvarangan R. Comparison of Six Sample-to-Answer Influenza A/B and Respiratory Syncytial Virus Nucleic Acid Amplification Assays Using Respiratory Specimens from Children. J Clin Microbiol 2018;56:e00930-18. [PMID: 30185508 DOI: 10.1128/JCM.00930-18] [Cited by in Crossref: 35] [Cited by in F6Publishing: 15] [Article Influence: 8.8] [Reference Citation Analysis]
505 Oliwa JN, Marais BJ. Vaccines to prevent pneumonia in children - a developing country perspective. Paediatr Respir Rev 2017;22:23-30. [PMID: 26364006 DOI: 10.1016/j.prrv.2015.08.004] [Cited by in Crossref: 4] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
506 Bozzola E, Ciarlitto C, Guolo S, Brusco C, Cerone G, Antilici L, Schettini L, Piscitelli AL, Chiara Vittucci A, Cutrera R, Raponi M, Villani A. Respiratory Syncytial Virus Bronchiolitis in Infancy: The Acute Hospitalization Cost. Front Pediatr 2020;8:594898. [PMID: 33537260 DOI: 10.3389/fped.2020.594898] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
507 Torow N, Marsland BJ, Hornef MW, Gollwitzer ES. Neonatal mucosal immunology. Mucosal Immunol 2017;10:5-17. [PMID: 27649929 DOI: 10.1038/mi.2016.81] [Cited by in Crossref: 63] [Cited by in F6Publishing: 60] [Article Influence: 10.5] [Reference Citation Analysis]
508 Zhu Y, Xu B, Li C, Chen Z, Cao L, Fu Z, Shang Y, Chen A, Deng L, Bao Y, Sun Y, Ning L, Yu S, Gu F, Liu C, Yin J, Shen A, Xie Z, Shen K. A Multicenter Study of Viral Aetiology of Community-Acquired Pneumonia in Hospitalized Children in Chinese Mainland. Virol Sin 2021. [PMID: 34523109 DOI: 10.1007/s12250-021-00437-0] [Reference Citation Analysis]
509 Masoud K, Hanna-Wakim R, Zaraket H, Kharroubi S, Araj GF, Matar GM, Dbaibo G. Viral Etiology of Acute Respiratory Infections in Pediatric Patients in Lebanon. Mediterr J Hematol Infect Dis 2019;11:e2019059. [PMID: 31700584 DOI: 10.4084/MJHID.2019.059] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
510 Morrison TG. Protein conformation in a vaccine matters. Oncotarget 2015;6:21781-2. [PMID: 26318167 DOI: 10.18632/oncotarget.5102] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
511 Lanaspa M, Annamalay AA, LeSouëf P, Bassat Q. Epidemiology, etiology, x-ray features, importance of co-infections and clinical features of viral pneumonia in developing countries. Expert Rev Anti Infect Ther 2014;12:31-47. [PMID: 24410617 DOI: 10.1586/14787210.2014.866517] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
512 Everard ML, Hind D, Ugonna K, Freeman J, Bradburn M, Cooper CL, Cross E, Maguire C, Cantrill H, Alexander J. SABRE: a multicentre randomised control trial of nebulised hypertonic saline in infants hospitalised with acute bronchiolitis. Thorax. 2014;69:1105-1112. [PMID: 25389139 DOI: 10.1136/thoraxjnl-2014-205953] [Cited by in Crossref: 67] [Cited by in F6Publishing: 58] [Article Influence: 9.6] [Reference Citation Analysis]
513 Rey-Jurado E, Kalergis AM. Immunological Features of Respiratory Syncytial Virus-Caused Pneumonia-Implications for Vaccine Design. Int J Mol Sci 2017;18:E556. [PMID: 28273842 DOI: 10.3390/ijms18030556] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 3.6] [Reference Citation Analysis]
514 Kenmoe S, Kengne-Nde C, Modiyinji AF, La Rosa G, Njouom R. Comparison of health care resource utilization among preterm and term infants hospitalized with Human Respiratory Syncytial Virus infections: A systematic review and meta-analysis of retrospective cohort studies. PLoS One 2020;15:e0229357. [PMID: 32084214 DOI: 10.1371/journal.pone.0229357] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
515 Jones BG, Sealy RE, Rudraraju R, Traina-Dorge VL, Finneyfrock B, Cook A, Takimoto T, Portner A, Hurwitz JL. Sendai virus-based RSV vaccine protects African green monkeys from RSV infection. Vaccine 2012;30:959-68. [PMID: 22119594 DOI: 10.1016/j.vaccine.2011.11.046] [Cited by in Crossref: 55] [Cited by in F6Publishing: 53] [Article Influence: 5.0] [Reference Citation Analysis]
516 Ugonna K, Bingle CD, Plant K, Wilson K, Everard ML. Macrophages are required for dendritic cell uptake of respiratory syncytial virus from an infected epithelium. PLoS One 2014;9:e91855. [PMID: 24651119 DOI: 10.1371/journal.pone.0091855] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
517 Schmidt R, Majer I, García Román N, Rivas Basterra A, Grubb E, Medrano López C. Palivizumab in the prevention of severe respiratory syncytial virus infection in children with congenital heart disease; a novel cost-utility modeling study reflecting evidence-based clinical pathways in Spain. Health Econ Rev 2017;7:47. [PMID: 29260345 DOI: 10.1186/s13561-017-0181-3] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
518 Turner P, Turner C, Watthanaworawit W, Carrara V, Cicelia N, Deglise C, Phares C, Ortega L, Nosten F. Respiratory virus surveillance in hospitalised pneumonia patients on the Thailand-Myanmar border. BMC Infect Dis 2013;13:434. [PMID: 24498873 DOI: 10.1186/1471-2334-13-434] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
519 Brasier AR, Zhou J. Validation of the epigenetic reader bromodomain-containing protein 4 (BRD4) as a therapeutic target for treatment of airway remodeling. Drug Discov Today 2020;25:126-32. [PMID: 31733396 DOI: 10.1016/j.drudis.2019.11.002] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 3.7] [Reference Citation Analysis]
520 Muralidharan A, Larocque L, Russell M, Creskey M, Li C, Chen W, Van Domselaar G, Cao J, Cyr T, Rosu-Myles M, Wang L, Li X. PD-1 of Sigmodon hispidus: Gene identification, characterization and preliminary evaluation of expression in inactivated RSV vaccine-induced enhanced respiratory disease. Sci Rep 2019;9:11638. [PMID: 31406266 DOI: 10.1038/s41598-019-48225-x] [Reference Citation Analysis]
521 Liu X, Liang B, Ngwuta J, Liu X, Surman S, Lingemann M, Kwong PD, Graham BS, Collins PL, Munir S. Attenuated Human Parainfluenza Virus Type 1 Expressing the Respiratory Syncytial Virus (RSV) Fusion (F) Glycoprotein from an Added Gene: Effects of Prefusion Stabilization and Packaging of RSV F. J Virol 2017;91:e01101-17. [PMID: 28835504 DOI: 10.1128/JVI.01101-17] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
522 Blanken MO, Frederix GW, Nibbelke EE, Koffijberg H, Sanders EAM, Rovers MM, Bont L; Dutch RSV Neonatal Network. Cost-effectiveness of rule-based immunoprophylaxis against respiratory syncytial virus infections in preterm infants. Eur J Pediatr 2018;177:133-44. [PMID: 29168012 DOI: 10.1007/s00431-017-3046-1] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 2.6] [Reference Citation Analysis]
523 Soto JA, Stephens LM, Waldstein KA, Canedo-Marroquín G, Varga SM, Kalergis AM. Current Insights in the Development of Efficacious Vaccines Against RSV. Front Immunol 2020;11:1507. [PMID: 32765520 DOI: 10.3389/fimmu.2020.01507] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
524 Kim AY, Jung SY, Choi JY, Kim GB, Kim YH, Shim WS, Kang IS, Jung JW. Retrospective Multicenter Study of Respiratory Syncytial Virus Prophylaxis in Korean Children with Congenital Heart Diseases. Korean Circ J 2016;46:719-26. [PMID: 27721865 DOI: 10.4070/kcj.2016.46.5.719] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
525 Garvey MI, Wilkinson MAC, Bradley CW, Biggs M, Reddy-Kolanu V, Osman H, Carmalt S, Holden E. Impact of a PCR point of care test for influenza A/B on an acute medical unit in a large UK teaching hospital: results of an observational, pre and post intervention study. Antimicrob Resist Infect Control 2019;8:120. [PMID: 31346461 DOI: 10.1186/s13756-019-0575-6] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
526 Swanson KA, Settembre EC, Shaw CA, Dey AK, Rappuoli R, Mandl CW, Dormitzer PR, Carfi A. Structural basis for immunization with postfusion respiratory syncytial virus fusion F glycoprotein (RSV F) to elicit high neutralizing antibody titers. Proc Natl Acad Sci U S A 2011;108:9619-24. [PMID: 21586636 DOI: 10.1073/pnas.1106536108] [Cited by in Crossref: 189] [Cited by in F6Publishing: 184] [Article Influence: 17.2] [Reference Citation Analysis]
527 Kamau E, Agoti CN, Lewa CS, Oketch J, Owor BE, Otieno GP, Bett A, Cane PA, Nokes DJ. Recent sequence variation in probe binding site affected detection of respiratory syncytial virus group B by real-time RT-PCR. J Clin Virol 2017;88:21-5. [PMID: 28107671 DOI: 10.1016/j.jcv.2016.12.011] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 5.4] [Reference Citation Analysis]
528 Cupul-Uicab LA, Terrazas-Medina EA, Hernández-Ávila M, Longnecker MP. Prenatal exposure to p,p'-DDE and p,p'-DDT in relation to lower respiratory tract infections in boys from a highly exposed area of Mexico. Environ Res 2014;132:19-23. [PMID: 24742723 DOI: 10.1016/j.envres.2014.03.017] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
529 Resch B. Burden of respiratory syncytial virus infection in young children. World J Clin Pediatr 2012; 1(3): 8-12 [PMID: 25254161 DOI: 10.5409/wjcp.v1.i3.8] [Cited by in CrossRef: 19] [Cited by in F6Publishing: 21] [Article Influence: 1.9] [Reference Citation Analysis]
530 Christiaansen AF, Knudson CJ, Weiss KA, Varga SM. The CD4 T cell response to respiratory syncytial virus infection. Immunol Res 2014;59:109-17. [PMID: 24838148 DOI: 10.1007/s12026-014-8540-1] [Cited by in Crossref: 55] [Cited by in F6Publishing: 51] [Article Influence: 7.9] [Reference Citation Analysis]
531 Chen J, Hu P, Zhou T, Zheng T, Zhou L, Jiang C, Pei X. Epidemiology and clinical characteristics of acute respiratory tract infections among hospitalized infants and young children in Chengdu, West China, 2009-2014. BMC Pediatr 2018;18:216. [PMID: 29976175 DOI: 10.1186/s12887-018-1203-y] [Cited by in Crossref: 22] [Cited by in F6Publishing: 16] [Article Influence: 5.5] [Reference Citation Analysis]
532 Srikantiah P, Vora P, Klugman KP. Assessing the Full Burden of Respiratory Syncytial Virus in Young Infants in Low- and Middle-Income Countries: The Importance of Community Mortality Studies. Clin Infect Dis 2021;73:S177-9. [PMID: 34472571 DOI: 10.1093/cid/ciab486] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
533 van Remmerden Y, Xu F, van Eldik M, Heldens JG, Huisman W, Widjojoatmodjo MN. An improved respiratory syncytial virus neutralization assay based on the detection of green fluorescent protein expression and automated plaque counting. Virol J 2012;9:253. [PMID: 23114196 DOI: 10.1186/1743-422X-9-253] [Cited by in Crossref: 26] [Cited by in F6Publishing: 19] [Article Influence: 2.6] [Reference Citation Analysis]
534 Xiao X, Tang A, Cox KS, Wen Z, Callahan C, Sullivan NL, Nahas DD, Cosmi S, Galli JD, Minnier M, Verma D, Babaoglu K, Su H, Bett AJ, Vora KA, Chen Z, Zhang L. Characterization of potent RSV neutralizing antibodies isolated from human memory B cells and identification of diverse RSV/hMPV cross-neutralizing epitopes. MAbs 2019;11:1415-27. [PMID: 31402751 DOI: 10.1080/19420862.2019.1654304] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
535 Yi H, Strauss JD, Ke Z, Alonas E, Dillard RS, Hampton CM, Lamb KM, Hammonds JE, Santangelo PJ, Spearman PW, Wright ER. Native immunogold labeling of cell surface proteins and viral glycoproteins for cryo-electron microscopy and cryo-electron tomography applications. J Histochem Cytochem 2015;63:780-92. [PMID: 26069287 DOI: 10.1369/0022155415593323] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 2.9] [Reference Citation Analysis]
536 Johnson TR, Rangel D, Graham BS, Brough DE, Gall JG. Genetic vaccine for respiratory syncytial virus provides protection without disease potentiation. Mol Ther 2014;22:196-205. [PMID: 23752342 DOI: 10.1038/mt.2013.142] [Cited by in Crossref: 32] [Cited by in F6Publishing: 31] [Article Influence: 3.6] [Reference Citation Analysis]
537 Collins PL, Melero JA. Progress in understanding and controlling respiratory syncytial virus: still crazy after all these years. Virus Res 2011;162:80-99. [PMID: 21963675 DOI: 10.1016/j.virusres.2011.09.020] [Cited by in Crossref: 294] [Cited by in F6Publishing: 285] [Article Influence: 26.7] [Reference Citation Analysis]
538 Swanson KA, Balabanis K, Xie Y, Aggarwal Y, Palomo C, Mas V, Metrick C, Yang H, Shaw CA, Melero JA, Dormitzer PR, Carfi A. A monomeric uncleaved respiratory syncytial virus F antigen retains prefusion-specific neutralizing epitopes. J Virol 2014;88:11802-10. [PMID: 25078705 DOI: 10.1128/JVI.01225-14] [Cited by in Crossref: 28] [Cited by in F6Publishing: 20] [Article Influence: 3.5] [Reference Citation Analysis]
539 Baumeister E, Duque J, Varela T, Palekar R, Couto P, Savy V, Giovacchini C, Haynes AK, Rha B, Arriola CS, Gerber SI, Azziz-Baumgartner E. Timing of respiratory syncytial virus and influenza epidemic activity in five regions of Argentina, 2007-2016. Influenza Other Respir Viruses 2019;13:10-7. [PMID: 30051595 DOI: 10.1111/irv.12596] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
540 Schmidt ME, Meyerholz DK, Varga SM. Pre-existing neutralizing antibodies prevent CD8 T cell-mediated immunopathology following respiratory syncytial virus infection. Mucosal Immunol 2020;13:507-17. [PMID: 31844172 DOI: 10.1038/s41385-019-0243-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
541 Ciencewicki JM, Wang X, Marzec J, Serra ME, Bell DA, Polack FP, Kleeberger SR. A genetic model of differential susceptibility to human respiratory syncytial virus (RSV) infection. FASEB J 2014;28:1947-56. [PMID: 24421397 DOI: 10.1096/fj.13-239855] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 2.8] [Reference Citation Analysis]
542 Ke Z, Dillard RS, Chirkova T, Leon F, Stobart CC, Hampton CM, Strauss JD, Rajan D, Rostad CA, Taylor JV, Yi H, Shah R, Jin M, Hartert TV, Peebles RS Jr, Graham BS, Moore ML, Anderson LJ, Wright ER. The Morphology and Assembly of Respiratory Syncytial Virus Revealed by Cryo-Electron Tomography. Viruses 2018;10:E446. [PMID: 30127286 DOI: 10.3390/v10080446] [Cited by in Crossref: 36] [Cited by in F6Publishing: 28] [Article Influence: 9.0] [Reference Citation Analysis]
543 Khamis FA, Al-Kobaisi MF, Al-Areimi WS, Al-Kindi H, Al-Zakwani I. Epidemiology of respiratory virus infections among infants and young children admitted to hospital in Oman. J Med Virol 2012;84:1323-9. [PMID: 22711362 DOI: 10.1002/jmv.23330] [Cited by in Crossref: 29] [Cited by in F6Publishing: 29] [Article Influence: 2.9] [Reference Citation Analysis]
544 Moore ML, Stokes KL, Hartert TV. The impact of viral genotype on pathogenesis and disease severity: respiratory syncytial virus and human rhinoviruses. Curr Opin Immunol 2013;25:761-8. [PMID: 24455766 DOI: 10.1016/j.coi.2013.09.016] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 3.0] [Reference Citation Analysis]
545 Hassan I, Gaines KS, Hottel WJ, Wishy RM, Miller SE, Powers LS, Rutkowski DT, Monick MM. Inositol-requiring enzyme 1 inhibits respiratory syncytial virus replication. J Biol Chem 2014;289:7537-46. [PMID: 24497642 DOI: 10.1074/jbc.M113.510594] [Cited by in Crossref: 25] [Cited by in F6Publishing: 16] [Article Influence: 3.1] [Reference Citation Analysis]
546 Lefebvre A, Manoha C, Bour JB, Abbas R, Fournel I, Tiv M, Pothier P, Astruc K, Aho-Glélé LS. Human metapneumovirus in patients hospitalized with acute respiratory infections: A meta-analysis. J Clin Virol 2016;81:68-77. [PMID: 27337518 DOI: 10.1016/j.jcv.2016.05.015] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 2.5] [Reference Citation Analysis]
547 Jackson S, Peret TCT, Ziegler TT, Thornburg NJ, Besselaar T, Broor S, Barr I, Baumeister E, Chadha M, Chittaganpitch M, Darmaa B, Ellis J, Fasce R, Herring B, Herve K, Hirve S, Li Y, Pisareva M, Moen A, Naguib A, Palekar R, Potdar V, Siqueira M, Treurnicht F, Tivane A, Venter M, Wairagkar N, Zambon M, Zhang W. Results from the WHO external quality assessment for the respiratory syncytial virus pilot, 2016-17. Influenza Other Respir Viruses 2020;14:671-7. [PMID: 32730685 DOI: 10.1111/irv.12771] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
548 Giersing BK, Vekemans J, Nava S, Kaslow DC, Moorthy V; WHO Product Development for Vaccines Advisory Committee. Report from the World Health Organization's third Product Development for Vaccines Advisory Committee (PDVAC) meeting, Geneva, 8-10th June 2016. Vaccine 2019;37:7315-27. [PMID: 28262332 DOI: 10.1016/j.vaccine.2016.10.090] [Cited by in Crossref: 24] [Cited by in F6Publishing: 26] [Article Influence: 4.8] [Reference Citation Analysis]
549 Taylor S, Taylor RJ, Lustig RL, Schuck-Paim C, Haguinet F, Webb DJ, Logie J, Matias G, Fleming DM. Modelling estimates of the burden of respiratory syncytial virus infection in children in the UK. BMJ Open 2016;6:e009337. [PMID: 27256085 DOI: 10.1136/bmjopen-2015-009337] [Cited by in Crossref: 32] [Cited by in F6Publishing: 32] [Article Influence: 5.3] [Reference Citation Analysis]
550 Cohen DM, Kline J, May LS, Harnett GE, Gibson J, Liang SY, Rafique Z, Rodriguez CA, McGann KM Sr, Gaydos CA, Mayne D, Phillips D, Cohen J. Accurate PCR Detection of Influenza A/B and Respiratory Syncytial Viruses by Use of Cepheid Xpert Flu+RSV Xpress Assay in Point-of-Care Settings: Comparison to Prodesse ProFlu. J Clin Microbiol 2018;56:e01237-17. [PMID: 29142048 DOI: 10.1128/JCM.01237-17] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 4.5] [Reference Citation Analysis]
551 Bilawchuk LM, Griffiths CD, Jensen LD, Elawar F, Marchant DJ. The Susceptibilities of Respiratory Syncytial Virus to Nucleolin Receptor Blocking and Antibody Neutralization are Dependent upon the Method of Virus Purification. Viruses 2017;9:E207. [PMID: 28771197 DOI: 10.3390/v9080207] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
552 Melero JA, Mas V, McLellan JS. Structural, antigenic and immunogenic features of respiratory syncytial virus glycoproteins relevant for vaccine development. Vaccine 2017;35:461-8. [PMID: 27692522 DOI: 10.1016/j.vaccine.2016.09.045] [Cited by in Crossref: 36] [Cited by in F6Publishing: 34] [Article Influence: 6.0] [Reference Citation Analysis]
553 Stewart-Jones GB, Thomas PV, Chen M, Druz A, Joyce MG, Kong WP, Sastry M, Soto C, Yang Y, Zhang B, Chen L, Chuang GY, Georgiev IS, McLellan JS, Srivatsan S, Zhou T, Baxa U, Mascola JR, Graham BS, Kwong PD. A Cysteine Zipper Stabilizes a Pre-Fusion F Glycoprotein Vaccine for Respiratory Syncytial Virus. PLoS One 2015;10:e0128779. [PMID: 26098893 DOI: 10.1371/journal.pone.0128779] [Cited by in Crossref: 28] [Cited by in F6Publishing: 30] [Article Influence: 4.0] [Reference Citation Analysis]
554 Caballero MT, Serra ME, Acosta PL, Marzec J, Gibbons L, Salim M, Rodriguez A, Reynaldi A, Garcia A, Bado D, Buchholz UJ, Hijano DR, Coviello S, Newcomb D, Bellabarba M, Ferolla FM, Libster R, Berenstein A, Siniawaski S, Blumetti V, Echavarria M, Pinto L, Lawrence A, Ossorio MF, Grosman A, Mateu CG, Bayle C, Dericco A, Pellegrini M, Igarza I, Repetto HA, Grimaldi LA, Gudapati P, Polack NR, Althabe F, Shi M, Ferrero F, Bergel E, Stein RT, Peebles RS, Boothby M, Kleeberger SR, Polack FP. TLR4 genotype and environmental LPS mediate RSV bronchiolitis through Th2 polarization. J Clin Invest 2015;125:571-82. [PMID: 25555213 DOI: 10.1172/JCI75183] [Cited by in Crossref: 84] [Cited by in F6Publishing: 58] [Article Influence: 12.0] [Reference Citation Analysis]
555 Li Y, Tang P, Cai S, Peng J, Hua G. Organoid based personalized medicine: from bench to bedside. Cell Regen 2020;9:21. [PMID: 33135109 DOI: 10.1186/s13619-020-00059-z] [Cited by in F6Publishing: 9] [Reference Citation Analysis]
556 Ouizougun-Oubari M, Pereira N, Tarus B, Galloux M, Lassoued S, Fix J, Tortorici MA, Hoos S, Baron B, England P, Desmaële D, Couvreur P, Bontems F, Rey FA, Eléouët JF, Sizun C, Slama-Schwok A, Duquerroy S. A Druggable Pocket at the Nucleocapsid/Phosphoprotein Interaction Site of Human Respiratory Syncytial Virus. J Virol 2015;89:11129-43. [PMID: 26246564 DOI: 10.1128/JVI.01612-15] [Cited by in Crossref: 31] [Cited by in F6Publishing: 18] [Article Influence: 4.4] [Reference Citation Analysis]
557 Yassine HM, Sohail MU, Younes N, Nasrallah GK. Systematic Review of the Respiratory Syncytial Virus (RSV) Prevalence, Genotype Distribution, and Seasonality in Children from the Middle East and North Africa (MENA) Region. Microorganisms 2020;8:E713. [PMID: 32403364 DOI: 10.3390/microorganisms8050713] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
558 Hodgson D, Atkins KE, Baguelin M, Panovska-Griffiths J, Thorrington D, van Hoek AJ, Zhao H, Fragaszy E, Hayward AC, Pebody R. Estimates for quality of life loss due to Respiratory Syncytial Virus. Influenza Other Respir Viruses 2020;14:19-27. [PMID: 31625688 DOI: 10.1111/irv.12686] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
559 Gosert R, Naegele K, Hirsch HH. Comparing the Cobas Liat Influenza A/B and respiratory syncytial virus assay with multiplex nucleic acid testing. J Med Virol 2019;91:582-7. [PMID: 30345524 DOI: 10.1002/jmv.25344] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
560 Bishop-Williams KE, Sargeant JM, Berrang-Ford L, Edge VL, Cunsolo A, Harper SL. A protocol for a systematic literature review: comparing the impact of seasonal and meteorological parameters on acute respiratory infections in Indigenous and non-Indigenous peoples. Syst Rev 2017;6:19. [PMID: 28122603 DOI: 10.1186/s13643-016-0399-x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.4] [Reference Citation Analysis]
561 Patel SM, Jallow S, Boiditswe S, Madhi SA, Feemster KA, Steenhoff AP, Arscott-Mills T, Muthoga C, Ajibola G, Shapiro R, Shah SS, Cunningham CK, Kelly MS. Placental Transfer of Respiratory Syncytial Virus Antibody Among HIV-Exposed, Uninfected Infants. J Pediatric Infect Dis Soc 2020;9:349-56. [PMID: 31549157 DOI: 10.1093/jpids/piz056] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
562 Razanajatovo NH, Guillebaud J, Harimanana A, Rajatonirina S, Ratsima EH, Andrianirina ZZ, Rakotoariniaina H, Andriatahina T, Orelle A, Ratovoson R, Irinantenaina J, Rakotonanahary DA, Ramparany L, Randrianirina F, Richard V, Heraud JM. Epidemiology of severe acute respiratory infections from hospital-based surveillance in Madagascar, November 2010 to July 2013. PLoS One 2018;13:e0205124. [PMID: 30462659 DOI: 10.1371/journal.pone.0205124] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
563 Mayor A, Chesnay A, Desoubeaux G, Ternant D, Heuzé-Vourc'h N, Sécher T. Therapeutic Antibodies for the Treatment of Respiratory Tract Infections-Current Overview and Perspectives. Vaccines (Basel) 2021;9:151. [PMID: 33668613 DOI: 10.3390/vaccines9020151] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
564 Tregoning JS, Wang BL, McDonald JU, Yamaguchi Y, Harker JA, Goritzka M, Johansson C, Bukreyev A, Collins PL, Openshaw PJ. Neonatal antibody responses are attenuated by interferon-γ produced by NK and T cells during RSV infection. Proc Natl Acad Sci U S A 2013;110:5576-81. [PMID: 23509276 DOI: 10.1073/pnas.1214247110] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 3.0] [Reference Citation Analysis]
565 López-Sagaseta J, Malito E, Rappuoli R, Bottomley MJ. Self-assembling protein nanoparticles in the design of vaccines. Comput Struct Biotechnol J 2016;14:58-68. [PMID: 26862374 DOI: 10.1016/j.csbj.2015.11.001] [Cited by in Crossref: 153] [Cited by in F6Publishing: 143] [Article Influence: 21.9] [Reference Citation Analysis]
566 Xu J, Singhera GK, Dorscheid DR. Expression of surfactant protein D in airways of asthmatics and interleukin-13 modulation of surfactant protein D in human models of airway epithelium. Respir Res 2015;16:26. [PMID: 25848896 DOI: 10.1186/s12931-015-0177-7] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 1.7] [Reference Citation Analysis]
567 Emukule GO, Spreeuwenberg P, Chaves SS, Mott JA, Tempia S, Bigogo G, Nyawanda B, Nyaguara A, Widdowson MA, van der Velden K, Paget JW. Estimating influenza and respiratory syncytial virus-associated mortality in Western Kenya using health and demographic surveillance system data, 2007-2013. PLoS One 2017;12:e0180890. [PMID: 28686692 DOI: 10.1371/journal.pone.0180890] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
568 Guo Y, Li X, Sun X, Wang J, Yang X, Zhou X, Liu X, Liu W, Yuan J, Yao L, Li X, Shen L. Combined Aberrant Expression of NDRG2 and LDHA Predicts Hepatocellular Carcinoma Prognosis and Mediates the Anti-tumor Effect of Gemcitabine. Int J Biol Sci 2019;15:1771-86. [PMID: 31523182 DOI: 10.7150/ijbs.35094] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 4.3] [Reference Citation Analysis]
569 Sebina I, Phipps S. The Contribution of Neutrophils to the Pathogenesis of RSV Bronchiolitis. Viruses 2020;12:E808. [PMID: 32726921 DOI: 10.3390/v12080808] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
570 Hayden FG. Advances in antivirals for non-influenza respiratory virus infections. Influenza Other Respir Viruses 2013;7 Suppl 3:36-43. [PMID: 24215380 DOI: 10.1111/irv.12173] [Cited by in Crossref: 33] [Cited by in F6Publishing: 27] [Article Influence: 4.1] [Reference Citation Analysis]
571 Lu L, Yan Y, Yang B, Xiao Z, Feng X, Wang Y, Ji W, Mize M, Hao C, Chen Z. Epidemiological and clinical profiles of respiratory syncytial virus infection in hospitalized neonates in Suzhou, China. BMC Infect Dis 2015;15:431. [PMID: 26470889 DOI: 10.1186/s12879-015-1155-x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
572 Meng J, Stobart CC, Hotard AL, Moore ML. An overview of respiratory syncytial virus. PLoS Pathog 2014;10:e1004016. [PMID: 24763387 DOI: 10.1371/journal.ppat.1004016] [Cited by in Crossref: 62] [Cited by in F6Publishing: 58] [Article Influence: 7.8] [Reference Citation Analysis]
573 Vitelli A, Nicosia A. Virus vs. virus: adenovirus vectored vaccine to defeat respiratory syncytial virus. Ann Transl Med 2016;4:489. [PMID: 28149851 DOI: 10.21037/atm.2016.12.08] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
574 Wiegand MA, Gori-Savellini G, Gandolfo C, Papa G, Kaufmann C, Felder E, Ginori A, Disanto MG, Spina D, Cusi MG. A Respiratory Syncytial Virus Vaccine Vectored by a Stable Chimeric and Replication-Deficient Sendai Virus Protects Mice without Inducing Enhanced Disease. J Virol 2017;91:e02298-16. [PMID: 28250126 DOI: 10.1128/JVI.02298-16] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
575 Geller R, Andino R, Frydman J. Hsp90 inhibitors exhibit resistance-free antiviral activity against respiratory syncytial virus. PLoS One 2013;8:e56762. [PMID: 23460813 DOI: 10.1371/journal.pone.0056762] [Cited by in Crossref: 40] [Cited by in F6Publishing: 35] [Article Influence: 4.4] [Reference Citation Analysis]
576 Eichinger KM, Egaña L, Orend JG, Resetar E, Anderson KB, Patel R, Empey KM. Alveolar macrophages support interferon gamma-mediated viral clearance in RSV-infected neonatal mice. Respir Res 2015;16:122. [PMID: 26438053 DOI: 10.1186/s12931-015-0282-7] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 3.9] [Reference Citation Analysis]
577 Ochoa TJ, Bautista R, Dávila C, Salazar JA, Bazán C, Guerra O, Llanos JP, López L, Zea-Vera A, Ecker L. Respiratory syncytial virus-associated hospitalizations in pre-mature infants in Lima, Peru. Am J Trop Med Hyg 2014;91:1029-34. [PMID: 25294617 DOI: 10.4269/ajtmh.13-0648] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
578 Lambert L, Culley FJ. Innate Immunity to Respiratory Infection in Early Life. Front Immunol 2017;8:1570. [PMID: 29184555 DOI: 10.3389/fimmu.2017.01570] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 4.6] [Reference Citation Analysis]
579 Sørup S, Benn CS, Stensballe LG, Aaby P, Ravn H. Measles-mumps-rubella vaccination and respiratory syncytial virus-associated hospital contact. Vaccine 2015;33:237-45. [PMID: 25446818 DOI: 10.1016/j.vaccine.2014.07.110] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 2.1] [Reference Citation Analysis]
580 Boyoglu-Barnum S, Todd SO, Meng J, Barnum TR, Chirkova T, Haynes LM, Jadhao SJ, Tripp RA, Oomens AG, Moore ML, Anderson LJ. Mutating the CX3C Motif in the G Protein Should Make a Live Respiratory Syncytial Virus Vaccine Safer and More Effective. J Virol 2017;91:e02059-16. [PMID: 28275196 DOI: 10.1128/JVI.02059-16] [Cited by in Crossref: 31] [Cited by in F6Publishing: 25] [Article Influence: 6.2] [Reference Citation Analysis]
581 Moesker FM, van Kampen JJA, Aron G, Schutten M, van de Vijver DAMC, Koopmans MPG, Osterhaus ADME, Fraaij PLA. Diagnostic performance of influenza viruses and RSV rapid antigen detection tests in children in tertiary care. J Clin Virol 2016;79:12-7. [PMID: 27045454 DOI: 10.1016/j.jcv.2016.03.022] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
582 Broadbent L, Groves H, Shields MD, Power UF. Respiratory syncytial virus, an ongoing medical dilemma: an expert commentary on respiratory syncytial virus prophylactic and therapeutic pharmaceuticals currently in clinical trials. Influenza Other Respir Viruses 2015;9:169-78. [PMID: 25847510 DOI: 10.1111/irv.12313] [Cited by in Crossref: 43] [Cited by in F6Publishing: 37] [Article Influence: 7.2] [Reference Citation Analysis]
583 Mehedi M, Collins PL, Buchholz UJ. A novel host factor for human respiratory syncytial virus. Commun Integr Biol 2017;10:e1319025. [PMID: 28702128 DOI: 10.1080/19420889.2017.1319025] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
584 Simões EAF, Dani V, Potdar V, Crow R, Satav S, Chadha MS, Hessong D, Carosone-Link P, Palaskar S, Satav A. Mortality From Respiratory Syncytial Virus in Children Under 2 Years of Age: A Prospective Community Cohort Study in Rural Maharashtra, India. Clin Infect Dis 2021;73:S193-202. [PMID: 34472578 DOI: 10.1093/cid/ciab481] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
585 Durigon GS, Oliveira DB, Felicio MC, Finelli C, Pereira MF, Storni JG, Caldeira RN, Berezin RC, Durigon EL, Berezin EN. Poor outcome of acute respiratory infection in young children with underlying health condition in Brazil. Int J Infect Dis 2015;34:3-7. [PMID: 25747778 DOI: 10.1016/j.ijid.2015.03.003] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
586 Ohol YM, Wang Z, Kemble G, Duke G. Direct Inhibition of Cellular Fatty Acid Synthase Impairs Replication of Respiratory Syncytial Virus and Other Respiratory Viruses. PLoS One 2015;10:e0144648. [PMID: 26659560 DOI: 10.1371/journal.pone.0144648] [Cited by in Crossref: 28] [Cited by in F6Publishing: 30] [Article Influence: 4.0] [Reference Citation Analysis]
587 Ascough S, Paterson S, Chiu C. Induction and Subversion of Human Protective Immunity: Contrasting Influenza and Respiratory Syncytial Virus. Front Immunol 2018;9:323. [PMID: 29552008 DOI: 10.3389/fimmu.2018.00323] [Cited by in Crossref: 28] [Cited by in F6Publishing: 23] [Article Influence: 7.0] [Reference Citation Analysis]
588 Prasad N, Trenholme AA, Huang QS, Thompson MG, Pierse N, Widdowson MA, Wood T, Seeds R, Taylor S, Grant CC, Newbern EC; SHIVERS team. Interactive effects of age and respiratory virus on severe lower respiratory infection. Epidemiol Infect 2018;146:1861-9. [PMID: 30047350 DOI: 10.1017/S0950268818002017] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
589 Barlotta A, Pirillo P, Stocchero M, Donato F, Giordano G, Bont L, Zanconato S, Carraro S, Baraldi E. Metabolomic Profiling of Infants With Recurrent Wheezing After Bronchiolitis. J Infect Dis 2019;219:1216-23. [PMID: 30445537 DOI: 10.1093/infdis/jiy659] [Cited by in Crossref: 8] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
590 Bracht M, Basevitz D, Cranis M, Paulley R. Impact of respiratory syncytial virus: the nurse's perspective. Drugs R D 2011;11:215-26. [PMID: 21902285 DOI: 10.2165/11593140-000000000-00000] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
591 Das S, St Croix C, Good M, Chen J, Zhao J, Hu S, Ross M, Myerburg MM, Pilewski JM, Williams J, Wenzel SE, Kolls JK, Ray A, Ray P. Interleukin-22 Inhibits Respiratory Syncytial Virus Production by Blocking Virus-Mediated Subversion of Cellular Autophagy. iScience 2020;23:101256. [PMID: 32580124 DOI: 10.1016/j.isci.2020.101256] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
592 Lindell DM, Morris SB, White MP, Kallal LE, Lundy PK, Hamouda T, Baker JR Jr, Lukacs NW. A novel inactivated intranasal respiratory syncytial virus vaccine promotes viral clearance without Th2 associated vaccine-enhanced disease. PLoS One 2011;6:e21823. [PMID: 21789184 DOI: 10.1371/journal.pone.0021823] [Cited by in Crossref: 53] [Cited by in F6Publishing: 47] [Article Influence: 4.8] [Reference Citation Analysis]
593 Popescu CM, Ursache AL, Feketea G, Bocsan C, Jimbu L, Mesaros O, Edwards M, Wang H, Berceanu I, Neaga A, Zdrenghea M. Are Community Acquired Respiratory Viral Infections an Underestimated Burden in Hematology Patients? Microorganisms 2019;7:E521. [PMID: 31684063 DOI: 10.3390/microorganisms7110521] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
594 Moesker FM, van Kampen JJ, van der Eijk AA, van Rossum AM, de Hoog M, Schutten M, Smits SL, Bodewes R, Osterhaus AD, Fraaij PL. Human bocavirus infection as a cause of severe acute respiratory tract infection in children. Clin Microbiol Infect 2015;21:964.e1-8. [PMID: 26100374 DOI: 10.1016/j.cmi.2015.06.014] [Cited by in Crossref: 29] [Cited by in F6Publishing: 29] [Article Influence: 4.1] [Reference Citation Analysis]
595 Rahman MM, Wong KK, Hanafiah A, Isahak I. Influenza and Respiratory Syncytial viral infections in Malaysia: Demographic and Clinical perspective. Pak J Med Sci 2014;30:161-5. [PMID: 24639853 DOI: 10.12669/pjms.301.4272] [Reference Citation Analysis]
596 Brand SP, Munywoki P, Walumbe D, Keeling MJ, Nokes DJ. Reducing respiratory syncytial virus (RSV) hospitalization in a lower-income country by vaccinating mothers-to-be and their households. Elife 2020;9:e47003. [PMID: 32216871 DOI: 10.7554/eLife.47003] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
597 Otieno JR, Kamau EM, Oketch JW, Ngoi JM, Gichuki AM, Binter Š, Otieno GP, Ngama M, Agoti CN, Cane PA, Kellam P, Cotten M, Lemey P, Nokes DJ. Whole genome analysis of local Kenyan and global sequences unravels the epidemiological and molecular evolutionary dynamics of RSV genotype ON1 strains. Virus Evol 2018;4:vey027. [PMID: 30271623 DOI: 10.1093/ve/vey027] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.8] [Reference Citation Analysis]
598 Wegzyn C, Toh LK, Notario G, Biguenet S, Unnebrink K, Park C, Makari D, Norton M. Safety and Effectiveness of Palivizumab in Children at High Risk of Serious Disease Due to Respiratory Syncytial Virus Infection: A Systematic Review. Infect Dis Ther 2014;3:133-58. [PMID: 25297809 DOI: 10.1007/s40121-014-0046-6] [Cited by in Crossref: 47] [Cited by in F6Publishing: 44] [Article Influence: 5.9] [Reference Citation Analysis]
599 Zhang D, Mao H, Lou X, Pan J, Yan H, Tang H, Shu Y, Zhao Y, Cheng X, Tao H, Zhang Y, Ma X. Clinical evaluation of a panel of multiplex quantitative real-time reverse transcription polymerase chain reaction assays for the detection of 16 respiratory viruses associated with community-acquired pneumonia. Arch Virol 2018;163:2855-60. [PMID: 29961119 DOI: 10.1007/s00705-018-3921-8] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
600 Hong S, Ruan S, Greenberg Z, He M, McGill JL. Development of surface engineered antigenic exosomes as vaccines for respiratory syncytial virus. Sci Rep 2021;11:21358. [PMID: 34725399 DOI: 10.1038/s41598-021-00765-x] [Reference Citation Analysis]
601 Singh C, Angurana SK, Bora I, Jain N, Kaur K, Sarkar S. Clinico demographic profiling of the Respiratory syncytial virus (RSV) infected children admitted in tertiary care hospital in North India. J Family Med Prim Care 2021;10:1975-80. [PMID: 34195134 DOI: 10.4103/jfmpc.jfmpc_2406_20] [Reference Citation Analysis]
602 Yamaji Y, Yasui Y, Nakayama T. Development of Acquired Immunity following Repeated Respiratory Syncytial Virus Infections in Cotton Rats. PLoS One 2016;11:e0155777. [PMID: 27224021 DOI: 10.1371/journal.pone.0155777] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
603 Blodörn K, Hägglund S, Fix J, Dubuquoy C, Makabi-Panzu B, Thom M, Karlsson P, Roque JL, Karlstam E, Pringle J, Eléouët JF, Riffault S, Taylor G, Valarcher JF. Vaccine safety and efficacy evaluation of a recombinant bovine respiratory syncytial virus (BRSV) with deletion of the SH gene and subunit vaccines based on recombinant human RSV proteins: N-nanorings, P and M2-1, in calves with maternal antibodies. PLoS One 2014;9:e100392. [PMID: 24945377 DOI: 10.1371/journal.pone.0100392] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 2.8] [Reference Citation Analysis]
604 Guerra-Maupome M, Palmer MV, McGill JL, Sacco RE. Utility of the Neonatal Calf Model for Testing Vaccines and Intervention Strategies for Use against Human RSV Infection. Vaccines (Basel) 2019;7:E7. [PMID: 30626099 DOI: 10.3390/vaccines7010007] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
605 Kim AR, Lee DH, Lee SH, Rubino I, Choi HJ, Quan FS. Protection induced by virus-like particle vaccine containing tandem repeat gene of respiratory syncytial virus G protein. PLoS One 2018;13:e0191277. [PMID: 29338045 DOI: 10.1371/journal.pone.0191277] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 3.3] [Reference Citation Analysis]
606 Taylor G. Animal models of respiratory syncytial virus infection. Vaccine 2017;35:469-80. [PMID: 27908639 DOI: 10.1016/j.vaccine.2016.11.054] [Cited by in Crossref: 79] [Cited by in F6Publishing: 77] [Article Influence: 13.2] [Reference Citation Analysis]
607 Shrestha N, Gall FM, Mathieu C, Hierweger MM, Brügger M, Alves MP, Vesin J, Banfi D, Kalbermatter D, Horvat B, Chambon M, Turcatti G, Fotiadis D, Riedl R, Plattet P. Highly Potent Host-Specific Small-Molecule Inhibitor of Paramyxovirus and Pneumovirus Replication with High Resistance Barrier. mBio 2021;:e0262121. [PMID: 34724816 DOI: 10.1128/mBio.02621-21] [Reference Citation Analysis]
608 Krishnamoorthy N, Abdulnour RE, Walker KH, Engstrom BD, Levy BD. Specialized Proresolving Mediators in Innate and Adaptive Immune Responses in Airway Diseases. Physiol Rev 2018;98:1335-70. [PMID: 29717929 DOI: 10.1152/physrev.00026.2017] [Cited by in Crossref: 34] [Cited by in F6Publishing: 35] [Article Influence: 8.5] [Reference Citation Analysis]
609 Bénet T, Sánchez Picot V, Messaoudi M, Chou M, Eap T, Wang J, Shen K, Pape JW, Rouzier V, Awasthi S, Pandey N, Bavdekar A, Sanghavi S, Robinson A, Rakoto-Andrianarivelo M, Sylla M, Diallo S, Nymadawa P, Naranbat N, Russomando G, Basualdo W, Komurian-Pradel F, Endtz H, Vanhems P, Paranhos-Baccalà G; Global Approach to Biological Research, Infectious diseases and Epidemics in Low-income countries (GABRIEL) Network., Global Approach to Biological Research, Infectious diseases and Epidemics in Low-income countries (GABRIEL) Network. Microorganisms Associated With Pneumonia in Children <5 Years of Age in Developing and Emerging Countries: The GABRIEL Pneumonia Multicenter, Prospective, Case-Control Study. Clin Infect Dis 2017;65:604-12. [PMID: 28605562 DOI: 10.1093/cid/cix378] [Cited by in Crossref: 12] [Cited by in F6Publishing: 41] [Article Influence: 3.0] [Reference Citation Analysis]
610 Turner C, Turner P, Cararra V, Eh Lwe N, Watthanaworawit W, Day NP, White NJ, Goldblatt D, Nosten F. A high burden of respiratory syncytial virus associated pneumonia in children less than two years of age in a South East Asian refugee population. PLoS One 2012;7:e50100. [PMID: 23185545 DOI: 10.1371/journal.pone.0050100] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
611 Gomez-Casado C, Villaseñor A, Rodriguez-Nogales A, Bueno JL, Barber D, Escribese MM. Understanding Platelets in Infectious and Allergic Lung Diseases. Int J Mol Sci 2019;20:E1730. [PMID: 30965568 DOI: 10.3390/ijms20071730] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 5.3] [Reference Citation Analysis]
612 Sanders SL, Agwan S, Hassan M, van Driel ML, Del Mar CB. Immunoglobulin treatment for hospitalised infants and young children with respiratory syncytial virus infection. Cochrane Database Syst Rev 2019;8:CD009417. [PMID: 31446622 DOI: 10.1002/14651858.CD009417.pub2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
613 Grimwood K, Chang AB. Long-term effects of pneumonia in young children. Pneumonia (Nathan) 2015;6:101-14. [PMID: 31641584 DOI: 10.15172/pneu.2015.6/671] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
614 Ramagopal G, Brow E, Mannu A, Vasudevan J, Umadevi L. Demographic, Clinical and Hematological Profile of Children with Bronchiolitis: A Comparative Study between Respiratory Synctial Virus [RSV] and [Non RSV] Groups. J Clin Diagn Res 2016;10:SC05-8. [PMID: 27656520 DOI: 10.7860/JCDR/2016/20331.8262] [Cited by in Crossref: 1] [Cited by in F6Publishing: 6] [Article Influence: 0.2] [Reference Citation Analysis]
615 Penkert RR, Hankins JS, Young NS, Hurwitz JL. Vaccine Design Informed by Virus-Induced Immunity. Viral Immunol 2020;33:342-50. [PMID: 32366204 DOI: 10.1089/vim.2019.0138] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
616 Harshbarger W, Abeyrathne PD, Tian S, Huang Y, Chandramouli S, Bottomley MJ, Malito E. Improved epitope resolution of the prefusion trimer-specific antibody AM14 bound to the RSV F glycoprotein. MAbs 2021;13:1955812. [PMID: 34420474 DOI: 10.1080/19420862.2021.1955812] [Reference Citation Analysis]
617 Walsh EE. Respiratory Syncytial Virus Infection: An Illness for All Ages. Clin Chest Med 2017;38:29-36. [PMID: 28159159 DOI: 10.1016/j.ccm.2016.11.010] [Cited by in Crossref: 30] [Cited by in F6Publishing: 31] [Article Influence: 5.0] [Reference Citation Analysis]
618 Brunwasser SM, Hartert TV. Practical and Conceptual Considerations for the Primary Prevention of Asthma. Clin Chest Med 2019;40:1-11. [PMID: 30691705 DOI: 10.1016/j.ccm.2018.10.002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
619 Hiriote W, Gias EL, Welsh SH, Toms GL. An investigation of the genetic basis of increased susceptibility to neutralization by anti-fusion glycoprotein antibody arising on passage of human respiratory syncytial virus in cell culture. J Med Virol 2015;87:130-40. [PMID: 24861209 DOI: 10.1002/jmv.23980] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
620 Smith TRF, Schultheis K, Broderick KE. Nucleic acid-based vaccines targeting respiratory syncytial virus: Delivering the goods. Hum Vaccin Immunother 2017;13:2626-9. [PMID: 28881156 DOI: 10.1080/21645515.2017.1363134] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
621 Moore HC, Jacoby P, Hogan AB, Blyth CC, Mercer GN. Modelling the seasonal epidemics of respiratory syncytial virus in young children. PLoS One 2014;9:e100422. [PMID: 24968133 DOI: 10.1371/journal.pone.0100422] [Cited by in Crossref: 25] [Cited by in F6Publishing: 20] [Article Influence: 3.1] [Reference Citation Analysis]
622 Wathuo M, Medley GF, Nokes DJ, Munywoki PK. Quantification and determinants of the amount of respiratory syncytial virus (RSV) shed using real time PCR data from a longitudinal household study. Wellcome Open Res 2016;1:27. [PMID: 28066826 DOI: 10.12688/wellcomeopenres.10284.2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 8] [Article Influence: 0.2] [Reference Citation Analysis]
623 Li HM, Ghildyal R, Hu M, Tran KC, Starrs LM, Mills J, Teng MN, Jans DA. Respiratory Syncytial Virus Matrix Protein-Chromatin Association Is Key to Transcriptional Inhibition in Infected Cells. Cells 2021;10:2786. [PMID: 34685766 DOI: 10.3390/cells10102786] [Reference Citation Analysis]
624 Griffiths C, Drews SJ, Marchant DJ. Respiratory Syncytial Virus: Infection, Detection, and New Options for Prevention and Treatment. Clin Microbiol Rev 2017;30:277-319. [PMID: 27903593 DOI: 10.1128/CMR.00010-16] [Cited by in Crossref: 190] [Cited by in F6Publishing: 118] [Article Influence: 38.0] [Reference Citation Analysis]
625 Kwakkenbos MJ, van Helden PM, Beaumont T, Spits H. Stable long-term cultures of self-renewing B cells and their applications. Immunol Rev 2016;270:65-77. [PMID: 26864105 DOI: 10.1111/imr.12395] [Cited by in Crossref: 29] [Cited by in F6Publishing: 25] [Article Influence: 4.8] [Reference Citation Analysis]
626 Jozwik A, Habibi MS, Paras A, Zhu J, Guvenel A, Dhariwal J, Almond M, Wong EHC, Sykes A, Maybeno M, Del Rosario J, Trujillo-Torralbo MB, Mallia P, Sidney J, Peters B, Kon OM, Sette A, Johnston SL, Openshaw PJ, Chiu C. RSV-specific airway resident memory CD8+ T cells and differential disease severity after experimental human infection. Nat Commun 2015;6:10224. [PMID: 26687547 DOI: 10.1038/ncomms10224] [Cited by in Crossref: 141] [Cited by in F6Publishing: 130] [Article Influence: 20.1] [Reference Citation Analysis]
627 Appak Ö, Duman M, Belet N, Sayiner AA. Viral respiratory infections diagnosed by multiplex polymerase chain reaction in pediatric patients. J Med Virol 2019;91:731-7. [PMID: 30570759 DOI: 10.1002/jmv.25379] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
628 Bollani L, Baraldi E, Chirico G, Dotta A, Lanari M, Del Vecchio A, Manzoni P, Boldrini A, Paolillo P, Di Fabio S, Orfeo L, Stronati M, Romagnoli C; Italian Society of Neonatology. Revised recommendations concerning palivizumab prophylaxis for respiratory syncytial virus (RSV). Ital J Pediatr 2015;41:97. [PMID: 26670908 DOI: 10.1186/s13052-015-0203-x] [Cited by in Crossref: 45] [Cited by in F6Publishing: 43] [Article Influence: 6.4] [Reference Citation Analysis]
629 Hause AM, Avadhanula V, Maccato ML, Pinell PM, Bond N, Santarcangelo P, Ferlic-Stark L, Munoz FM, Piedra PA. A Cross-sectional Surveillance Study of the Frequency and Etiology of Acute Respiratory Illness Among Pregnant Women. J Infect Dis 2018;218:528-35. [PMID: 29741642 DOI: 10.1093/infdis/jiy167] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
630 Sánchez-Luna M, Medrano C, Lirio J; RISK-21 Study Group. Down syndrome as risk factor for respiratory syncytial virus hospitalization: A prospective multicenter epidemiological study. Influenza Other Respir Viruses 2017;11:157-64. [PMID: 27611835 DOI: 10.1111/irv.12431] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 3.7] [Reference Citation Analysis]
631 Harwig A, Landick R, Berkhout B. The Battle of RNA Synthesis: Virus versus Host. Viruses 2017;9:E309. [PMID: 29065472 DOI: 10.3390/v9100309] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 3.8] [Reference Citation Analysis]
632 Zylbersztejn A, Pembrey L, Goldstein H, Berbers G, Schepp R, van der Klis F, Sande C, Mason D, Wright J, Smyth R, Hardelid P. Respiratory syncytial virus in young children: community cohort study integrating serological surveys, questionnaire and electronic health records, Born in Bradford cohort, England, 2008 to 2013. Euro Surveill 2021;26. [PMID: 33573711 DOI: 10.2807/1560-7917.ES.2021.26.6.2000023] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
633 Picone S, Fabiano A, Roma D, Paolillo P. Comparing of two different epidemic seasons of bronchiolitis. Ital J Pediatr 2018;44:11. [PMID: 29338779 DOI: 10.1186/s13052-018-0454-4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
634 Wei T, Li D, Marcial D, Khan M, Lin MH, Snape N, Ghildyal R, Harrich D, Spann K. The eukaryotic elongation factor 1A is critical for genome replication of the paramyxovirus respiratory syncytial virus. PLoS One 2014;9:e114447. [PMID: 25479059 DOI: 10.1371/journal.pone.0114447] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
635 Yu J, Xie Z, Zhang T, Lu Y, Fan H, Yang D, Bénet T, Vanhems P, Shen K, Huang F, Han J, Li T, Gao Z, Ren L, Wang J. Comparison of the prevalence of respiratory viruses in patients with acute respiratory infections at different hospital settings in North China, 2012-2015. BMC Infect Dis 2018;18:72. [PMID: 29422011 DOI: 10.1186/s12879-018-2982-3] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
636 Paes B, Mitchell I, Li A, Harimoto T, Lanctôt KL. Respiratory-related hospitalizations following prophylaxis in the Canadian registry for palivizumab (2005-2012) compared to other international registries. Clin Dev Immunol 2013;2013:917068. [PMID: 23861694 DOI: 10.1155/2013/917068] [Cited by in Crossref: 28] [Cited by in F6Publishing: 27] [Article Influence: 3.1] [Reference Citation Analysis]
637 Leemans A, Boeren M, Van der Gucht W, Pintelon I, Roose K, Schepens B, Saelens X, Bailey D, Martinet W, Caljon G, Maes L, Cos P, Delputte P. Removal of the N-Glycosylation Sequon at Position N116 Located in p27 of the Respiratory Syncytial Virus Fusion Protein Elicits Enhanced Antibody Responses after DNA Immunization. Viruses 2018;10:E426. [PMID: 30110893 DOI: 10.3390/v10080426] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
638 Stollar F, Gervaix A, Argiroffo CB. Safely Discharging Infants with Bronchiolitis from an Emergency Department: A Five Step Guide for Pediatricians. PLoS One 2016;11:e0163217. [PMID: 27690359 DOI: 10.1371/journal.pone.0163217] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
639 McCallum GB, Morris PS, Chatfield MD, Maclennan C, White AV, Sloots TP, Mackay IM, Chang AB. A single dose of azithromycin does not improve clinical outcomes of children hospitalised with bronchiolitis: a randomised, placebo-controlled trial. PLoS One 2013;8:e74316. [PMID: 24086334 DOI: 10.1371/journal.pone.0074316] [Cited by in Crossref: 28] [Cited by in F6Publishing: 27] [Article Influence: 3.1] [Reference Citation Analysis]
640 Hosken N, Plikaytis B, Trujillo C, Mahmood K, Higgins D; Participating Laboratories Working Group. A multi-laboratory study of diverse RSV neutralization assays indicates feasibility for harmonization with an international standard. Vaccine 2017;35:3082-8. [PMID: 28476625 DOI: 10.1016/j.vaccine.2017.04.053] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
641 Lau JW, Kim YI, Murphy R, Newman R, Yang X, Zody M, DeVincenzo J, Grad YH. Deep sequencing of RSV from an adult challenge study and from naturally infected infants reveals heterogeneous diversification dynamics. Virology 2017;510:289-96. [PMID: 28779686 DOI: 10.1016/j.virol.2017.07.017] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
642 Schubert L, Steininger J, Lötsch F, Herdina AN, Redlberger-Fritz M, Tobudic S, Kundi M, Strassl R, Steininger C. Surveillance of respiratory syncytial virus infections in adults, Austria, 2017 to 2019. Sci Rep 2021;11:8939. [PMID: 33903713 DOI: 10.1038/s41598-021-88537-5] [Reference Citation Analysis]
643 Shi T, McAllister DA, O'Brien KL, Simoes EAF, Madhi SA, Gessner BD, Polack FP, Balsells E, Acacio S, Aguayo C, Alassani I, Ali A, Antonio M, Awasthi S, Awori JO, Azziz-Baumgartner E, Baggett HC, Baillie VL, Balmaseda A, Barahona A, Basnet S, Bassat Q, Basualdo W, Bigogo G, Bont L, Breiman RF, Brooks WA, Broor S, Bruce N, Bruden D, Buchy P, Campbell S, Carosone-Link P, Chadha M, Chipeta J, Chou M, Clara W, Cohen C, de Cuellar E, Dang DA, Dash-Yandag B, Deloria-Knoll M, Dherani M, Eap T, Ebruke BE, Echavarria M, de Freitas Lázaro Emediato CC, Fasce RA, Feikin DR, Feng L, Gentile A, Gordon A, Goswami D, Goyet S, Groome M, Halasa N, Hirve S, Homaira N, Howie SRC, Jara J, Jroundi I, Kartasasmita CB, Khuri-Bulos N, Kotloff KL, Krishnan A, Libster R, Lopez O, Lucero MG, Lucion F, Lupisan SP, Marcone DN, McCracken JP, Mejia M, Moisi JC, Montgomery JM, Moore DP, Moraleda C, Moyes J, Munywoki P, Mutyara K, Nicol MP, Nokes DJ, Nymadawa P, da Costa Oliveira MT, Oshitani H, Pandey N, Paranhos-Baccalà G, Phillips LN, Picot VS, Rahman M, Rakoto-Andrianarivelo M, Rasmussen ZA, Rath BA, Robinson A, Romero C, Russomando G, Salimi V, Sawatwong P, Scheltema N, Schweiger B, Scott JAG, Seidenberg P, Shen K, Singleton R, Sotomayor V, Strand TA, Sutanto A, Sylla M, Tapia MD, Thamthitiwat S, Thomas ED, Tokarz R, Turner C, Venter M, Waicharoen S, Wang J, Watthanaworawit W, Yoshida LM, Yu H, Zar HJ, Campbell H, Nair H; RSV Global Epidemiology Network. Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in young children in 2015: a systematic review and modelling study. Lancet 2017;390:946-58. [PMID: 28689664 DOI: 10.1016/S0140-6736(17)30938-8] [Cited by in Crossref: 815] [Cited by in F6Publishing: 527] [Article Influence: 163.0] [Reference Citation Analysis]
644 Esteban I, Stein RT, Polack FP. A Durable Relationship: Respiratory Syncytial Virus Bronchiolitis and Asthma past Their Golden Anniversary. Vaccines (Basel) 2020;8:E201. [PMID: 32357557 DOI: 10.3390/vaccines8020201] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
645 Outlaw VK, Cheloha RW, Jurgens EM, Bovier FT, Zhu Y, Kreitler DF, Harder O, Niewiesk S, Porotto M, Gellman SH, Moscona A. Engineering Protease-Resistant Peptides to Inhibit Human Parainfluenza Viral Respiratory Infection. J Am Chem Soc 2021;143:5958-66. [PMID: 33825470 DOI: 10.1021/jacs.1c01565] [Reference Citation Analysis]
646 Arnott A, Vong S, Mardy S, Chu S, Naughtin M, Sovann L, Buecher C, Beauté J, Rith S, Borand L, Asgari N, Frutos R, Guillard B, Touch S, Deubel V, Buchy P. A study of the genetic variability of human respiratory syncytial virus (HRSV) in Cambodia reveals the existence of a new HRSV group B genotype. J Clin Microbiol 2011;49:3504-13. [PMID: 21865418 DOI: 10.1128/JCM.01131-11] [Cited by in Crossref: 77] [Cited by in F6Publishing: 47] [Article Influence: 7.0] [Reference Citation Analysis]
647 Enkirch T, von Messling V. Ferret models of viral pathogenesis. Virology 2015;479-480:259-70. [PMID: 25816764 DOI: 10.1016/j.virol.2015.03.017] [Cited by in Crossref: 84] [Cited by in F6Publishing: 85] [Article Influence: 12.0] [Reference Citation Analysis]
648 Choudhary ML, Wadhwa BS, Jadhav SM, Chadha MS. Complete Genome Sequences of Two Human Respiratory Syncytial Virus Genotype A Strains from India, RSV-A/NIV1114046/11 and RSV-A/NIV1114073/11. Genome Announc 2013;1:e00165-13. [PMID: 23887906 DOI: 10.1128/genomeA.00165-13] [Cited by in Crossref: 17] [Cited by in F6Publishing: 10] [Article Influence: 1.9] [Reference Citation Analysis]
649 Xie Q, Wang Z, Ni F, Chen X, Ma J, Patel N, Lu H, Liu Y, Tian JH, Flyer D, Massare MJ, Ellingsworth L, Glenn G, Smith G, Wang Q. Structure basis of neutralization by a novel site II/IV antibody against respiratory syncytial virus fusion protein. PLoS One 2019;14:e0210749. [PMID: 30730999 DOI: 10.1371/journal.pone.0210749] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
650 Sharma A, Wu W, Sung B, Huang J, Tsao T, Li X, Gomi R, Tsuji M, Worgall S. Respiratory Syncytial Virus (RSV) Pulmonary Infection in Humanized Mice Induces Human Anti-RSV Immune Responses and Pathology. J Virol 2016;90:5068-74. [PMID: 26962219 DOI: 10.1128/JVI.00259-16] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 2.5] [Reference Citation Analysis]
651 Feng Q, Zhao H, Xu L, Xie Z. N6-Methyladenosine Modification and Its Regulation of Respiratory Viruses. Front Cell Dev Biol 2021;9:699997. [PMID: 34368152 DOI: 10.3389/fcell.2021.699997] [Reference Citation Analysis]
652 Palomo C, Mas V, Thom M, Vázquez M, Cano O, Terrón MC, Luque D, Taylor G, Melero JA. Influence of Respiratory Syncytial Virus F Glycoprotein Conformation on Induction of Protective Immune Responses. J Virol 2016;90:5485-98. [PMID: 27009962 DOI: 10.1128/JVI.00338-16] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 4.0] [Reference Citation Analysis]
653 Robbie GJ, Makari D, Harris B, Losonsky GA, Jafri HS. Randomized, Double-Blind Study of the Pharmacokinetics and Safety of Palivizumab Liquid Formulation Compared with Lyophilized Formulation. Infect Dis Ther 2014;3:203-14. [PMID: 25269648 DOI: 10.1007/s40121-014-0042-x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
654 Suryadevara M, Domachowske JB. Epidemiology and Seasonality of Childhood Respiratory Syncytial Virus Infections in the Tropics. Viruses 2021;13:696. [PMID: 33923823 DOI: 10.3390/v13040696] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
655 Veeranki SP, Gebretsadik T, Dorris SL, Mitchel EF, Hartert TV, Cooper WO, Tylavsky FA, Dupont W, Hartman TJ, Carroll KN. Association of folic acid supplementation during pregnancy and infant bronchiolitis. Am J Epidemiol 2014;179:938-46. [PMID: 24671071 DOI: 10.1093/aje/kwu019] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 2.9] [Reference Citation Analysis]
656 Yamaguchi-Sasaki T, Tokura S, Ogata Y, Kawaguchi T, Sugaya Y, Takahashi R, Iwakiri K, Abe-Kumasaka T, Yoshida I, Arikawa K, Sugiyama H, Kanuma K. Discovery of a Potent Dual Inhibitor of Wild-Type and Mutant Respiratory Syncytial Virus Fusion Proteins. ACS Med Chem Lett 2020;11:1145-51. [PMID: 32550994 DOI: 10.1021/acsmedchemlett.0c00008] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
657 Jordan PC, Stevens SK, Deval J. Nucleosides for the treatment of respiratory RNA virus infections. Antivir Chem Chemother 2018;26:2040206618764483. [PMID: 29562753 DOI: 10.1177/2040206618764483] [Cited by in Crossref: 58] [Cited by in F6Publishing: 53] [Article Influence: 19.3] [Reference Citation Analysis]
658 Gálvez NMS, Soto JA, Kalergis AM. New Insights Contributing to the Development of Effective Vaccines and Therapies to Reduce the Pathology Caused by hRSV. Int J Mol Sci 2017;18:E1753. [PMID: 28800119 DOI: 10.3390/ijms18081753] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
659 Patel RB, Mathur MB, Gould M, Uyeki TM, Bhattacharya J, Xiao Y, Khazeni N. Demographic and clinical predictors of mortality from highly pathogenic avian influenza A (H5N1) virus infection: CART analysis of international cases. PLoS One 2014;9:e91630. [PMID: 24667532 DOI: 10.1371/journal.pone.0091630] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 2.3] [Reference Citation Analysis]
660 Hashimoto K, Hosoya M. Neutralizing epitopes of RSV and palivizumab resistance in Japan. Fukushima J Med Sci 2017;63:127-34. [PMID: 28867684 DOI: 10.5387/fms.2017-09] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
661 Jans J, Wicht O, Widjaja I, Ahout IM, de Groot R, Guichelaar T, Luytjes W, de Jonge MI, de Haan CA, Ferwerda G. Characteristics of RSV-Specific Maternal Antibodies in Plasma of Hospitalized, Acute RSV Patients under Three Months of Age. PLoS One 2017;12:e0170877. [PMID: 28135305 DOI: 10.1371/journal.pone.0170877] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 3.4] [Reference Citation Analysis]
662 Palermo LM, Uppal M, Skrabanek L, Zumbo P, Germer S, Toussaint NC, Rima BK, Huey D, Niewiesk S, Porotto M, Moscona A. Features of Circulating Parainfluenza Virus Required for Growth in Human Airway. mBio 2016;7:e00235. [PMID: 26980833 DOI: 10.1128/mBio.00235-16] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
663 Rudan I, Campbell H, Marušić A, Sridhar D, Nair H, Adeloye D, Theodoratou E, Chan KY. Assembling GHERG: Could "academic crowd-sourcing" address gaps in global health estimates? J Glob Health 2015;5:010101. [PMID: 26445671 DOI: 10.7189/jogh.05.010101] [Cited by in Crossref: 33] [Cited by in F6Publishing: 23] [Article Influence: 4.7